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1. Summary & Zusammenfassung
Summary
Successful synthesis and folding of proteins is a prerequisite for cellular function and 
failure of protein homeostasis leads to disease or death. Within the cell, molecular 
chaperones  ensure  correct  protein  folding  or  aid  in  the  disposal  of  terminally 
misfolded  protein  substrates.  Among  these  chaperones,  small  heat  shock 
proteins (sHsps) are ATP-independent members of the proteostasis network, which 
are  known  to  inhibit  the  aggregation  of  their  protein  substrates  before  ATP-
dependent chaperones may take over. In the genomes of metazoans like C. elegans, 
a high number of sHsps are encoded and their specific functions that necessitate this 
variety are not yet understood.
In this work, I analyzed the so far under-researched C. elegans sHsp HSP-17. Unlike 
other sHsps, HSP-17 exhibited only weak activity in preventing aggregation of protein 
substrates. Instead, I could show in vitro that HSP-17 can promote the aggregation of 
protein substrates, which was previously demonstrated for yeast and bacterial sHsps 
and  is  a  first  demonstration  for  metazoan  sHsps.  HSP-17  co-precipitates  with 
substrates  and  potentially  modifies  the  aggregates. In  vivo,  C.  elegans reporter 
strains revealed that HSP-17 is abundant, most expressed in the alimentary system 
and the excretory tract.  HSP-17 colocalizes with  aggregates and pro-aggregation 
activity is present in vivo, which I demonstrated for the physiological substrate KIN-19 
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and  heterologously  expressed  amyloidogenic  polyQ  peptides.  By  physiological, 
biochemical  and  proteomic  analysis  I  showed that  HSP-17  activity  is  relevant for 
organismal fitness, reproduction and development and protective under heat, osmotic 
and biotic stress.
In  vivo microscopy,  short  generation times and a conserved proteostasis  network 
make C. elegans a powerful model organism for aging and disease. Humanized C. 
elegans strains  allow  bridging  the  gap  from  insights  into C.  elegans chaperone 
activity to understanding proteostasis in the human context. The amyloid  peptide 
can form amyloid fibrils and is associated with the neurodegenerative Alzheimer’s 
disease. 
In a second project, I contributed to the development and characterization of a novel 
model of A pathology in C. elegans. This new AD model employs sub-stoichiometric 
labeling to  allow live visualization of A aggregation in  distinct  cell  types such as 
neurons  or body  wall  muscle.  The  model  mirrors known  phenotypes  of A 
proteotoxicity  in  humans  and  existing C.  elegans A strains,  including  defects  in 
autophagy and the endo-membrane system which were demonstrated by proteomic, 
biochemical and physiological methods. Interestingly, a subset of neurons, the IL2 
neurons, is shown to be more vulnerable to A proteotoxicity and targeted depletion 
of A in  these  neurons  systemically  ameliorates  pathology.  Thereby,  the  model 
presents a new platform to assess the relevance of molecular chaperones such as 
sHsps in amyloidosis with a perspective on human disease.
Zusammenfassung
Die erfolgreiche Synthese und Faltung von Proteinen ist  eine Voraussetzung der 
Zellfunktion und ein Versagen der Proteinhomöostase führt zu Krankheit oder Tod. In 
der  Zelle  sichern  molekulare  Chaperone  die  korrekte  Faltung  der  Proteine  oder 
tragen zur  Entsorgung unwiederbringlich  fehlgefalteter  Proteinsubstrate bei.  Unter 
diesen Chaperonen sind kleine Hitzeschockproteine (sHsp) ein ATP-unabhängiger 
Teil des Proteostasenetzwerks, von denen bekannt ist, dass sie die Aggregation ihrer 
Proteinsubstrate inhibieren, bevor diese von anderen ATP-abhängigen Chaperonen 
weiter prozessiert werden. Die Genome von Metazoen wie C. elegans kodieren eine 
Vielzahl von sHsps und deren spezifische Funktionen, die diese Vielfalt erfordern, 
sind noch nicht bekannt.
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In  dieser  Arbeit  habe  ich  das  bisher  wenig  erforschte  sHsp  HSP-17 
aus C. elegans untersucht. Im Gegensatz zu anderen sHsps zeigte HSP-17 nur eine 
geringe  Aktivität  beim  Verhindern  der  Aggregation  von 
Proteinsubstraten. Stattdessen  konnte  ich in  vitro  zeigen, dass  HSP-17  die 
Aggregation von Modellsubstraten fördert, was im Vorfeld für bestimmte sHsps aus 
Hefe  und  Bakterien  beschrieben  und  hier  für  Metazoen-sHsps  erstmals  gezeigt 
wurde. HSP-17  kopräzipitiert  mit  Substraten  und  modifiziert  deren  Aggregate 
möglicherweise. In  vivo enthüllten C.  elegans-Reporterstämme,  dass  HSP-17  ein 
abundantes  Protein  ist,  welches  vorwiegend  im  Verdauungssystem  und  dem 
exkretorischen Kanal exprimiert wird. HSP-17 kolokalisiert mit Aggregaten, und seine 
aggregationsfördernde Aktivität  konnte ich  in  vivo für  das physiologische Substrat 
KIN-19 und  heterolog  exprimierte  polyQ-Peptide  validieren.  Durch  physiologische, 
biochemische und proteomische Analysen konnte ich zeigen, dass die Aktivität von 
HSP-17 für die Fitness, Reproduktion und Entwicklung relevant ist und unter Hitze-, 
osmotischem oder biotischem Stress schützend wirkt.
In  vivo Mikroskopie,  kurze  Generationszeiten  und  ein  konserviertes 
Proteostasenetzwerk  machen  C.  elegans zu  einem  attraktivem  Modellsystem  für 
Forschungsfragen  zu  Alterung  und  Krankheit.  Humanisierte C.  elegans-Stämme 
ermöglichen das Überbrücken der  Lücke von Erkenntnissen der  Chaperonaktivität 
in C.  elegans bis  zum  Verständnis  von  Proteostase  im  menschlichen  Kontext. 
Das Amyloid  ist ein Peptid, welches amyloide Fibrillen ausbilden kann und mit der 
Entstehung der neurodegenerativen Alzheimerschen Erkrankung assoziiert wird.
In  einem zweiten  Projekt  habe ich  zur  Entwicklung eines neuen Modelles für A-
Pathologie in C.  elegans  beigetragen,  welches substöchiometrische  Markierungen 
verwendet, um  eine  zeitnahe  Visualisierung der A-Aggregation  in  spezifischen 
Zelltypen  wie  Neuronen oder  Körperwandmuskeln  zu  ermöglichen. Das  Modell 
spiegelt  bekannte  Phänotypen der A-Proteotoxizität aus  Menschen 
und bestehenden C.  elegans A-Stämmen  wider,  einschließlich  Defekten der 
Autophagie und  des  Endomembranystems,  was hier  durch  proteomische, 
biochemische und physiologische Methoden gezeigt wurde. Interessanterweise zeigt 
eine  Untergruppe  der  Neuronen,  die  IL2-Neuronen,  eine  höhere  Anfälligkeit  für 
die Aggregation  und  Proteotoxizität  von  A1-42. Eine  gezielte  Reduktion von A1-42 
in IL2 Neuronen führt zu einer systemischen Reduktion der Pathologie. Somit bietet 
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das Modell eine neue Plattform, um die Bedeutung molekularer Chaperone, wie z. B. 
der  sHsps, für  Amyloidosen  zu  untersuchen, auch  im  Hinblick  auf  menschliche 
Erkrankungen.
2. Authorship Disclaimer
The  work  I  present  here  was  accomplished  at  the  Leibniz-Forschungsinstitut  für 
Molekulare Pharmakologie (FMP), in the research group and under the supervision 
of Prof. Dr. Janine Kirstein. Parts of my work were done in close collaboration with  
fellow researchers.  Because these data  are  indispensable  to  provide  a  complete 
context  of  the experiments carried out,  I  will  present  some data prepared by my 
colleagues in text or graphic form and this will be noted in the respective part of the 
results section. Colleagues who contributed data presented here are in particular, in  
order of the first data presented:
Alice Baumann, who provided intact protein QTof-MS analysis (Figure 6).
Dr. Fan Liu and Heike Stephanowitz of the MS core facility, who performed MS/MS 
experiments and support in their evaluation (Supplementary Tables 1 & 2, Figures 44 
& 45).
Dr.  Dmytro  Puchkov,  who  provided  the  preparation  and  imaging  of  electron 
microscopy samples, including TEM and CLEM data (Figures 23, 31, 36, 46).
The generation of a new C. elegans model of A pathology (presented as part 3.2) 
was carried out  in close cooperation with  Christian Gallrein.  I  refer  to  FLIM data 
generated by Christian Gallrein and we also shared work in molecular cloning and 
handling of  C. elegans  as noted in the text of that section. We also cooperated in 
generating the swim-exhaustion data presented in Figure 52.
Dr.  Sara  Ayala  Mariscal  and  I  worked  together  to  generate  the  lifespan  data 




The cell needs to generate proteins to carry out its biological tasks and their variety is 
enormous – on average, more than 20,000 different proteins in human cells. After 
synthesis at the ribosome, most proteins need to attain a correct three-dimensional 
folding state to be functional (1), which is inherent to their primary structure, but not 
guaranteed (2). Starting at synthesis, proteins are thermodynamically and kinetically 
challenged  and  at  risk  of  misfolding  with  potentially  deleterious  consequences. 
Hence, the large protein family of molecular chaperones supports nascent proteins in  
reaching the correct folding state and maintaining it throughout their lifetime (3). This 
provides a challenge as proteins face molecular crowding of 200-300 g protein / l 
within the cell,  which causes competition for correct folding and poses the risk of 
protein aggregation (4,5). Next to this cellular hindrance to protein folding, heat stress 
is the most common and ubiquitous non-physiological cause of protein misfolding 
and aggregation.  Molecular  chaperones,  whose expression  is  induced upon heat 
shock,  have  also  been  labeled  “heat  shock  proteins”  (HSPs),  although  their 
expression  is  not  exclusive  to  heat  stress  and  plays  a  role  under  constitutive, 
unstressed  conditions  (6).  Likewise,  oxidative  stress,  osmotic  stress  and  aging 
(among others) are risk factors of protein aggregation and induce the expression of 
chaperone proteins  (6-8). Finally, spontaneous mutations in protein sequences can 
destabilize the resulting protein  structure and chaperones buffer  such proteins to 
prevent  deleterious  consequences  or  enable  evolution  (9).  Proteins  that  become 
terminally misfolded or aggregated can be degraded by the cell, another process that 
is aided by molecular chaperones (1). 
The entire process of proteins attaining their  correct folding state against intrinsic 
challenges,  maintaining  it  against  external  insults  and  otherwise  salvaging  or 
degradation of aggregated proteins is known as protein homeostasis (proteostasis), 
the machinery behind this mechanism is the proteostasis network (PN). The eventual  
failure of  proteostasis  can lead to  protein  aggregation disease and is  not  only  a 
consequence, but also a cause of organismal aging (10).
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3.1.1. Molecular chaperones
The prominent involvement of  molecular chaperones in heat stress which lead to 
their labeling as heat shock proteins also became the basis for naming chaperone 
families: Hsp60 or the chaperonins, the Hsp70 family and their co-chaperones, the 
Hsp40 or J-proteins, Hsp90 and Hsp100 (3). These ATP-dependent chaperones are 
joined by  the  family  of  small  heat  shock proteins,  which  range in  individual  size 
between 12  and 43 kDa,  are  ATP-independent  (11,12) and  will  be  discussed  in 
section 2.2.
Notably, the Hsp100 family contains members such as yeast Hsp104 or E. coli ClpB, 
both of which work to resolubilize aggregated protein substrates in cooperation with 
Hsp70 and Hsp40 members (13,14). These disaggregases belong to the larger AAA+ 
protein family  which also contains AAA+ proteases that  target  their  substrates to 
degradation  (15).  The  Hsp100  chaperones  are  strikingly  absent  from  eukaryotic 
cytosol  (besides  mitochondria  and  plastids)  and  until  recently  this  has  led  to 
assumptions that disaggregases are absent from the eukaryotic cell at large (16). 
The Hsp70 members, or Hsc70 (“heat shock cognate”), for constitutive, heat shock 
independent  members,  are  almost  universal  chaperones that  recognize  and bind 
unfolded substrates. In addition, they can also aid in membrane transposition or the 
assembly of  select  protein  complexes,  making them the most  versatile  molecular 
chaperones (17). Hsp70 chaperones are monomeric and undergo an ATP-dependent 
substrate binding cycle that is strongly dependent on nucleotide exchange factors 
(NEFs) and J-proteins / Hsp40 members as co-chaperones (9). The Hsp40 proteins 
in particular aid the Hsp70 system by leading Hsp70 members to specific substrates 
and localizations or binding substrates themselves and delivering them to Hsp70. 
The J-domain  coined the  name J-protein  for  Hsp40 members  and  interacts  with 
Hsp70, stimulating ATPase activity. ATP-bound Hsp70 is open for substrate binding; 
interaction with the J-protein and the substrate leads to hydrolysis of ATP and the 
ADP-bound  Hsp70  has  a  strongly  reduced  on/off  ratio  for  the  protein  substrate. 
Finally,  ADP and the substrate are released by binding of  the NEF  (18).  The J-
proteins  are  highly  diverse  (with  49  different  members  in  humans  and  32  in  C. 
elegans) and share little common structure outside the J-domain, enabling the high 
versatility in combination with Hsp70 chaperones (19,20).
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3.1.2. Protein disaggregation and degradation
Although in yeast, Hsp70 members can disaggregate and refold aggregated protein 
substrates with the help of Hsp40 and Hsp100 chaperones  (21),  the genomes of 
higher eukaryotes do not encode Hsp100 members (16). Instead, disaggregation in 
metazoans  is  enabled  by  the  cooperation  of  Hsp70  with  Hsp40  members  and 
Hsp110  (22).  Members of the Hsp110 group are related to the Hsp70 chaperone 
family (not the Hsp100 family), have a nucleotide binding domain themselves and 
can act as NEFs for other Hsp70 chaperones  (23). Disaggregation by the human 
triad  of  Hsc70  (Hsp70  member),  Hdj1  (Hsp40  /  J-protein)  and  Apg2  (Hsp110 
member) is comparable in efficiency to the yeast system  in vitro and flexible, i.e., 
other Hsp110 members can be utilized. Intriguingly, Hsp110 chaperones are present 
in yeast, but cannot replace Hsp100 members in this function, and the NEF function, 
but not ATPase activity of Hsp110, is required for disaggregation (24). The metazoan 
disaggregation machinery was actually  demonstrated first  in  C. elegans (24) and 
involves the sole cytosolic nematode Hsp110 member HSP-110, combined with at 
least one J-protein (such as DNJ-12 or DNJ-13) and one Hsp70 member (i. e. HSP-
1). Interestingly, a tight stoichiometrical combination of type I (also: type A, e. g. DNJ-
12 in C. elegans) and type II (also: type B, e. g. DNJ-13 in C. elegans) J-proteins was 
shown  to  enable  significantly  more  effective  protein  disaggregation  in  this  triad 
compared to a single J-protein, showcasing the minute control of Hsp70 machinery 
by  its  cochaperones  (25).  Besides  amorphous  aggregates,  disaggregation  in 
metazoans extends to amyloids such as -synuclein fibrils, which are “pulled apart" 
by  the  same machinery  (consisting  of  Hsp70,  the  type B J-protein  DNAJB1 and 
Hsp110),  generating  non-toxic  monomers  (26).  The  same  was  demonstrated  for 
fibrils of the polyQ amyloid Huntingtin, where C. elegans HSP-1, DNJ-13 and HSP-
110 can prevent and revert  native or seeded amyloid formation by the huntingtin 
species HttEx1Q48 (Huntingtin exon 1, pathologically elongated polyQ stretch of 48 
glutamine  residues).  In  this  context  it  was  also  demonstrated  that  amorphous 
aggregates compete with amyloid fibrils for the disaggregation machinery (27).  This 
machinery,  which  controls  protein  aggregation  is  essential  for  viability,  be  it  in 
bacteria,  yeast  or  metazoans  and  particularly  under  (heat)  stressed  conditions 
(14,24,28). 
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As an additional layer of protection, proteins that are terminally misfolded and pose a 
risk  for  the  cell  can  be  targeted  to  degradation.  Soluble  protein  species  can  be 
guided to proteolysis by Hsp70 and its cochaperones (e.  g.  the NEF BAG1) – in  
eukaryotes, this happens via ubiquitination and the proteasome (29). As ubiquitin is 
absent in prokaryotes, AAA+ proteases (e. g. the Clp proteins that Hsp100 members 
belong to) perform proteolysis aided by their own set of adaptors and cochaperones, 
using  other  means  of  substrate  identification  (15).  In  contrast  to  this  targeted 
degradation of individual proteins, autophagy is a cellular mechanism of bulk self-
digestion, to generate nutrients under starvation or to eliminate biotic intrusions. In 
the context of proteostasis, autophagy is important because misfolded or aggregated 
proteins  can  become  substrates  and  be  degraded,  adding to  the  proteasomal 
pathway  (30). Hsp70  members,  paired  with  BAG3  as  NEF,  can  induce  the 
ubiquitination of protein substrates that failed to be folded correctly, targeting them 
for  autophagy.  This  is followed  by  the  binding  of  autophagic  adaptors  such  as 
p62/SQSTM-1  (itself  a  substrate)  identify  proteins  as  autophagy  substrates.  The 
adaptor recruits LC3 (human) or LGG-1 (C. elegans) to induce the formation of an 
autophagosome which eventually merges with a lysosome to recycle the degraded 
proteins (31).
3.1.3. Amyloids and neurodegeneration
Mutations in chaperone proteins, consistent expression of aggregation-prone protein 
substrates, repeated stress and sporadic or programmed effects of aging eventually 
overpower the PN, leading to the accumulation of aggregated proteotoxic species 
(32). Unchallenged misfolding and aggregation of proteins can lead to a variety of 
progressive diseases with common features despite them being caused by various 
proteins forming distinct aggregate species  (33). These protein misfolding diseases 
are  commonly  referred  to  as  neurodegenerative  diseases,  as  neurons  are  most 
vulnerable  to  proteostasis  failure  (34) and  consequently  include  afflictions  with 
cognitive  defects,  such  as  Alzheimer’s  disease  (AD)  or  frontotemporal  dementia 
(FTD), as well as motor dysfunction diseases such as amyotrophic lateral sclerosis 
(ALS),  Huntington’s  disease  (HD)  or  Parkinson’s  disease  (PD),  although  these 
symptoms are not exclusive  (35). Among different protein folding states, amyloids, 
consisting of stacked -sheets, present a thermodynamic sink and easily self-interact, 
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first forming oligomers and ultimately aggregating into insoluble amyloid fibrils. The 
formation of amyloids is a general property of peptides, although some proteins are 
particularly prone to it and some amyloids are functional within the cell. Proteostasis 
can be overwhelmed by amyloid  accumulation and many amyloidogenic peptides 
stand at the center of specific neurodegenerative diseases (36,37). 
First described over a century ago (38,39), AD has risen to be the most prominent 
neurodegenerative disease. AD poses a global  problem, being the most common 
cause of dementia (40) and leading to economic and social disturbance for societies 
and patients (41,42).  Although hereditary forms of AD exist and can manifest early in 
life, sporadic forms dominate (43) and while environmental factors play a role, aging 
is the primary risk factor (44). In hereditary cases, disease causing mutations mainly 
appear  in  the Amyloid Precursor  Protein (APP)  or  Presenilin-1/2  (PSEN-1/2)  (45). 
PSEN specifically affects cleavage of APP by -&γ-secretases, leading to the release 
of the amyloidogenic peptide amyloid-β1-42 (Aβ1-42; the 42 amino acid species is more 
proteotoxic  than  Aβ1-40), a  principal  proteotoxic  agent  in  AD  (46). The  generation 
of Aβ-peptides  by  cleavage  through  secretases from  APP  is  required  for 
neuronal viability  and  synaptic  plasticity  (47,48), but  the  ongoing  proteotoxic 
aggregation of Aβ both challenges the PN and is exacerbated by the PN declining in 
age (10). In early interpretations, the role of Aβ in AD on a biochemical level is the 
formation of aggregates that eventually accumulate in extracellular amyloid plaques, 
which would then cause all downstream symptoms of the disease such as systemic 
dysfunction and death of neurons. Placing this cumulative, proteotoxic aggregation of 
Aβ at the basis of AD is the “amyloid cascade hypothesis”  (49,50). 
Attempts at treatment have fallen short so far and recent findings mandate significant 
additions  to  this  hypothesis.  In  particular,  the  tau-protein  (MAPT),  forming 
intracellular  neurofibrillary  tangles  in  AD  pathology,  is  believed  to  be  equally 
important in proteotoxicity  (51) and both peptides interact in a proteotoxic feedback 
loop  (52).  More  so  than  amyloid  plaques,  the  oligomers  of  Aβ  appear  to  be 
proteotoxic  and  cytotoxic,  indicating  that  insoluble  amyloid  plaques  may  be  a 
symptom rather than causative agents (53,54). Following biochemical considerations, 
the “cellular phase” of Aβ proteotoxicity includes spreading into and dysfunction of 
the  glia,  the  vascular  system  or  oligodendrocytes  coupled  to  inflammation  and 
inhibited clearance of aggregates (55). Indeed, it could be demonstrated that soluble 
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Aβ species can cause membrane damage  (56), further aggregation in a prion-like 
manner  (57) and  spread  proteotoxicity  systemically  to  vulnerable  cells,  causing 
neurodegeneration (58). All these eventually culminate in the “clinical phase” of AD, 
where memory dysfunction, loss of spatial orientation and dementia in addition to a 
multitude of other symptoms become progressively apparent  (59). In principle, the 
PN can target amyloids like Aβ to stave off neurodegeneration by disaggregation or 
degradation and it remains unclear what makes this mechanism prevail or collapse. 
Moreover, clearance mechanisms such as autophagy were not only reported to fail in 
neurodegeneration, but subsequently exacerbate pathology (60). Therefore, modern 
approaches at therapy not only utilize small molecules to target amyloids, but also 
aim to activate and direct the PN to ameliorate pathologies like AD (34,36,61).
Figure 1: Introduction to proteostasis
Proteostasis is the process of proteins attaining their correct fold (black) while preventing or reversing 
misfolded and aggregated protein states (red) or else degradation of the off-pathway species (purple), 
which  is  aided  by  molecular  chaperones  (blue,  represented  by  an  Hsp70  member  and  a 
cochaperone). Top row, I: at the ribosome, a nascent polypeptide is synthesized. II: unfolded proteins 
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have to reach their correct folding state to be functional but are also at risk of misfolding  III: native 
proteins can become misfolded under stress conditions (orange). Steps I-III are commonly aided by 
molecular chaperones. IV: a misfolded protein can be rescued by chaperones and return to the native 
folding pathway. If this fails, it is at risk of aggregation.  V: amorphous aggregates are the insoluble 
product  of  unordered  aggregation  of  misfolded  proteins.  VI:  ordered,  thermodynamically  stable 
aggregation mediated by -sheet interactions can lead to amyloid species of lower order (oligomers). 
VII: lower order amyloids can form large, insoluble amyloid fibrils. Misfolded and aggregated protein 
species (red) are often proteotoxic and deleterious, but can be disaggregated and recovered by the 
molecular  chaperones (blue).  VIII:  off-pathway proteins can also be degraded by proteasomes or 
autophagy (purple) and this process is also promoted by molecular chaperones. The graphic is not to  
scale and represents events in a purely qualitative manner.
3.2. Small heat shock proteins
Within the PN, small heat shock proteins (sHsps) are typically described as “first line 
defenders”, chaperones that buffer unfolded protein substrates against aggregation 
in an ATP-independent fashion (11), leading to their description as “holdases” (62). 
The sHsps are evolutionarily old and conserved, ubiquitous molecular chaperones 
present in all domains of life with implications in neurodegenerative disease, healthy 
aging, stress resistance, cancer (63) and longevity (64). The genomes of prokaryotes 
or  single-cellular  eukaryotes  (e.g.  yeast)  often  encode  one  or  two  sHsp  genes, 
whereas higher eukaryotes can express a large number of sHsps (65). Plant sHsps 
are  particularly  variable  (e.g.  23  different  sHsps  in  O.  sativa),  expressed 
constitutively,  developmentally  or  in  response  to  specific  stressors,  to  different 
organelles, form a number of sub-families  (66) and can be divided into two large 
classes  (67).  In  metazoans,  sHsps  are  not  divided  into  sub-families,  but  the  10 
human sHsps (also labeled HSPB1-10) still localize to different tissues and are either 
stress-induced or constitutively expressed.  Consequently,  human sHsps and their 
mutations are also implied in motor and neuronal diseases (68). 
3.2.1. The structure and activity of small heat shock proteins
Small heat shock proteins range in size from 12 (69) to 43 kDa (12) but their critical 
feature  is  the  oligomerization  into  quarternary  assemblies  of  larger  size  (70). 
Heterooligomerization  of  different  sHsps is  possible  (62) and conversely,  a  small 
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number of sHsps do not form oligomers  (71,72). The structure of sHsps is divided 
into a disordered, highly variable N-terminal domain (NTD), a central, conserved -
crystallin domain (ACD) and a shorter C-terminal domain (CTD)  (73). Due to their 
flexible nature, only a few sHsp structures have been analyzed: among others,  S. 
pombe Hsp16 (74), M. jannaschii Hsp16.5 (75,76), T. aestivum Hsp16.9 (77) and B-
crystallin (the basis for the name “-crystallin domain”) or HSPB5 (78,79). The ACD 
consists of a  -sandwich fold and the interaction of two ACDs is the basis of sHsp 
dimerization,  whereas the  NTD and the  CTDs IXI-motif  mediate  the assembly of 
dimers into higher oligomers  (73). The assembly of sHsps into oligomers is highly 
dynamic and a single sHsp may occupy a number of  oligomerization states. This 
plasticity is integral to sHsp function and a shift in oligomer size can lead to activation 
(80),  as  can  be  induced  by  factors  such  as  heat  (81) or  reduced  pH  (82). 
Heterooligomerization enables additional stabilization and regulation: the insolubility 
of  HSPB5  mutants  could  be  rescued  by  heterooligomerization  with  other,  native 
sHsps (83). In turn, excessive phase separation by the nuclear HSPB2 is regulated 
by HSPB3 (84). Finally, heterooligomers of HSPB5 and HSPB1 (other name: Hsp27) 
combine the improved thermostability of HSPB1 oligomers with the better chaperone 
activity of HSPB5 (85).
Larger oligomers of sHsps appear to be spherical and hollow, although this does 
not define their activity  (73): sHsps bind unfolded protein substrates, prevent their 
aggregation  and  keep  them  in  a  folding-competent  state  (86).  Substrate-sHsp 
interaction  is  based  on  exposed  hydrophobic  stretches  and  sHsps  can  facilitate 
substrate  refolding  by  ATP-dependent  molecular  chaperones  after  forming 
complexes of variable stoichiometry (87-89). While the dynamic subunit exchange of 
sHsp oligomers is required for activity, the sHsp-substrate interaction is not dynamic 
and sHsps do not spontaneously release their substrate (90). Part of the sHsps are 
promiscuous chaperones while others are more substrate-selective, but all sHsps are 
sensitive  to  the  surrounding  conditions  and  prevent  aggregation  of  different 
substrates  with  varying  efficiency  (91).  Recent  studies  hinted  that  the  substrate 
binding  of  sHsps  is  based  on  their  domain  structure  and  flexibility:  amorphous 
aggregates are bound by the intrinsically disordered NTD of HSBP5, whereas the 
fibril forming Aβ1-40 was recognized by the β-sandwich of the ACD (92). Besides data 
that a heterologous sHsp can alleviate the proteotoxicity of Aβ (93) and that HSPB5 
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inhibits Aβ fibril elongation (94), other amyloids implied in neurodegeneration are also 
sHsp  substrates:  HSPB5  and  HSPB1  can  inhibit  aggregation,  elongation  and 
cytotoxicity of -synuclein fibrils in vitro and in vivo (95,96). HSPB1 also recognizes 
tau protein  via  the ACD  (97) and HSPB5 inhibits  aggregation and cytotoxicity  of 
Huntingtin  (98).  Upon  co-aggregating  with  protein  substrates,  sHsps  can  still 
cooperate  with  ATP-dependent  chaperones.  Both  in  prokaryotes  and  eukaryotes, 
sHsp-substrate  aggregates  have  an  altered  shape  and  are  more  accessible  to 
disaggregation by Hsp100 members in combination with Hsp70 members  (99,100) 
and in metazoans, by Hsp70 members in cooperation with Hsp110 members (24,25).
3.2.2. SHsps impact protein aggregation beyond being “holdases”
The consideration that sHsps generally perform a singular inhibition of aggregation or 
“holdase”  function  is  contrasted  by  the  fact  that  often  a  multitude  of  sHsps  are 
expressed in parallel in the same tissue with specific interactions (91,101,102). One 
factor to integrate the activity of sHsps with the Hsp70 chaperones is the NEF BAG3 
(103). Following this, the specific interaction of HSPB8 with BAG3 is required for the 
aggresome-deposition of ubiquitinated substrates and subsequent recruitment of the 
autophagy  marker  p62  (104),  tying  sHsp  activity  to  the  Hsp70-BAG3 autophagy 
induction (31). More recently, even a direct involvement with p62 and the formation of 
autophagosomes has  been  demonstrated  (105),  implying  that  HSPB1 or  HSPB8 
could promote autophagy rather  than holding substrates  for  refolding.  Other  than 
autophagy,  pro-  and  eukaryotic  sHsps  were  found  to  act  as  “sortases”  or 
“sequestrases” and direct the deposition of aggregated proteins to specific locations 
(106-108).  Furthermore,  bacterial  YocM  or  yeast  Hsp42  promote  cytoprotective 
aggregation of their substrates as “aggregases” (109,110). Distinct sHsps may then 
stabilize these aggregates or prime them for disaggregation (111), so they become 
available  in  the  presence  of  sufficient  Hsp70  chaperones  (112) or  their  specific 
cochaperones (113). 
Indeed,  data  from  C.  elegans indicate  that  progressive  protein  aggregation  is  a 
general property of aging (114) coupled to a physiological, age dependent change in 
PN activity  (115).  In  yeast,  this  aggregation  was  shown to  be  selective,  that  is, 
potentially proteotoxic species can be sequestered in this manner to protect the cell  
(116) and  salvageable  proteins  can  be  saved  for  later  recovery  (117).  This 
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aggregation may be native-like and is directly required for continued viability after 
stress situations (118,119). For C. elegans it was demonstrated that the sHsps (HSP-
16.48, SIP-1 / HSP-20A, HSP-17, HSP-21 / Y55F3BR.6, HSP-43) are enriched in 
such aggregates, more so in the long-lived  daf-2 mutants, and that their depletion 
could impede this pro-longevity aggregation (120). Promoting aggregation, even into 
amyloid fibrils,  was also shown to be a defensive strategy against  amyloidogenic 
peptides such as RNQ (121) or Huntingtin (122). Here as well, sHsps were shown to 
aid the assembly of cytotoxic amyloid oligomers into larger, insoluble species (123-
125).  The  combination  of  these  recent  data  indicate  that  beyond  the  canonical 
“holdase function”, sHsps may work as “aggregation managers” directing the fate of 
aggregating proteins as “sequestrases”, “sortases” and “aggregases”.
Figure 2: Overview of sHsp activity
The rectangle marks the canonical activity of sHsps. If a protein is misfolded (I), it can be recognized 
by a pool of sHsps in the cell (II, depicted as an oligomer). Binding of sHsps results in sHsp-bound 
species of misfolded proteins (III). The multiple mechanisms of sHsps activation or the mode of sHsp-
substrate interaction are not depicted here. The formation of insoluble aggregates is inhibited by the 
sHsps (IV).  Dashed arrows represent more recent insights into sHsp activity: sHsps may promote 
degradation (V) or selective, site specific aggregate formation (VI). Substrate-sHsp binding may also 
alter how chaperones interact with protein substrates (VII).
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3.3. The model organism C. elegans
The nematode C. elegans was first acknowledged in 1974 by S. Brenner as a model 
organism for biology accessible to genetic studies and with metazoan features such 
as distinct tissues, e.g. neurons or muscles. C. elegans grow into adults of about 1 
mm length within 4 days and exist as hermaphrodites with 6 chromosomes or less 
common males with 5 chromosomes, lacking the gonosome (126). C. elegans feeds 
on bacteria, including  E. coli in laboratory conditions, and each hermaphrodite lays 
around 300 eggs during its average lifespan of 2-3 weeks  (127).  Whole genome 
sequencing  revealed  more  than  19 000  different  genes  and  a  high  degree  of 
conservation to the human genome  (128), with at least 80 % of genes conserved 
between both (129). The nematodes are most viable at ambient temperature (around 
20 °C), develop from eggs (embryos) to egg-laying adults passing 4 larval stages 
(L1-L4) and can be kept on agar media  (130). Notably,  C. elegans development is 
invariant, meaning that starting with the embryo, fixed cell lineages develop, forming 
adults  following  a  deterministic  program  where  individual  cells  remain  traceable 
(131).  The  simple  organism  has  an  alimentary  system:  the  muscular  pharynx 
pumping food into the intestine ending in an anus. Additionally, the nematodes have 
a hypodermis, body wall muscle, an excretory tract, gonads and neurons, resulting in 
precisely 959 cells (“eutely”) in hermaphrodites and 1031 cells in males  (132). The 
high  level  of  conservation,  genetic  accessibility  and  simple  structure  lead  to 
C. elegans being  recognized  as  a  model  organism  with  relevance  to  human 
physiology and disease (133).
3.3.1. C. elegans as a model in aging, proteostasis and neurodegeneration
The percentage of people in the world who are “old” – aged over 60 or over 80 years, 
is  projected  to  continuously  increase  over  the  coming  decades  (134) and  aging 
correlates with declining proteostasis  (135). Consequently, aging is a risk factor for 
disease,  including  neurodegeneration.  Key  findings  regarding  mechanisms  of 
longevity and health and disease in aging have been made in C. elegans, a valuable 
model  organism in  this  field  (136).  As  a  poignant  example,  mutations  in  the  C. 
elegans genes  age-1 or  daf-2 were demonstrated to drastically extend organismal 
lifespan at the cost of fertility  (137,138). Both share a common pathway dependent 
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on the downstream factor  daf-16 (139), a fork head transcription factor linking this 
longevity pathway to insulin-like signaling (ILS) (140). Most importantly, this pathway 
is conserved in humans  (141) and thereby  C. elegans research unveiled hormonal 
and nutrient signaling as a pillar in organismal aging  (142). A possible pivot of this 
pathway  was  identified  in  stress  resistance:  long  lived  C.  elegans mutants  have 
increased thermotolerance (143). ILS as a factor of longevity was indeed shown to 
depend  on  hsf-1,  a  general  heat  stress  regulator  inducing  the  expression  of 
molecular  chaperones  (among  others),  thus  revealing  the  PN  as  an  agent  of  
longevity  (144).  Like aging, stress response is cell  non-autonomous  (145) and its 
eventual decline impairs chaperone activity and enables protein aggregation as key 
factors of aging (114,115). The highly heat-inducible hsp-16 family is one arm of the 
ILS / hsf-1 controlled chaperones which mediate longevity (146) and belong to the 16 
different sHsps encoded in the C. elegans genome (147). The discoveries regarding 
the conserved connection between aging, stress and proteostasis have positioned 
C. elegans as  a  platform  for  modeling  neurodegenerative  disease:  amyloidosis 
caused  by  MAPT  (148),  -synuclein  (149) or  polyQ  peptides  (150) has  been 
introduced into the C. elegans system. Moreover, a number of AD models expressing 
A have been realized in  C. elegans. The first model of muscular A revealed the 
formation of amyloid fibrils  in vivo (151) and intracellularly  (152). While the model 
expressed A3-42 instead of the intended species A1-42  (153), this could be remedied 
in a subsequent model (154). The addition of a neuronal model completed an initial 
set  of  AD  phenotypes  in  C.  elegans:  muscular  expression  leads  to  progressive 
paralysis and neuronal expression causes defects in chemotaxis and learning (155). 
The models lacked fluorescent labeling and visualization of A was dependent on 
extrinsic  dyes  (152),  whereas  recent  attempts  at  GFP-labeling  revealed  non-
physiological aggregation behavior in tagged A species (156). Utilizing the fixed cell 
lines of C. elegans, modeling was furthered by expressing A in specific subsets of 
neurons (157-159). More importantly, the sHsp HSP-16 was shown to interact with 
heterologous A (160) and overexpression could reduce proteotoxicity of A (161). In 
summary,  C. elegans is a powerful system to model amyloidosis  in vivo and cell-
specifically, correlating AD pathology with aging and a complex PN that is amenable 
to genetic and pharmacologic modulation.
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Figure 3: Overview of C. elegans life cycle and shape
A depiction of  C. elegans development, starting with an egg, laid by an adult hermaphrodite, at the 
center  top.  Continuing  clockwise:  stages  of  development  in  ovo &  ex  utero  (eggs  not  to  scale) 
culminating in hatching. The four larval stages L1-L4 are depicted, underlining their increase in size.  
Each stage transition requires molting. The possibility of larvae entering a stagnant “Dauer” stage 
under unfavorable conditions is indicated. Blue letters indicate the relative time spent in each stage. 
Center top: reproductive adult hermaphrodite with depictions of the pharynx (green), intestine (mauve), 
gonads (dark blue) and eggs  in utero (light blue), the most prominent structures. This graphic was 
taken from WormAtlas (162) and is based on work by Byerly et al. (130).
3.4. Aims of this study
The  role  of  small  heat  shock  proteins  in  the  proteostasis  network  has  been 
extensively described over the last three decades, but many knowledge gaps remain 
in their understanding. Based on previous advances in researching the versatility of 
sHsps and their unexpected roles in protein aggregation, I aimed to analyze as of yet  
non-canonical activities of sHsps in the background of  C. elegans as a metazoan 
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model organism. Amyloid pathologies such as AD are protein aggregation diseases 
and therefore inextricably linked to molecular chaperones, including the sHsps. Yet, a 
consistent model of labeled A pathology in C. elegans did not exist. Consequently, I 
set  out  to  work  on  the  development  of  an  improved  model  of  amyloidosis  in  C. 
elegans to establish a platform for analyzing the role of  molecular chaperones in 
metazoans in vivo. The questions addressed were as follows:
3.4.1. Novel activities of metazoan sHsps
1. Among the numerous sHsps of C. elegans, do some have non-canonical 
chaperone activity?
2. What effect does their chaperone activity have in vitro and does it include 
metazoan pro-aggregation activity? 
3. Can the non-canonical activity of C. elegans sHsps be verified in vivo and 
which physiological impact does it have?
3.4.2. Improved models of protein folding disease in C. elegans
1. Can sub-stoichiometric labeling of A expressed in C. elegans provide “native-
like” fibril formation?
2. Does this model reiterate established phenotypes of A pathology?
3. Can the novel model reveal new corridors for understanding amyloid 
pathogenesis and its treatment?
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4. Results
4.1. Small heat shock proteins
Small  heat  shock  proteins  (sHsps)  have  been  long  known  to  act  as  first-line 
defenders and buffers against protein aggregation (11). However, the high number of 
sHsps in metazoan genomes (10 in humans, 16 in  C. elegans) hints at diversified 
modes of action and recent research has brought to light a more complex field of 
sHsp activities. Notably, this includes facilitated aggregation and deposition in cellular 
loci of aggregation (163). 
4.1.1. Molecular cloning and recombinant expression of sHsps
I set out to elucidate such new modes of sHsp activity by utilizing the availability of 
C. elegans for  in and  ex  vivo analysis,  combined  with  in  vitro analysis  of  sHsp 
activity, including sHsps which had been analyzed before. The CDS of six sHsps 
were  cloned  for  His-SUMO-tagged  overexpression  and  subsequent  protein 
purification,  with  a focus on sHsps that  were not  extensively  analyzed before.  In 
particular, I included hsp-17, which was recently analyzed in a recombinant context in 
E. coli (164) and had not been considered in previous studies (165). The construct 
for hsp-12.6 was available in Kirstein Laboratory (cloned by Ellen Malovrh). All sHsp 
CDS were cloned into pSumo to allow for tagged overexpression, purification and 
subsequently, seamless removal of the His-SUMO-tag by SUMO protease. Table 1 
below contains a list of sHsp CDS which were cloned in this study for SUMO-tagged 
overexpression, including attempts at purification:
Table 1 sHsp CDS available for SUMO-tagged overexpression
sHsp Results of purification
hsp-12.6 Soluble
hsp-17 (Isoform B) Soluble
hsp-20B / ZK1128.7 Insoluble
hsp-21 / Y55F3BR.6 Insoluble
hsp-25 (Isoform A & B) A insoluble, B soluble
hsp-43 (Isoform Insoluble
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Names of proteins are given as published, particularly under 
(147).
HSP-17 was previously excluded from thorough analysis of C. elegans sHsps (165) 
and recent analysis, in a non-physiological context, indicated that it does not exhibit  
typical sHsp activity  (166). HSP-17 was reported to colocalize with age dependent 
aggregates  (120) and  preliminary  analysis  revealed  that  soluble  expression  was 
possible. In the light of data indicating that HSP-17 did not have the classic “holdase”  
activity,  I  therefore  hypothesized that  HSP-17 could  play  a  non-canonical  role  in 
protein aggregation and chose it for thorough investigation. HSP-12.6 was included 
in  the  study  because  it  was  previously  analyzed  and  found  to  exhibit  only  little 
molecular chaperone activity (71), making it an apt control for in vitro studies of sHsp 
activity. Conversely, I did not pursue investigation of other sHsps that were previously 
described: SIP-1  (82) and HSP-25 (Isoform B; A was insoluble as reported)  (167). 
ZK1128.7 and HSP-43 were insoluble in my hands as reported previously (12,168), 
which was also true for the completely unresearched Y55F3BR.6 (HSP-21).
After overexpression of recombinant proteins, purification of HSP-17 and HSP-12.6 
was  carried  out  by  IMAC,  followed  by  anion  exchange chromatography.  HSP-17 
could be isolated as a pure peak from AEC:
Figure 4: Purification of recombinant HSP-17
SDS-PAGE of samples taken during an exemplary purification of HSP-17. S is the total, unpurified, 
soluble bacterial lysate; 0-2 are fractions eluted from IMAC; R/C is the rebuffered, pooled sample after 
removal of SUMO-tag; I is the diluted input for AEC; 17 is the peak containing HSP-17 received from 
AEC; T is the peak containing SUMO-tag that eluted shortly after. The peak “17” or comparable peaks 
from other purifications were used for further in vitro analysis.
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The purified sample of HSP-17 shows a low concentration (approximately 0,3 mg / ml 
or 20 µM) and was concentrated for in vitro analysis by pooling samples in centrifugal 
filter units with a low MWCO, as necessary.
HSP-12.6 was purified analogously. Notably, the yields of purification were higher 
than the binding capacity of the anion exchange column used, leading to the purest 
fraction being washed out prior to elution:
Figure 5: Purification of recombinant HSP-12.6
SDS-PAGE of samples taken during purification of HSP-12.6. AEX marks five peaks eluted from the 
anion exchange column containing, HSP-12.6, SUMO-tag and SUMO-tagged HSP-12.6;  A3 is the 
fraction that was collected before gradient elution and contains pure HSP-12.6. “A3” was used for 
further in vitro analysis
I  noticed that the purification of HSP-17 yielded low amounts of pure protein and 
wanted to ensure that the sample is indeed intact HSP-17. Intact protein QToF-MS 
analysis was used to determine the total mass and purity of my protein sample. The 
experiment yielded one peak containing protein, which was deconvoluted to a major 
peak of 17417,5 Da (theoretical mass of HSP-17, isoform B: 17417,52 Da) and an 
unidentified minor peak of 17433,5 Da:
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Figure 6: QTof-MS analysis of purified HSP-17
QToF-MS analysis of purified HSP-17. The left side shows the m/z spectrogram of the single protein 
peak identified (peaks are normalized to the highest peak, values are given in arbitrary units). For the 
right side, peaks ranging from an absolute m/z ratio between 600 and 1700 were deconvoluted and 
the x-axis shows the absolute peptide mass. The sample was applied as received from purification 
and operation of the device was carried out by A. Baumann.
As sHsps have an intrinsic propensity to form higher-order oligomers (62), I also set 
out to confirm the formation of oligomers by HSP-17 in a native context. To this end I  
employed SEC to  calibrate  the  elution  volume of  my sample  against  proteins  of  
known mass:
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Figure 7: Analytical SEC of purified HSP-17
SEC analysis of purified HSP-17. 100 µl of HSP-17 at a concentration of 1,5 mg / ml were loaded onto 
an analytical column, which had been calibrated with a high molecular weight calibration kit (indicated 
by red arrows). Absorbance was measured at 220 nm and is shown in arbitrary units on the y-axis,  
with the x-axis showing total elution volume. Arrow EV marks the exclusion volume (approximately 8 
ml),  F1 marks the start  of  sample fractionation and FL marks the end of  sample fractionation.  A 
selection of elution fractions was analyzed by SDS-PAGE, as shown on the bottom.
The peak observed at an elution volume of around 15 ml (> 440 kDa) corresponds to 
HSP-17, as shown by SDS-PAGE, and indicates formation of an oligomer of around 
460 kDa, corresponding to a 26-mer. A similar result was published previously in a 
study where HSP-17 was purified from insoluble material (166) and I interpret this as 
confirmation of my sample as intact HSP-17. A second peak, eluting around 19 ml, is  
likely  a  trace  of  SUMO-tag  remaining  from  purification  (compare  Figure  4). 
Analogously, I used SEC to assess the native state of HSP-12.6:
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Figure 8 Analytical SEC of purified HSP-12.6 
SEC analysis of purified HSP-12.6. 100 µl of HSP-12.6 at a concentration of 5 mg / ml were subjected 
to  an  analytical  column,  which  had  been  calibrated  with  a  high  molecular  weight  calibration  kit 
(indicated by red arrows). Absorbance was measured at 220 nm and is shown in arbitrary units on the  
y-axis,  with  the  x-axis  showing  total  elution  volume.  Arrow  EV  marks  the  exclusion  volume  (at  
approximately 8 ml),  F1 marks the start  of  sample fractionation and FL marks the end of sample 
fractionation. A selection of elution fractions was analyzed by SDS-PAGE, as shown on the bottom.
The  peak  at  an  elution  volume  of  18  ml  corresponds  to  HSP-12.6,  which  was 
confirmed  by  SDS-PAGE,  and  I  interpret  the  peak  around  24  ml  as  non-protein 
material. The elution volume of HSP-12.6 indicates an oligomer size of around 25 
kDa (corresponding to a dimer), as described previously  (71), confirming my HSP-
12.6 samples to be intact and pure.
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4.1.2. In vitro analysis of HSP-17 activity
It has been long known that sHsps can bind unfolded protein substrates, delay or  
prevent their aggregation, and keep them in a refolding-competent state (86,169). To 
assay the molecular chaperone activity of the purified HSP-17, I performed static light 
scattering assays. This method has been used frequently to demonstrate that sHsps 
can prevent or delay the aggregation of model substrates such as citrate synthase 
(CS), malic dehydrogenase (MDH) or glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (91).
When performing analysis of static light scattering on CS, I found that even a high 
excess of HSP-17 is not sufficient to completely prevent aggregation of CS, however, 
there is a concentration dependent delay of aggregation by adding HSP-17:
Figure 9: HSP-17 can delay the aggregation of CS 
Static light  scattering analysis  of  75 nM CS,  alone (blue curve),  or in  the presence of  increasing 
concentrations of HSP-17 (red curves, darker shades of red indicate higher concentrations, as visible 
in the legend). All curves are averages of triplicate measurements. The highest concentration of HSP-
17 used, 32-fold / 2400 nM, was analyzed by itself under the same conditions (black curve). The buffer  
used was also analyzed (grey curve). Light scattering intensity is given in arbitrary units (au). 
When  performing  analogous  experiments  with  GAPDH,  the  observed 
inhibition-of-aggregation activity was comparable and only higher concentrations of 
HSP-17 could delay, but not prevent aggregation of the model substrate:
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Figure 10: HSP-17 can delay the aggregation of GAPDH 
Static light scattering analysis of 150 nM GAPDH, alone (blue curve), or in the presence of increasing  
concentrations of HSP-17 (red curves, darker shades of red indicate higher concentrations, as visible 
in the legend). All curves are averages of triplicate measurements. The highest concentration of HSP-
17 used, 16-fold / 2400 nM, was analyzed by itself under the same conditions (black curve). The buffer  
used was also analyzed (grey curve). Light scattering intensity is given in arbitrary units (au).
Based  on  this  observation  I  concluded  that  HSP-17  can  perform  the  classical 
“holdase” activity of sHsps, but only in a limited manner. 
Asking whether this is a general  activity of HSP-17, I  continued by analyzing the 
activity of HSP-17 on MDH in the same format. Notably, I was unable to observe 
inhibition of aggregation by HSP-17 as instead, the aggregation of MDH commenced 
sooner and lead to higher total signal intensities in the presence of HSP-17, even at 
sub-stoichiometric ratios:
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Figure 11: HSP-17 enhances the aggregation of MDH at 47 °C 
Static light scattering analysis of 500 nM MDH, alone (blue curve), or in the presence of increasing  
concentrations of HSP-17 (red curves, darker shades of red indicate higher concentrations, as visible 
in the legend). All curves are averages of triplicate measurements. The highest concentration of HSP-
17 used, 2-fold / 1000 nM, was analyzed by itself under the same conditions (black curve). The buffer  
used was also analyzed (grey curve). Light scattering intensity is given in arbitrary units (au).
This observation is unusual as it suggests that HSP-17 speeds up the formation of 
MDH aggregates, which does not match described sHsp activity. I took note of recent 
observations that yeast Hsp42, one of the two sHsps in yeast, was shown to enable 
aggregation of  MDH at  otherwise  non-aggregating conditions,  which  was dubbed 
“aggregase” activity  (110).  In  the assay described, MDH was subjected to 41 °C, 
which only allows for slow and incomplete aggregation. Addition of Hsp42 lead to 
faster aggregation kinetics and a plateau of signal.
I reconstituted this experimental setup with C. elegans HSP-17 to investigate if HSP-
17 could promote aggregation of MDH at 41 °C. I found that at stoichiometric ratios, 
HSP-17 could enable the formation of MDH aggregates, as shown by signal plateaus 
within 60 minutes of measurement:
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Figure 12: HSP-17 enables the aggregation of MDH at 41 °C 
Static light scattering analysis of 500 nM MDH, alone (blue curve), or in the presence of increasing  
concentrations of HSP-17 (red curves, darker shades of red indicate higher concentrations, as visible 
in the legend). All curves are averages of triplicate measurements. The highest concentration of HSP-
17 used, 2-fold / 1000 nM, was analyzed by itself under the same conditions (black curve). The buffer  
used was also analyzed (grey curve). Light scattering intensity is given in arbitrary units (au).
I considered the possibility that these observations stem from buffer effects or simple 
molecular crowding and that any protein added to the aggregation analysis of MDH 
at 41 °C or 47 °C may produce similar signals in static light scattering. As a first  
control, I repeated the same experiments with HSP-12.6. HSP-12.6 was reported to 
not have the classic molecular chaperone activity of sHsps. In comparable assays, 
HSP-12.6 was titrated to up to 225-fold excess over its substrate with little impact on 
aggregation (71). I observed at both 41 °C and 47 °C that HSP-12.6 did not affect the 
aggregation  of  MDH  if  added  at  the  same  concentration  as  HSP-17  (see 
supplementary Figure 1). I conclude that addition of HSP-17, but not any sHsp can 
promote the aggregation of MDH under the given conditions.
It is also conceivable that HSP-17 could delay the aggregation of MDH, as shown for 
CS and GAPDH in Figures 9 & 10, but the assay conditions chosen for MDH prohibit 
the inhibition of aggregation  in general. I therefore utilized HSPB5, also known as 
B-crystallin,  a viable molecular chaperone  (169).  HSPB5 should also be able to 
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inhibit the aggregation of MDH (91) and I applied it under the same assay conditions 
as before:
Figure 13: HSPB5 delays aggregation of MDH at 47 °C 
Static light scattering analysis of 500 nM MDH, alone (blue curve), or in the presence of increasing  
concentrations of HSPB5 (red curve). All curves are averages of triplicate measurements. The highest 
concentration of HSPB5 used, 2-fold / 1000 nM, was analyzed by itself under the same conditions 
(black curve). The buffer used was also analyzed (grey curve). Light scattering intensity is given in 
arbitrary units (au).
At 47 °C, as little as two-fold excess of HSPB5 is sufficient to delay the aggregation  
of MDH. I conclude that it is possible to observe molecular chaperone activity under 
my assay conditions and – combined with  the observation that  HSPB5 does not 
affect aggregation of MDH at 41 °C (see supplementary Figure 2) and the findings for  
HSP-12.6 – that the pro-aggregation activity is a specific feature of HSP-17.
The obtained data indicate that HSP-17 can act as a molecular “aggregase”. For 
yeast Hsp42, this activity was linked to an N-terminal “prion-like” domain which was 
reported to be integral for promoting aggregation (170) (see supplementary Figure 3). 
Thus, the HSP-17 protein sequence was analyzed with the online tool PLAAC to test 
for prion-like features:
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Figure 14: HSP-17 does not have a prion-like domain 
Output of a PLAAC analysis of the primary sequence of HSP-17 (isoform B), assuming a C. elegans 
background and using a frame of 30 amino acids. On the top, the likelihood of the input sequence 
(with the x-axis ranging from N- to C-terminus) being like the species background (here: C. elegans, 
black) or prion-domain like (red) is indicated. In the segment below, each colored bar indicates one 
amino acid, with blue-green colors indicating a higher prion-likelihood and orange-red indicating a 
lower likelihood. The bars above and below indicate the prion-domain likeness by map algorithm 
(MAP)  or  Viterbi  algorithm (VIT)  (in  red  or  black).  The  tool  integrates  other  scoring  methods  to  
increase its accuracy, as shown below: the measure of intrinsic disorder, potentially coinciding with  
prion-likeness, is given (FoldIndex, grey). PAPA (green) indicates a related, non-redundant algorithm 
to  identify  prion-like  domains  (lower  values  indicate  prion-like  domains).  The  dashed  green  line 
indicates a threshold for prion-likeness in PAPA. Both parameters are provided to supplement PLAAC 
(red).  Mathematical  transformation  (PLAAC multiplied  by  -1,  PAPA multiplied  by  -4)  are  used  to 
visualize all graphs in a similar frame.  PLAAC could not determine a COREscore and the LLR (log-
likelihood ratio) is -7,176 (171).
As HSP-17 did not seem to have any prion-like properties, I concluded that the exact  
interaction  site  required  to  enhance  the  aggregation  of  model  substrates  differs 
between the two proteins. I also took note that Hsp42 can inhibit the aggregation of 
MDH under the right conditions  (170). Since Hsp42 is significantly larger (42,8 kD) 
than  HSP-17  (17,4  kD),  I  surmise  that  Hsp42  might  exhibit  additional  features,  
whereas HSP-17 may be more specialized.
Since HSP-17 interacts with the model substrate MDH and causes aggregation, I 
considered whether  HSP-17 itself  would be part  of  the aggregates formed by its 
35
substrates. To elucidate this, I replicated the conditions depicted in Figures 11 & 12. 
500 nM MDH was co-incubated with two-fold excess of HSP-17 at 41 °C or 47 °C, for 
30 min (47 °C) or for 60 min (41 °C). The soluble and insoluble fraction were then 
separated by centrifugation and subjected to SDS-PAGE:
Figure 15: HSP-17 co-aggregates with MDH at 41 °C and 47 °C 
Sedimentation analysis of MDH after heat treatment, in presence or absence of two-fold excess of  
HSP-17. The soluble fraction (S) and the insoluble fraction (P) are shown side by side. The protein  
bands corresponding to MDH (around 36 kDa) or HSP-17 (around 17 kDa) are indicated. The relative 
intensity of the bands, quantified by Fiji  and normalized to 100%, is tabulated below the gel.  The 
numbers  represent  averages  of  3  repeats  of  the  same  analysis  and  the  depicted  gel  is  a 
representative example. The standard deviation is provided for each average band quantification.
My analysis indicates that MDH can be sedimented even in the absence of HSP-17, 
after heat treatment at 41 °C (less than 50%). The addition of HSP-17 enables two 
thirds of MDH to be sedimented. At 47 °C, both in the presence or absence of HSP-
17, the bulk of MDH became insoluble. This reinforces the observations shown in  
Figures 11 & 12.
Interestingly, at both temperatures analyzed, 20-25% of total HSP-17 co-sediment 
with MDH. This is in contrast to the observations from Figures 11 & 12, where HSP-
17 (black curves) does not exhibit light scattering when analyzed alone. By this, the 
sedimentation assay reveals that at least a fraction of HSP-17 will co-sediment with 
its substrate. I have repeated the same analysis without MDH, by simply analyzing 
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HSP-17 upon heat treatment.  At  both 41 °C and 47 °C, HSP-17 remains almost  
completely soluble (see supplementary Figure 4), as shown in Figures 11 & 12. 
So far,  I  could demonstrate that HSP-17 can facilitate the aggregation of specific 
substrates such as MDH and a fraction of HSP-17 also becomes a part of these 
aggregates.  What  could  be  the  consequence  of  this  co-aggregation  in  the 
downstream processes?  To  tackle  this  question,  I  switched  to  a  different  model 
protein substrate, firefly luciferase. Firefly luciferase can be denatured and then used 
in assays of protein disaggregation and subsequent refolding, where the protein’s 
light-emitting  activity  is  used  to  quantify  recovery  from aggregates  over  time.  In 
metazoans like C. elegans, this can be achieved by a combination of HSP-1, HSP-
110 (both from the Hsp70 chaperone family)  (24) and a mixture of type A and B J-
proteins for high disaggregation efficiency (25). Previous studies have shown that co-
aggregation of sHsps with their substrates can enhance disaggregation and refolding 
by  molecular  chaperones,  in  bacteria  (99) and  even  in  the  C.  elegans system 
employed here  (25) (utilizing the yeast sHsp Hsp26).  To asses if  HSP-17 affects 
downstream chaperone processes, I utilized HSP-1, HSP-110, DNJ-12 and DNJ-13 
to  disaggregate  and  refold  luciferase  from  aggregates,  while  quantifying  light 
emission. HSP-17 was added to luciferase before heat denaturation, as illustrated in 
this experimental schematic: 
Figure 16: Experimental setup of luciferase assay with HSP-17 co-aggregation 
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Luciferase is aggregated by heat treatment in absence (I) or presence (II) of HSP-17. Following this,  
molecular chaperones are added as indicated. If HSP-17 was not added for aggregation, it is heat 
treated by itself and added with the chaperones (I). Disaggregation is then measured by quantifying  
light-emitting activity of luciferase over 120 min. For normalization, native luciferase is measured in 
parallel and assumed to represent 100% signal.
The signal resulting from disaggregation of luciferase by itself or co-aggregated with  
various concentrations of HSP-17 was then compared:
Figure 17: Reactivation of luciferase is inhibited by co-aggregation of HSP-17 
Luciferase was aggregated by heat treatment. The disaggregation was carried out by the indicated 
molecular chaperones and measured by quantifying emitted light, normalized to native luciferase (blue 
curve). The same measurement was carried out after luciferase was aggregated in the presence of 
increasing concentrations of HSP-17 (red curves, darker shades of red indicate higher concentrations 
of HSP-17 as indicated in the legend). All data points are averages of triplicate measurements.
Firstly,  these  data  indicate  that  the  co-aggregation  of  HSP-17  with  luciferase 
aggregates can inhibit subsequent disaggregation and refolding by the established 
disaggregation machinery of C. elegans. This is reminiscent of observations made for 
the E. coli sHsp IbpA (111). Furthermore, the concentrations of HSP-17 that yield a 
significant effect are high – close to the concentration of HSP-1 used (4 µM). This 
may indicate  that  a  competition with  molecular  chaperones plays a role,  likewise 
reported for bacterial sHsps (112). 
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Does this mean that co-aggregation of HSP-17 with luciferase is irrelevant and the 
inhibited disaggregation results from a direct interaction with HSP-70? To elucidate 
this, I performed the same assay, but heat treated HSP-17 separately and added it to  
the luciferase afterwards, together with the remaining molecular chaperones (refer to 
Figure 16):
Figure 18: Reactivation of luciferase is unaffected by addition of HSP-17 post-aggregation 
Luciferase was aggregated by heat treatment. The disaggregation was carried out by the indicated 
molecular chaperones and measured by quantifying emitted light, normalized to native luciferase (blue 
curve).  The same measurement  was carried  out  with  increasing  concentrations of  HSP-17 being 
added for the disaggregation step (red curves, darker shades of red indicate higher concentrations of 
HSP-17 as indicated in the legend). All data points are averages of triplicate measurements.
In brief, the addition of HSP-17 to luciferase post-aggregation has little to no effect on  
the efficiency of disaggregation. I conclude from this that HSP-17 has to interact with 
luciferase during aggregation and co-aggregate to inhibit subsequent disaggregation. 
To exclude that the observed inhibition of disaggregation is merely a consequence of 
molecular crowding or unproductive interaction between excess HSP-17 and HSP-1, 
I  performed  the  same  experiments  with  HSP-12.6  instead  of  HSP-17.  In  these 
experiments,  HSP-12.6  could  not  affect  disaggregation  of  luciferase  in  any 
concentration,  regardless  if  added  before  or  after  aggregation  of  luciferase 
(supplementary  Figure  5).  Notably,  the  highest  concentration  of  HSP-12.6  used 
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(10 µM)  could  reproducibly  facilitate  disaggregation  of  luciferase  by  the  ATP-
dependent chaperones if added post-aggregation (this observation, while interesting, 
will not be discussed further in this work).
The yeast  molecular  aggregase Hsp42,  together  with  the sHsp-like Btn2,  provide 
cellular  sequestrase  activity  in  yeast  and  are  sufficient  for  the  formation  of 
intracellular foci (INQ and CytoQ) (106). For Btn2, it has been shown that a yeast J-
protein, Sis1, is able to alleviate the aggregation of Btn2 dependent foci and allow for  
disaggregation  by  molecular  chaperones  (113).  Hence,  it  is  possible  that  a  yet 
unknown  interaction  partner  is  missing  in  the  in  vitro system that  is  required  to 
process HSP-17-bound aggregates. This leads me to speculate that members of the 
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alleviate inhibition of disaggregation in a fashion similar to Sis1.
Therefore, analysis of HSP-17  in vivo was necessary to fortify my observations  in 
vitro with physiological data. Does HSP-17 hetero-oligomerize with other sHsps, bind 
other molecular chaperones or have preferred substrates? To illuminate this issue, I 
planned immunoprecipitation experiments of HSP-17 from C. elegans lysates. As a 
first step, polyclonal antibodies for HSP-17 were obtained. Purified HSP-17 was used 
to immunize rabbits (performed by Pineda Antikörper Service, Berlin, Germany). 
Co-IP of HSP-17 was performed followed by MS/MS analysis to identify proteins that  
are enriched in binding to HSP-17 over a control (where immunoprecipitation was 
carried out with an anti-GFP antibody). Among the proteins identified were the sHsps 
Y55F3BR.6  (HSP-21),  SIP-1,  HSP-16.1  and  HSP-12.2  as  well  as  nematode 
homologs of the model protein GAPDH (GPD-1 & GPD-4). I hypothesize that other 
sHsps are likely hits in this experiment due to their propensity to interact among each  
other (62) and that GPD proteins are substrates as shown in vitro (see Figure 10).
Subsequently, the 200 most enriched proteins were subjected to a gene ontology 
(GO) analysis with the DAVID online tool, to generate a set of functional annotation 
data  for  HSP-17.  Below,  I  provide  a  curated  list  of  GO-terms  identified  in  this 
analysis1:
1 A dataset containing raw MS/MS-data, the search results derived from my raw data, as well as a list 
of individual proteins identified has been uploaded to the PRIDE repository. A supplementary table 
with additional information is also provided (see Data availability, 10.2).
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Table 2: List of notable GO-terms identified in IP-MS/MS analysis of HSP-17




1 Embryo development ending in birth 
or egg hatching
111 2,04E-25
2 Nematode larval development 88 2,05E-24
3 Reproduction 92 4,75E-24
4 Hermaphrodite genitalia development 25 1,99E-04
5 Receptor-mediated endocytosis 30 8,89E-07
6 Intracellular protein transport 7 2,20E-03
7 Determination of adult lifespan 33 1,25E-05
8 Apoptotic process 20 7,89E-05
9 Oxidation-reduction process 19 6,70E-04
The  analysis  of  GO-terms  enriched  in  MS/MS analysis  pointed  to  at  least  three 
physiological  functions  for  HSP-17:  the  generation  of  offspring  (1  –  4),  protein 
transport and vesicular trafficking (5 & 6) and proteostasis (7 – 9) as shown in table  
2. In combination with the individual  protein hits mentioned above, I  surmise that 
these findings match with the role described for molecular chaperones and sHsps in 
particular. Nonetheless, I planned to confirm my findings with a physiological analysis 
(a list of individual proteins identified as enriched and all derived GO-terms can be 
found  in  supplementary  table  1,  see  Data  availability,  10.2).  In  addition  to 
understanding physiological interaction partners of HSP-17, I asked how abundant 
HSP-17  is  in  C.  elegans.  Utilizing  the  HSP-17  antibodies,  I  performed  ex  vivo 
quantification  of  total  HSP-17  from  nematode  lysates.  I  obtained  an  estimate  of 
HSP-17 mass per total mass of protein in cleared lysates (concentrations of other 
chaperones have been determined previously (27) and are provided for comparison):
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Table 3: Absolute quantification of HSP-17 levels in C. elegans
Protein nMol / total g protein in lysate
HSP-17 477  154
HSP-1 525  136
HSP-110 566  72
DNJ-12 45  13
DNJ-13 64  7
Standard error of means is indicated for quantification.
The  determined  concentration  levels  of  HSP-17  in  C.  elegans are  high  and 
comparable to HSP-1, which matches my observations from Figures 9-12, where 
HSP-17  activity  is  only  observed  when  HSP-17  is  present  in  excess.  More 
importantly, HSP-17 being on a similar level of concentration to HSP-1 supports the 
findings displayed in Figure 17, where inhibition of disaggregation is observed when 
HSP-17 was titrated to concentrations close to the level of HSP-1. It is also important  
to note that I could only analyze whole nematode lysates and the concentrations of 
the  analyzed  chaperones  may  be  higher  locally,  in  specific  tissues,  cells  or 
subcellularly (e.g. in aggregation foci).
4.1.3. In vivo analysis of hsp-17 and its physiological activity
Analysis of the  in vivo localization of HSP-17, what relevance the protein has in a 
native context, which proteins might be physiological interaction partners and if HSP-
17 can perform an unusual chaperone function in living C. elegans necessitated the 
generation of suitable in vivo reporters. I created three transgenic reporter strains of 
hsp-17 in  C. elegans,  phsp-17::GFP (strain p17G, a transcriptional reporter),  phsp-
17::hsp-17::GFP (strain p17tG, a translational reporter overexpressing HSP-17 with a 
C-terminal GFP-tag) and  phsp-17::hsp-17::wrmScarlet (strain p17tR, a translational 
reporter  overexpressing  HSP-17  with  a  C-terminal  wrmScarlet-tag).  For  initial 
analysis, I performed confocal laser scanning microscopy to visualize the distribution 
of fluorescent protein in these models1: 
1 Z-stacks,  further  elucidating  the  distribution  of  HSP-17  within  C.  elegans,  are  available  on  the 
platform Zenodo (see Data availability, 10.1).
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Figure 19: Confocal LSM imaging of translational hsp-17 reporter strain 
LSM of phsp-17::hsp-17::wrmScarlet. Whole nematode is visible, including eggs in utero & ex utero. 
Image shows an overlay of dissecting microscopy and RFP channel.  Scale bar is 100 µm. White 
arrows mark, from top to bottom: anus / lower end of intestine; diffuse fluorescence in intestine; vulva;  
pseudocoelomic material; excretory channel; pharynx.
Figure 20: Confocal LSM imaging of translational hsp-17 reporter strain (detail) 
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LSM  of  phsp-17::hsp-17::wrmScarlet.  Close  up  images  of  the  above  (images  show  different 
individuals). Images show an overlay of dissecting microscopy and RFP channel. Scale bars are 20  
µm. Images depict:  i)  HSP-17 localizes to the pharynx. ii)  HSP-17 localizes around the endotube, 
within the intestine. iii) HSP-17 localizes to structures in the pseudocoelom and close to the body wall.  
iv) In the lower intestine, HSP-17 localizes around the anus. v) HSP-17 localizes to the excretory canal 
cell, including a line of smaller foci. vi) HSP-17 localizes to the vulva.
HSP-17  is  most  visibly  expressed  in  the  alimentary  system  (consisting  of  the 
pharynx, the intestine and the anus), the excretory canal and also found dispersed to 
smaller structures in the nematode. This data also matches to a previous automated 
approach,  in  which  promoter  regions  where  cloned  based  on  computerized 
predictions.  Transcriptional  GFP-reporters  of  many  C.  elegans  proteins  were 
generated and analyzed, including HSP-17 (172). Next, I wanted to ascertain that my 
models express the HSP-17-fluorophore fusion protein as intended and approximate 
the level of overexpression of the fusion protein. To this end, I performed western  
blot analysis of lysates of the strains N2, p17tG and p17tR.
Figure 21: Levels of HSP-17 overexpression in transgenic reporter strains 
Lysates of  C. elegans  strains N2 (wild type), p17tG (G) and p17tR (R) were adjusted to the same 
protein level and western blotted. Detection by antibodies against HSP-17 and Tubulin was performed. 
Endogenous HSP-17, Tubulin and the fusion proteins were marked. Relative band intensities were 
quantified by Fiji and normalized to Tubulin. Below the blot, the level of the fusion protein relative to  
endogenous  HSP-17  is  provided.  The  depicted  image  is  representative  and  the  experiment  was 
carried out in three independent repeats, the relative band intensities are given as averages. 
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The  western  blot  reveals  that  both  the  HSP-17-GFP  as  well  as  the  HSP-17-
wrmScarlet fusion can be detected in lysates of the transgenic reporters, but not wild 
type nematodes. Furthermore, quantification of the bands suggests that the level of 
the  fusion  protein  is  similar  to  the  wild  type  protein,  amounting  to  a  two-fold 
overexpression of HSP-17 in the translational reporter strains. This also implies that 
the level of fusion protein approximates the physiological concentration of HSP-17. 
All lysates analyzed show additional bands at a size slightly smaller than 40 kDa. 
These  bands  are  either  the  result  of  SDS-resistant  HSP-17  dimers  or  due  to 
unspecific binding of the antibody. 
The  confocal  microscopy  analyses  revealed  two  structures,  the  excretory  canal 
(prominently seen in Figure 19) and the endotube (compare Figure 20, ii) which both 
span  the  length  of  the  entire  nematode.  To  validate  these  specific  localizations, 
genetic  crosses  of  p17tR  with  additional  reporter  strains  were  performed.  As 
reporters,  the  C.  elegans strain  BJ49,  expressing  IFB-2-CFP  in  the  intestine 
(intermediary  filament-B2  localizes  around  the  endotube  (173)),  and  BK36, 
expressing GFP to the excretory canal cell were used.
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Figure  22:  Colocalization  of  HSP-17  with  markers  for  the  excretory  canal  cell  and  the  intestinal 
endotube 
Representative confocal LSM of  C. elegans p17tR crossed with strains BK36 (expression of GFP in 
the excretory canal cell,  i-iii)  and BJ49 (expression of  IFB-2-CFP in the intestine,  iv-vi).  Separate 
channels and combined channel are provided, as noted on the images. Scale bars are 20 µm.
The  co-expression  of  fluorophore-tagged  reporters  confirms  that  HSP-17  clearly 
localizes to the excretory canal cell  (but does not perfectly overlap with the GFP-
reporter)  and also localizes to the intestine, particularly to the endotube, where it  
colocalizes with IFB-2. In an attempt to further observe the subcellular localization of 
HSP-17 in the intestine, correlative light electron microscopy (CLEM) was employed 
to generate ultrastructure images of HSP-17 localization within C. elegans. 
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Figure 23: HSP-17 localizes around the apical membrane of the intestinal endotube 
CLEM of a  C. elegans p17tG specimen. A section of an intestinal cell is shown. Image i shows the 
ultrastructure,  including  the  lumen  (in  the  middle,  surrounded  by  cilia),  and  lipid  droplets  (white 
spheroids).  Image  ii  shows  an  overlay  of  HSP-17-GFP  fluorescence,  notably  localizing  to  the 
membrane covering the lumen (and some spots outside thereof), but not overlapping with the cilia. 
Image iii  shows the total  perspective of  the EM-grid including HSP-17-GFP overlay and image iv 
shows a DAPI-staining of the sample, including HSP-17-GFP overlay. Scale bars are 4 µm (i, ii) or 10 
µm (iii, iv). CLEM experiments were performed by D. Puchkov.
The specific enrichment of HSP-17 around the endotube raises the question if HSP-
17 in general has a specific subcellular localization, in the intestine and other tissues. 
I set out to elucidate this by first performing fixation of p17tR nematodes and then 
conducting a DAPI staining to visualize cellular nuclei in the nematode sample. I then 
analyzed the samples by LSM:
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Figure 24: HSP-17 is excluded from cellular nuclei in C. elegans 
Representative confocal LSM of C. elegans p17tR after fixation and DAPI staining. DAPI is visualized 
by  fluorescence  (teal).  Images i-iii  show the  pharynx  of  a  young (<  4  days)  animal.  In  image  i, 
representative spots were HSP-17 is excluded are marked by white arrows. Separate channels and 
combined channel are provided, as noted on the images. Scale bars are 20 µm.
My microscopy analysis  suggested that  HSP-17-wrmScarlet  is  excluded from the 
nucleus. To reinforce these findings, I  also conducted an  in  silico analysis of  the 
HSP-17  primary  structure,  using  the  integrated  online  tool  BUSCA to  analyze 
markers of subcellular localization. Analysis predicted the most likely localization of 
HSP-17 to be the cytosol (70%), or alternatively the nucleus (30%). As my DAPI 
staining revealed no nuclear localization of HSP-17, I concluded that HSP-17 is most 
likely a cytosolic protein.
To complement my two-fold overexpression model of HSP-17 I also generated an 
RNAi construct to perform a knockdown of hsp-17, which was previously unavailable 
from  the  Ahringer  Library  (174).  This  construct  has  been  utilized  in  a  recent 
publication of AG Kirstein to successfully deplete HSP-17 by roughly 50 % (175). 
With  the overexpression  lines  and the  RNAi  construct  a  toolset  was available  to 
access physiological roles of HSP-17 in living C. elegans. As HSP-17 is a molecular 
chaperone of high abundance (Table 3), a modulation of HSP-17 protein levels either 
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by overexpression or RNAi-mediated depletion might affect physiological fitness and 
stress resistance. For the related C. elegans sHsp SIP-1, reduced lifespan and heat 
survival upon deletion have been reported (82). Here, I set out to asses viability  of 
C. elegans upon RNAi-mediated knockdown of hsp-17. 
Figure 25: Lifespan of C. elegans is decreased upon knockdown of hsp-17 
N2 nematodes were subjected to control  RNAi (blue) or  hsp-17 RNAi (red).  The number of living 
nematodes is given as percentage of total specimen used in the assay. Mean lifespans as determined 
by the OASIS online tool are also provided.
Indeed,  knockdown  of  hsp-17 has  a  small,  but  significant  effect  on  C. elegans 
lifespan, reducing it by about 1,5 days even in the absence of external stressors. This 
also corroborates the finding that HSP-17 is involved in the adult lifespan from my 
GO-analysis (Table 2). As an additional readout of fitness, I assayed the fecundity of 
N2 nematodes subjected to control RNAi or knockdown of hsp-17. This dataset was 
supplemented by analysis of N2 nematodes and the strains p17tG or p17tR in the 
absence of any RNAi:
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Figure 26: Fecundity of C. elegans is decreased upon knockdown of hsp-17 
For N2 nematodes subjected to control RNAi (blue) or hsp-17 RNAi (red), the total number of progeny 
produced was counted. Data is also given for HSP-17 overexpressing nematodes (green) and finally, 
for N2 animals in the absence of RNAi (blue). Each spot on the graphs marks an individual. One-way 
ANOVA testing (followed by Bonferroni’s multiple comparisons test)  was performed. The standard 
deviation for each column is indicated and significant results are marked by stars (N2 control vs. N2, 
hsp-17 RNAi: p < 0,0001; N2 control RNAi vs. hsp-17::mScarlet: p = 0,027; N2 control RNAi vs. hsp-
17::gfp: p = 0,016).
Knockdown of  hsp-17 severely reduces fecundity indicating either a general loss of 
physiological fitness or a specific defect in the gestation of progeny caused by the 
reduction of HSP-17. As before, this finding matches the GO-analysis, where HSP-17 
was associated with the generation of offspring (Table 2). Notably, overexpression of 
HSP-17  does  not  alter  fecundity  of  wild  type  animals,  but  both  wild  type  and 
overexpression nematodes lay a reduced amount of  eggs compared to the RNAi 
control – this may indicate that the bacterial RNAi-feeding strain E. coli HT115 itself 
has a slight effect on egg laying or fecundity.
HSP-17 appeared to be constitutively expressed in my reporter strains and I did not 
observe  induction  upon  heat  stress  in  vivo (although  previous  ex  vivo analysis 
indicated heat stress induction (176)). As is the case for SIP-1, I assumed that HSP-
17 expression is  not  dependent  on  heat  stress,  yet  the  protein  may still  exert  a 
cytoprotective  role  during  heat  stress.  Hence,  a  thermotolerance  assay  was 
performed to measure recovery and survival of nematodes subjected to heat stress 
upon modulation of HSP-17 levels. To this end, nematodes were subjected to heat 
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stress of 35 °C for 6 h before being allowed to recover at 20 °C for 24 h and surviving 
animals were counted.
Figure 27: Thermotolerance of C. elegans is decreased upon knockdown of hsp-17 
For N2 nematodes subjected to control RNAi (blue) or hsp-17 RNAi (red), the percentage of survivors 
24 h after heat stress was plotted. Data is also given for HSP-17 overexpressing nematodes (green)  
and finally,  for N2 animals in the absence of  RNAi  (blue).  Experiments were carried out  in three  
independent repeats. One-way ANOVA testing (followed by Dunnett’s multiple comparisons test) was 
performed.  The standard deviation for each column is indicated and significant results are marked by 
stars (N2 control vs. N2, hsp-17 RNAi: p < 0,0014).
The experiment revealed a strong defect in heat stress survival for hsp-17 depleted 
nematodes. In contrast, overexpression of HSP-17 did not alter survival compared to 
wild type nematodes or animals subjected to RNAi control conditions. It follows that 
HSP-17 can confer resistance to heat stress, possibly due to its ability to prevent 
aggregation  of  selected  substrates,  or  perhaps  by  facilitating  the  aggregation  of 
others.
The specific localization of HSP-17 in the alimentary system of C. elegans suggested 
an involvement of HSP-17 in distinct physiological processes. As shown in Figure 22, 
HSP-17  localizes  to  the  excretory  cell  which  is  implied  in  water  balance  and 
osmoregulation  (177) posing  the  question  whether  HSP-17  is  cytoprotective  in 
osmotic stress. To elucidate this question, I transferred nematodes, on day 4 of life, 
to NGM-agar plates with 250 mM NaCl (regular: 50 mM) to cause osmotic stress:
51
Figure 28: Osmotolerance of C. elegans is decreased upon knockdown of hsp-17 
For N2 nematodes subjected to control RNAi (blue) or  hsp-17 RNAi (red) and for the strain p17tR 
overexpressing HSP-17 (green), survival under osmotic stress was plotted. Survival is indicated as the 
percentage of  C. elegans alive compared to the initial population. Experiments were carried out in 
three independent repeats. Standard deviation is indicated.
Again, the data indicates that depletion of  hsp-17 slightly diminishes resistance of 
C. elegans to osmotic stress. Conversely, overexpression of HSP-17 does not seem 
to  be beneficial  or  deleterious.  I  conclude that  HSP-17 plays  a  role  in  excretory 
channel function. 
Figures  22 and  23  also  show a  distinct  localization  of  HSP-17  to  the  endotube, 
around the apical membrane of the intestinal lumen. The intestine surrounding the 
lumen is an interface with nutrients or toxins the nematode comes into contact with 
and reports that HSP-17 is induced upon heavy metal stress (cadmium), support my 
observation (176). As C. elegans subsists on bacterial cells, the intestinal lumen may 
furthermore be a site challenged by biotic stressors. Aiming to understand if HSP-17 
is  relevant  in  biotic  stress  defense,  I  transferred  adult  nematodes  to  NGM-agar 
harboring the pathogenic bacterial strain Serratia marcescens DB11.
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Figure 29: Biotic stress resistance of C. elegans is decreased upon knockdown of hsp-17 
For N2 nematodes subjected to control RNAi (blue) or  hsp-17 RNAi (red) and for the strain p17tR 
overexpressing HSP-17 (green), survival under biotic stress was plotted. Survival is indicated as the 
percentage of C. elegans alive compared to the initial population. Experiments were carried out in two 
independent repeats. Standard deviation is indicated. 
As with the osmotic stress, I observed a slight defect in  C. elegans resistance to 
biotic stress upon depletion of  hsp-17, leading me to assume that HSP-17 confers 
resistance to external stressors. It is of note that overexpression of HSP-17 cannot 
produce  a  significant  change  in  any  of  the  biomarkers  I  have  explored  so  far,  
implying that HSP-17 cytoprotective activity hinges on the interaction of HSP-17 with 
a  limiting  substrate  or  that  overexpression  of  the  chaperone  causes  protein 
homeostatic  imbalance  as  much  as  its  depletion.  I  had  so  far  analyzed  the 
distribution of HSP-17 inside C. elegans paired with its physiological relevance and 
the  ability  to  confer  resistance  to  specific  stressors.  This  leaves  unanswered, 
however,  which  specific  substrates  HSP-17 might  bind  and exhibit  its  chaperone 
activity on and what the nature of this chaperone activity is. Can HSP-17 enact the  
molecular  aggregase  activity  described  in  3.1.2 in  vivo and  is  this  part  of  its 
cytoprotective function?
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4.1.4. HSP-17 acts as a molecular aggregase in vivo
The data depicted in Figures 12, 15 and 17 show that in vitro, HSP-17 can facilitate 
the  aggregation  of  a  model  substrate  and  become  part  of  the  aggregate  itself, 
stabilizing the insoluble species against subsequent disaggregation. To test these 
observations in a physiological context,  I  aimed to analyze if  HSP-17 localizes to 
aggregates in living C. elegans. The microscopic images depicted in Figures 19 & 20 
show the general localization of HSP-17. Although the animals presented there are 
young, some foci in the intestine can be observed (Figure 19 and Figure 20, vi).  
However, aggregation is typically related to stress or aging and many  C. elegans 
proteins tend to become insoluble upon aging (114). An analysis of old nematodes 
(14 days) confirms an age-dependent aggregation of HSP-17:
Figure 30: HSP-17-GFP, but not GFP alone, forms foci upon aging in C. elegans 
Nematodes of the strain p17tG were analyzed at day 14 of life. Images show the head including the 
pharynx (i), the excretory tract (ii), the intestine and the excretory tract (iii) and the tail (iv). The strain 
p17G, expressing GFP under hsp-17 promoter control, was also imaged: (v) shows the pharynx and 
(vi) shows the excretory tract. Images are representative. Scale bars are 20 µm.
A widespread formation of foci could be observed for HSP-17-GFP with little diffusive 
material remaining, spanning the head, intestine and tail of  C. elegans. Notably, a 
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distinct localization inside the excretory tract remains visible. Conversely, GFP alone 
under the same promoter shows diffusive behavior even at day 14 of age in the 
pharynx. While both HSP-17-GFP or GFP alone do not seem to aggregate in the 
excretory tract,  GFP alone is  distributed diffusely  throughout  the entire  cell  while 
HSP-17-GFP maintains  an  inhomogeneous  distribution.  I  conclude  from this  that 
HSP-17 has a specific propensity to form foci in C. elegans which is independent of 
the GFP-fusion. 
Visualization of foci of HSP-17-GFP as seen in Figure 30 at an ultra-resolved level by 
CLEM was attempted, to assess whether they have a specific subcellular localization 
or association. Imaging of the pharyngeal bulb of an adult animal revealed a cellular 
structure that could be correlated with HSP-17-GFP fluorescence:
Figure 31: HSP-17 localizes to cellular, electron-dense foci in the pharynx 
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CLEM of a  C. elegans p17tG specimen. A section of the pharyngeal bulb and surrounding tissue is 
shown. Image i shows the ultrastructure of a part of the pharyngeal bulb. Red arrow indicates an  
electron dense, membrane-less structure. Image ii shows an overlay of HSP-17-GFP fluorescence, 
colocalizing with the indicated structure. Image iii shows a total perspective of the surrounding EM-
grid, including an overlay of the GFP-channel (the structure is indicated by a red arrow and the field of  
view in i & ii is marked. Image iv shows a DAPI-staining of the sample, including HSP-17-GFP overlay.  
Scale bars are 2 µm (i, ii) or 10 µm (iii, iv). CLEM experiments were performed by D. Puchkov.
While I was unable to clearly designate any spheroid structure observed by CLEM to 
be a cellular aggregate, I note that the structure contains HSP-17, is electron dense 
and adjacent to the nucleus. The structure has uneven edges distinct from nearby 
spheroids (possibly with membranes). I deduce that this is either a different type of  
structure to which HSP-17 specifically localizes, or that all spheroids are the same (i. 
e. aggregates), but HSP-17 does not colocalize with every cellular aggregate.
To biochemically validate this formation of aggregates and quantify it  as systemic 
behavior, I undertook analysis of C. elegans proteins ex vivo. Revisiting my approach 
depicted in Figure 15, I first generated lysates of N2 nematodes aged 2, 4, 6 and 8 
days respectively. After all lysates were adjusted to the same protein concentration, 
soluble  and  insoluble  material  was  separated  by  centrifugation  and  analyzed  by 
western blot using HSP-17 polyclonal antibodies.  
Figure 32: HSP-17 transitions to the insoluble state with age in C. elegans 
Lysates of N2 nematodes of the indicated age were fractionated into soluble and insoluble fractions 
and HSP-17 was quantified in each fraction by western-blot immunodetection. The experiment was 
performed in triplicates and error bars are indicating SEM.
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Nematodes were  analyzed throughout  their  reproductive  phase  (day 4  –  day 8), 
which  also  marks  the  onset  of  aging,  proteostatic  decline  and  systemic  protein 
aggregation (115). Indeed, HSP-17 insolubility coincides with this window and by the 
end of the reproductive phase, the majority of HSP-17 is found in cellular aggregates. 
This indicates that either HSP-17 itself becomes insoluble upon stress and aging or 
else that it actively co-aggregates with its protein substrates. I decided to investigate 
this question by observing if HSP-17 binds to an aggregation-prone protein substrate 
in vivo and the effect it has on the aggregation propensity. As a model, nematodes 
expressing  iQ44-YFP  in  the  intestine  were  utilized.  This  polyglutamine  protein 
generates  distinct  and  scorable  foci  of  protein  aggregation  in  an  age-dependent  
manner  (178) and  presents  an  opportunity  for  robust  quantification  of  pro-
aggregation activity. It  has been demonstrated that intestinal iQ44-YFP is prone to 
aggregate under osmotic stress, meaning it is vulnerable to at least one stressor that 
HSP-17 is physiologically implied in (179). I observed nematodes from day 4 to day 8 
of  life  that  were  either  depleted for  hsp-17,  applying  a  knockdown of  hsp-17, or 
overexpressed HSP-17:
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Figure 33: HSP-17 enhances formation of iQ44-foci in vivo 
Confocal laser scanning microscopy of nematodes expressing Q44-YFP to the intestine. Left: control 
RNAi condition; middle: iQ44-YFP + HSP-17-wrmScarlet overexpression; right: iQ44-YFP +  hsp-17 
RNAi. Images show the intestine for day 4, 5 and day 6 (top to bottom) and white arrows indicate 
cellular foci of aggregation. Images are representative. Scale bars are 20 µm.
I observed that foci in nematodes overexpressing HSP-17 appeared more frequently 
and earlier compared to the control condition, whereas hsp-17 RNAi slightly delayed 
the formation of iQ44-YFP foci. To quantify this effect, the occurrence of foci for each 
nematode and day of life was counted and grouped into those that exhibited more 
than zero foci or multiple (> 3) foci:
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Figure 34: HSP-17 enhances formation of iQ44 foci in vivo (quantification) 
Quantification of foci observed in C. elegans as presented in Figure 33. Animals with more than 0 foci 
(left) or more than 3 foci (right) were counted. Intestinal Q44 nematodes subjected to control RNAi 
(blue) or hsp-17 RNAi (red) were scored alongside the crossing between iQ44 and p17tR (green). The 
number of nematodes scored in either group is given as percentage of total animals analyzed. The 
data resulted from two independent repeats and standard deviation is indicated.
With  these  data  I  could  demonstrate  for  the  first  time  that  HSP-17  affects  the 
aggregation of a model substrate in vivo. Depletion of hsp-17 can reduce the speed 
and severity of iQ44-YFP aggregation, while the HSP-17 overexpression enhances it. 
Is this the consequence of direct binding between HSP-17 and iQ44-YFP, or do I 
observe  increased  aggregation  of  iQ44-YFP  because  HSP-17  alters  cellular 
proteostasis by binding a different, independent substrate? To address this question, 
I analyzed whether HSP-17 is colocalizing with iQ44-YFP foci in vivo by crossing the 
strain p17tR with the polyQ-model strain, iQ85-YFP. This strain expresses a highly 
elongated polyQ-peptide  stretch  and shows notable  foci-formation  even in  young 
animals:
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Figure 35: HSP-17 colocalizes with some iQ85-YFP-foci in vivo 
Microscopies of a crossing between the hsp-17 translational reporter and an iQ85-YFP polyQ reporter 
strain. Individual channels for HSP-17-wrmScarlet and iQ85-YFP are provided alongside an overlay. 
White arrows mark instances of HSP-17-foci colocalizing with iQ85-foci. The image is representative 
and scale bars are 20 µm.
Not all iQ85-YFP foci colocalize with HSP17-foci and both fusion proteins can form 
cellular aggregates independently of each other. Nonetheless, the images show that 
foci of iQ85-YFP can incorporate HSP-17, demonstrating that both proteins interact in 
vivo. This result still leaves the possibility that the interaction between HSP-17 and 
the  polyQ-construct  is  mediated  by  or  depending  on  a  further,  unknown  factor. 
Hence, I decided to assay the interaction of both partners in vitro. Purified HttEx1Q48 
was aggregated in the presence of HSP-17 and the association of HSP-17 to the 
generated HttEx1Q48 fibrils was analyzed by immunogold-labeling using the HSP-17 
antibodies.  This  method  has previously  been used  to  visualize  the  interaction  of 
molecular chaperones with HttEx1Q48 fibrils in vitro (27). 
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Figure 36: HSP-17 colocalizes with HttEx1Q48 fibrils in vitro 
HttEx1Q48 was aggregated in the presence of 5-fold excess of HSP-17. Fibrillary material was located 
on the EM-grid for imaging and red arrows indicate immunogold-beads colocalizing with fibrils. Scale 
bar is 100 nm.
As  can  be  seen  in  Figure  36,  HSP-17  can  interact  with  HttEx1Q48 fibrils  in  the 
absence of any additional factors. In summary, the intestinal Q44-YFP construct was 
used to demonstrate molecular aggregase activity of HSP-17 in vivo. However, Q44-
YFP is an artificial substrate and I thus wanted to analyze endogenous proteins and 
potential  substrates.  I  set  out  to  identify  in  vivo substrates of  HSP-17 for  further 
analysis. First, I crossed the phsp-17::hsp-17::GFP translational reporter strain with a 
reporter strain of a known C. elegans stress granule reporter (strain DCD214), pab-1, 
which  shares  pharyngeal  localization  (180).  Yet,  the  microscopy  images  of  the 
crossed strain indicate that HSP-17-GFP and tagRFP-PAB-1 do not colocalize but 
rather occupy distinct foci within the pharynx (supplementary Figure 6). Notably, the 
localization of proteins such as PAB-1 to stress granules is associated with prion-like 
domains, which are absent in HSP-17 (see Figure 14). Thus, I focused on a different 
protein,  KIN-19,  which  is  likewise  reported  to  become insoluble  upon organismal 
aging and to be excluded from stress granules (114,180). I generated a genetic cross 
of the translational HSP-17-GFP reporter with a reporter expressing KIN-19-tagRFP 
controlled by the native promoter:
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Figure 37: HSP-17 and KIN-19 colocalize in the pharynx and excretory tract 
Representative confocal LSM of C. elegans p17tG crossed with the strain CF3166 (expression of KIN-
19-tagRFP controlled by the native promoter). Separate channels and combined channel are provided, 
as noted on the images. The excretory tract (i-iii) and the pharynx (iv-vi) have been monitored. Scale  
bars are 20 µm.
My observation points to a colocalization between KIN-19 and HSP-17, including in 
foci. This indicates that HSP-17 and KIN-19 co-aggregate, however, I also observed 
HSP-17 and KIN-19 moieties that did not colocalize. 
To  quantify  colocalization,  I  analyzed  multiple  microscopies  by  the  Fiji  plugin 
EzColocalization. I focused on the pharynx, as this was an area of the nematode 
marked  by  a  high  number  of  foci  for  both,  KIN-19  and  HSP-17.  Colocalization 
analysis between HSP-17-GFP and KIN-19-tagRFP yielded a Pearson’s correlation 
coefficient  of  0,58  and  a  Spearman’s  rank  correlation  coefficient  of  0,63 
(representative images used for the analysis are found in supplementary Figure 7).  
Assuming values of -1 for the PCC or SRCC to indicate total exclusion, 0 to indicate 
no correlation and 1 to indicate complete colocalization, I interpret these values as a 
significant, but not complete colocalization between both proteins.
Consequently,  I  asked  if  KIN-19  aggregation  is  affected  by  HSP-17.  For  that,  I  
analyzed  groups  of  nematodes  overexpressing  KIN-19-tagRFP  alone  or  in 
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conjunction  with  HSP-17-GFP  overexpression.  Furthermore,  I  subjected  KIN-19-
tagRFP nematodes to  hsp-17 knockdown by RNAi. The number of KIN-19-tagRFP 
foci were analyzed in the head region of each nematode and the total number of KIN-
19-tagRFP foci for each group of nematodes was quantified:
Figure 38: HSP-17 overexpression increases the formation of pharyngeal KIN-19 foci 
For  nematodes  overexpressing  KIN-19-tagRFP,  the  number  of  fluorescent  foci  in  the  head  was 
quantified (blue) and visualized as a violin-plot. Quantification was also carried out for the same strain  
subjected to hsp-17 RNAi (red) and for this strain, crossed with a translational reporter overexpressing 
HSP-17-GFP (green).  The experiment was carried out  in three independent repeats and one-way 
ANOVA testing (followed by Bonferroni’s multiple comparisons test) was performed. Significant results 
were indicated by stars (Kin-19 OE control RNAi vs. KIN-19 OE hsp-17 RNAi: p = 0,0031).
I took these data as confirmation that HSP-17 overexpression can indeed enhance 
the formation of KIN-19 foci  in vivo, recapitulating the molecular aggregase activity 
observed in Figures 11 & 12. Depletion of  hsp-17 did not appear to diminish foci 
formation of KIN-19. This might be due to the fact that the KIN-19 reporter strain itself  
constitutes an overexpression condition, and the sensitivity of  KIN-19 aggregation 
depends  on  a  specific  ratio  to  HSP-17.  Indeed,  maintenance  of  the  KIN-19 
overexpressing strain CF3166 revealed severe physiological defects. To correlate an 
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increase of aggregation of KIN-19 with organismal defects and toxicity, I monitored 
the development of the same C. elegans strains from L1 larval stage to adulthood.  
Figure 39: HSP-17 mediates deleterious effects of KIN-19 overexpression 
Development was monitored for nematodes starting with L1 larvae and the number of nematodes 
reaching adulthood by day 4 of life was plotted. N2 nematodes and N2 nematodes subjected to control 
RNAi (blue) or hsp-17 RNAi (red), as well as the strain p17tG (green) were used as control. The KIN-
19 overexpressing strain CF3166 was subjected to no RNAi or control RNAi (purple) and hsp-17 RNAi 
(orange). The crossing of p17tG and CF3166 is depicted in light blue. The experiment was carried out  
in three independent repeats and one-way ANOVA testing (followed by Sidak’s multiple comparisons 
test) was performed. Significant results were indicated by stars (N2 vs. KIN-19 OE: p < 0,0001; N2 vs.  
KIN-19 OE / HSP-17 OE: p < 0,0001; Kin-19 OE control RNAi vs.  KIN-19 OE  hsp-17 RNAi:  p = 
0,0393).
I  conclude from this  experiment  that  overexpression  of  KIN-19 has a deleterious 
effect  on  C.  elegans development  which  is  exacerbated  by  concurrent 
overexpression  of  HSP-17.  Conversely,  knockdown  of  hsp-17 in  the  KIN-19 
overexpressing  nematode  slightly,  but  significantly,  rescues  development.  In 
conjunction with the observations from Figures 37 & 38, I interpret these results as 
confirmation that KIN-19 is an in vivo interaction partner of HSP-17, that aggregation 
of KIN-19 can be enhanced by HSP-17 and that modulation of KIN-19 by HSP-17 is 
relevant for physiological fitness.
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On a final note, HSP-17 was found in my IP-MS/MS approach to be involved in the 
gestation of offspring and membrane transport  (Table 2).  Based on my data that  
HSP-17 localizes to some intestinal membranes (Figures 20, 22 & 23) and is relevant 
for  fecundity  in  C. elegans (Figure 26),  I  generated a genetic cross between the 
strain p17tR and the VIT-2-GFP translational reporter strain DH1033 (vitellogenin-2 is 
an egg yolk protein, synthesized in the intestine and translocated to eggs (181), also 
found  to  interact  with  SIP-1  (82)).  While  I  did  not  observe  major  colocalization 
between the two fluorophores, the crossed nematodes exhibited a dumpy phenotype, 
as shown in supplementary Figure 8. Furthermore, HSP-17 does seem to colocalize 
with  vesicular  structures  (compare  the  “dotted”  line  around  the  excretory  tract  in 
Figure 20 v,  Figure 23 and also refer to Table 2).  Hypothesizing that  HSP-17 is 
involved  in  membrane  transport  or  endo-  and  exocytosis,  I  crossed  the  HSP-17 
translational  reporter  with  additional  reporter  strains1.  Initial  screenings  revealed 
infrequent  colocalization  between  HSP-17  and  markers  of  vesicular  traffic 
(supplementary Figures 9 & 10). In summary, these analyses suggest that HSP-17 
plays an undiscovered role in  C. elegans vesicular traffic, membrane transport and 
fat metabolism.
4.2. A new model of A toxicity in C. elegans
My  work  on  HSP-17,  which  exhibits  a  non-canonical  chaperone  activity,  has 
demonstrated that  molecular  chaperone activity  is  strongly dependent  on specific 
protein  substrates  in  vitro.  Adding to  this  in  vivo,  many physiological  effects  can 
spring  from  this  activity  and  chaperoning  is  possible  even  for  non-physiological 
amyloids  like  polyQ-peptides.  This  underlines  the  need  to  develop  new  in  vivo 
models to expand the substrate repertoire that can be assayed. 
Neurodegenerative  disease  is  often  preceded  by  a  collapse  of  the  proteostatic 
network,  a  process  in  which  amyloidogenic  proteins  such  as  A are  either  key 
substrates or agents (10,36). While the membrane protein APP has a homolog in C. 
elegans (the essential APL-1), the A peptide is not encoded and likely vertebrate-
specific (182). This has incited the generation of humanized C. elegans models of A 
1 The list of strains in the materials section shows an oversight of available strains crossed with my 
HSP-17 reporter, including reporters of endo- and exocytosis (rab genes, clathrin).
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pathology,  expressing the peptide cellularly  (151),  which have been subsequently 
improved  (154).  These  models  recapitulate  the  formation  of  amyloids  leading  to 
physiological defects (155) and also reveal action of molecular chaperones such as 
Hsc70 or sHsps on A (160,161). Nonetheless, existing models forwent labeling of 
the peptide,  mandating visualization of  amyloids  by  staining  (151,152) or  labeled 
every moiety of A, preventing “native” amyloid formation  (156). A new model with 
powerful and versatile labeling could enhance the analysis of the chaperone network 
and sHsps in the context of amyloid pathogeny.
4.2.1.  Generation of a new C. elegans A model strain
Together  with  Christian  Gallrein  (CG),  I  set  out  to  generate  a new model  of  A 
pathology in  C.  elegans,  combining  facile  in  vivo visualization  with  “native”-like 
fibrilization properties. To this end, untagged A1-42 was expressed in combination 
with a sub-stoichiometric moiety of labeled A1-42. As a label, the high quantum yield, 
monomeric  red-spectrum  fluorophore  mScarlet  (183) was  used,  in  a  version 
optimized for expression in C. elegans (wrmScarlet, (184)). To achieve pan-neuronal 
expression, the promoter region of rgef-1 was chosen. Because the A peptide lacks 
an N-terminal  methionine,  it  was headed by a signal  peptide for  ER-import.  This 
signal  peptide  is  cleaved  to  yield  full-length  A1-42,  which  is  reportedly 
retrotranslocated  to  the  cytosol  (152,154).  Finally,  to  achieve  sub-stoichiometric 
labeling, the unlabeled A peptide is followed by the IRES-element of  C. elegans 
hsp-3, followed by wrmScarlet-A1-42. IRES-dependent initiation of translation is less 
efficient than cap-dependent initiation of translation, leading to a reduced expression 
of N-terminally tagged A1-42 (185,186).
To achieve the desired construct, I performed molecular cloning to replace the CDS 
of  GFP in  the  vector  pPD95.77  with  A1-42,  before  adding  wrmScarlet  to  the  N-
terminus  and  then  cloning  the  promoter  of  rgef-1 into  the  vector.  In  parallel,  a 
construct consisting of signal-peptide::A1-42::IRES was generated (CG). The latter 
was then cloned into  the  first  to  achieve the  depicted  construct.  Additionally,  for 
expression to the body wall muscle, the promoter of myo-3 was cloned to replace the 
promoter of rgef-1 (CG).
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Figure 40: Genetic construct for expression of A1-42 in C. elegans 
The construct cloned for expression of A1-42 with sub-stoichiometric expression of wrmScarlet A1-42. 
From 5’ to 3’: promoter regions of rgef-1 (pan-neuronal) or myo-3 (body wall muscle), 5’-methionine-
signal peptide (cleaved upon failed ER-entry), full-length A1-42, IRES of hsp-3 for attenuated initiation 
of translation, wrmScarlet-A1-42. 
Subsequently,  microinjection  was  performed  to  generate  the  neuronal  A strain 
(JKM2 /  nA).  The muscular  A strain  (JKM7 /  mA),  as  well  as  control  strains 
expressing only wrmScarlet controlled by the promoters of rgef-1 (JKM3 / nScarlet) or 
myo-3 (JKM8 / mScarlet), were generated by microparticle bombardment. All strains 
except JKM8 were chromosomally integrated (CG).
To  confirm  successful  generation  of  the  planned  transgenic  strain  I  performed 
blotting of lysates of the strains nA and mA. In parallel, I visualized the generated 
strains by laser scanning microscopy:
Figure 41: Visualization and biochemical analysis of C. elegans strain nA
Left side: expression of  wrmScarlet-A1-42  in neurons of  C. elegans, with details of head (i), body (ii) 
and tail (iii). Scale bar is 100 µm for whole animal and 50 µm for detail. Right side: Western blotting of  
JKM2 lysates with 6E10 antibodies to detect wrmScarlet-A1-42  (around 35 kDa) and A1-42  (below 10 
kDa).
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Figure 42: Visualization and biochemical analysis of C. elegans strain mA
Left side: expression of  wrmScarlet-A1-42  in body wall muscle of  C. elegans, with details of head (i), 
lower body (ii) and tail (iii). Scale bar is 100 µm for whole animal and 50 µm for detail. Right side:  
Western blotting of JKM7 lysates with 6E10 antibodies to detect wrmScarlet-A1-42  (around 35 kDa) 
and A1-42 (around 10 kDa).
By  western  blotting  I  could  demonstrate  that  co-expression  of  the  tagged  and 
untagged A moiety was achieved as planned. In addition, microscopy demonstrated 
that  wrmScarlet-A1-42  is  present  in  C.  elegans neurons  or  body  wall  muscle, 
respectively. The signal acquired from blotting JKM2 lysates is very faint (Figure 41), 
implying that the total mass of the peptide expressed to the neurons is a relatively 
small fraction of total protein mass per nematode. By comparison, detection of A in 
JKM7 lysates leads to a stronger signal (Figure 42). I surmise that the total mass of 
A peptide expressed to body wall muscles per nematode is higher and therefore 
more suitable for biochemical analysis. To estimate the relative levels of labeled and 
unlabeled A in the model, I performed additional western blot experiments with the 
muscular  strain  to  perform  quantification  by  band  intensity.  I  observed  a  high 
variance in the relative levels of labeled to unlabeled A, implying uneven blotting or 
detection efficiency for A (Supplementary Figure 11). 
A key feature of the new AD model is that a large moiety of unlabeled A peptide is 
to interact with a smaller fraction of labeled peptide, to combine easy visualization 
with  unhindered formation of  fibrils.  To demonstrate that  both moieties interact,  I 
prepared  lysates  of  mA nematodes  and  used  them  for  an  immunoprecipitation 
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experiment  (with  anti-GFP  antibodies,  binding  wrmScarlet)  followed  by  western 
blotting. If both moieties of A interact in vivo, pulldown of wrmScarlet-A should be 
sufficient to enrich unlabeled A:
Figure 43: Immunoprecipitation of A peptide in C. elegans strain mA
Lysates of  mA were used to perform IP of  wrmScarlet-A1-42 by anti-GFP antibodies, followed by 
western blotting with anti-A-antibodies. On the left side, whole lysate was blotted. On the right side, 
the IP-sample was blotted. In both lanes, labeled and unlabeled peptide were detected as indicated.  
Detection was carried out with 6E10 antibodies.
Notably,  IP of wrmScarlet-A1-42 was sufficient to enrich the sample for unlabeled 
A1-42, implying that both peptides interact  in vivo, as intended in the experimental 
design.  Following  the  establishment  of  the  new  model  strains,  I  then  set  out  to 
analyze the impact of A1-42  overexpression on the  C. elegans organism  in  and ex 
vivo.  To  validate  the  use  of  the  model  it  had  to  be  demonstrated  that  A1-42 
overexpression has deleterious effects in vivo, including defects that were previously 
observed.  Moreover,  the  fluorescently  labeled  wrm-Scarlet-A1-42 would  need  to 
provide information on localization and aggregation of A in living C. elegans.
4.2.2. Biochemical analysis of C. elegans A1-42 model strains
I  first  set  out  to  characterize  the  in  vivo interactome  of  A1-42  overexpressed  in 
C. elegans through IP-MS/MS experiments. Two main questions can be addressed in 
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this fashion: does the  C. elegans proteostasis network exert molecular chaperone 
activity  in  this  humanized  model  of  A pathology  and  does  the  peptide  have 
deleterious effects on specific cellular mechanisms? I performed immunoprecipitation 
with 6E10 anti-A-antibodies on lysates of mA and nA. As controls for background 
and antibody specificity, the strains expressing muscular or neuronal wrmScarlet, but 
not A, were used. Analysis of the samples by MS/MS was performed and proteins 
that were either significantly detected exclusively in the mA and nA fractions, or 
significantly increased in those fractions compared to the controls, were considered 
to be enriched and thus part of the A interactome1. 
For mA, a large set of proteins was identified as significantly enriched, including the 
Hsc70-family chaperone HSP-1 and the sHsp HSP-16.41. Both were reported to be 
interacting with A previously in the muscular mA model CL2006 (160). Moreover, I 
identified  the  Hsp90  homolog  DAF-21  and  the  ER-chaperone  CNX-1  (calnexin). 
Other chaperones were identified that had not previously been reported to interact  
with A in vivo: the J-proteins DNJ-2, DNJ-13, DNJ-19 and DNJ-29. The identification 
of  numerous  molecular  chaperones  as  A interaction  partners  indicates  that  the 
peptide is recognized as misfolded or proteotoxic.  To visualize the enrichment of  
proteins detected by IP-MS/MS, I generated a volcano plot:
1 Raw  data  for  the  IP-MS/MS  experiments  and  resulting  search  files,  as  well  as  experimental 
parameters,  have been uploaded to  the PRIDE repository.  A supplementary  table  with  additional 
information is also provided (see data availability, 10.3).
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Figure 44: Volcano plot of IP-MS/MS results (mA)
Each dot represents a protein identified by IP-MS/MS and red dots are proteins significantly enriched. 
Proteins of particular interest have been labeled in blue, including the target of IP, wrmScarlet-A. The 
x-axis  can  be  considered  a  measure  of  enrichment  in  the  sample  and  the  y-axis  a  measure  of  
significance (-log2). IP-MS/MS analysis was performed in triplicates. One set of sample and control 
was similar to each other and censored from the final result.
IP-MS/MS analysis  of  nA yielded  only  a  small  number  of  significantly  enriched 
proteins. Comparing the western blots in Figures 41 & 42 already demonstrated that 
the total fraction of A peptide upon neuronal overexpression is very low and difficult 
to  detect  biochemically.  Hence,  I  also  cannot  exclude  false-positive  protein  hits. 
Unsurprisingly,  previous  proteomic  analyses  of  A overexpression  in  C.  elegans 
have  also  focused  on  muscular  models  (160,187).  Nonetheless  the  chaperone 
protein F44E5.4 (HSP-70) was identified in the neuronal model strain, as previously 
reported  (187), hinting that molecular chaperones are involved in remodeling  A in 
the neurons as in the muscles. To exemplify the resulting data, I prepared another 
volcano plot:
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Figure 45: Volcano plot of IP-MS/MS results (nA)
Each dot represents a protein identified by IP-MS/MS and red dots are proteins significantly enriched. 
Proteins of particular interest have been labeled in blue. The x-axis can be considered a measure of 
enrichment in the sample and the y-axis a measure of significance (-log2). IP-MS/MS was performed 
as a triplicate experiment.
The small dataset generated from the neuronal strain was insufficient for systemic 
analysis. However, close to 300 proteins were identified (Figure 44, colored dots) in 
the muscular strain. Based on the assumption that many cellular features such as 
membranes, protein transport and protein folding or degradation are conserved in all  
cells, I decided to analyze the muscular model as a proxy for organismal effects of  
A. To systemically analyze the large set of enriched proteins identified from mA, I 
performed functional  annotation analysis using the online tool  DAVID to generate 
GO-terms for the mA strain:
72
Table 4: List of notable GO-terms identified in IP-MS/MS analysis of mA




1 Receptor-mediated endocytosis 54 1,05E-13
2 Cullin deneddylation 5 4,30E-6
3 Endoplasmatic reticulum UPR 9 2,99E-4
4 Protein transport 11 1,70E-3
5 Secretion by cell 8 2,16E-3
6 Apoptotic process 35 7,38E-9
7 Determination of adult lifespan 42 1,77E-4
8 Protein folding 10 2,34E-4
9 Response to starvation 5 8,78E-3
10 Response to heat 7 9,35E-3
11 Locomotion 64 2,15E-7
12 Body morphogenesis 29 6,11E-4
13 Oxidation-reduction process 24 2,80E-3
In  the  selection  of  GO-terms  I  present,  a  number  of  terms  relate  to  protein 
homeostasis (6-10). Indeed, stress response upon A overexpression in body wall 
muscle was reported ((188), by induction of hsp-16 promoter) and these terms mirror 
the selection of individual  chaperones presented above. I  surmise that the model 
undergoes  proteotoxic  stress  as  intended.  Motility  (11-12)  is  also  implied  in  the 
dataset and it has been shown that muscular A expression in C. elegans can lead to 
progressive  paralysis  (151,189).  Moreover,  redox-process (13)  is  among my hits, 
matching  previous  reports  that  A overexpression  can  lead  to  an  impairment  of 
redox-homeostasis  (190), as does proteotoxic stress in general  (191). Finally, GO-
terms related to protein trafficking, membrane- and vesicular transport  as well  as 
secretion (1-5) are significant among my identified proteins. This may be due to the 
peptide being targeted to the ER, or a more general membrane-damaging effect of  
A, which has recently been described in C. elegans (56). This observation may point 
to intercellular spreading of  A occurring in the new model, which is a hallmark of 
amyloid pathology (58).
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To  reinforce  these  proteomic  observations,  subsequent  experiments  had  to  be 
carried out. First, TEM analysis of the strains mA and nA was performed. For both 
strains, adult nematodes on day 10 of life were analyzed:
Figure 46: TEM of amphisomes and swollen ER in mA and nA
TEM was performed on mA and nA nematodes and representative images are presented. On the 
left side, muscular tissue of mA is shown and in the middle, a zoom as indicated by the dashed white 
lines  in  the  left  image.  The  red  arrows  indicate  instances  of  incomplete  or  aberrant  membrane 
structures. On the right side, an image of nA is presented and the white arrows indicate instances of 
swollen ER. TEM experiments were performed by Dmytro Puchkov.
For the muscular strain, striking clusters of incomplete membrane structures, of either 
endo-/exosomal,  lysosomal  or  autophagosomal  nature  (hence  referred  to  as 
“amphisomes”)  were  frequently  detected  (Figure  46  left  side  and  zoom).  These 
structures  could  be  interpreted  as  loci  of  failed  autophagy,  which  is  commonly 
reported in AD pathology (192). Furthermore, in the context of A spreading, these 
structures could represent aberrant multivesicular bodies resulting from A trafficking 
(193).  In  the  neuronal  model,  amphisome  formation  was  less  pronounced,  but 
bloated ER-structures were frequently observed. While the ultrastructural analysis of 
mA and nA did not yield identical findings, it can be concluded that both models 
show aberrant autophagy or impairments in the endo-membrane system and that the 
neuronal model has defects in the ER.
I attempted to corroborate these findings with further biochemical analyses. First, I  
crossed the strains JKM2, 3, 7 and 8 with a strain bearing a YFP-reporter controlled 
by the  hsp-3 promoter region. As HSP-3 (BiP-homolog) is an ER-chaperone, it is 
induced  upon  ER-stress  and  both  the  GO-terms in  table  4  as  well  as  the  TEM 
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analysis  indicate  that  this  should  occur.  I  quantified  the  induction  of  YFP  in 
nematodes on day 7 of life for each crossed strain compared to the respective control  
strains:
Figure 47: Quantification of phsp-3 induction by overexpression of A
Left  side:  YFP-fluorescence  in  nematode  intestines  was  quantified  for  10-20  nematodes in  three 
independent experiments. The y-axis indicates the fold-induction normalized to the controls (set as 1). 
One-way ANOVA testing was performed. The muscular control (cyan) was compared to mA (purple) 
and the neuronal control was compared to nA (red) by Bonferroni’s multiple comparisons test and 
significant  results  were  indicated  by  stars  (neuronal  control  vs.  nA: p  =  0,0003).  Right  side: 
microscopies exemplifying the induction of YFP in the neuronal control (top) or nA (bottom). Scale 
bars are 50 µm.
My analysis revealed that,  in line with the observations from TEM, the ER stress 
response is induced in the nA background. This is also in line with my observations 
from the IP-MS/MS experiment on mA (Table 4, 1-6), although YFP-induction in the 
muscular  strain  was  not  significant.  Indeed,  mA did  not  show  the  swollen  ER 
phenotype in TEM experiments (Figure 46, right side). I conclude that while there 
might be an involvement of ER stress in mA, this effect is too subtle to be detected 
by methods other than MS/MS.
TEM experiments  also  pointed  to  defects  in  autophagy  upon  A overexpression 
(Figure  46,  left  side).  Since  the  observed  amphisomes  can  be  interpreted  as 
remainders  of  failed  initiation  of  autophagy,  I  set  out  to  biochemically  analyze 
expression levels of  autophagy markers in the  A background. Using  C. elegans 
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lysates  of  young  adult  animals,  I  performed  western  blotting  with  subsequent 
detection  utilizing  anti-SQST-1 antibodies  or  anti-LGG-1 antibodies.  SQST-1 is  a 
homolog of human p62 (an adaptor and substrate of autophagy) and LGG-1 is a 
homolog of human LC3 (an initiator of phagophore formation). Detection was carried 
out as described previously (175):
Figure 48: Quantification of SQST-1 in A1-42 expressing nematodes
Left side: SQST-1 expression levels were quantified in three independent experiments. The y-axis 
indicates  the  fold-induction  normalized  to  the  controls  (set  as  1).  One-way  ANOVA  testing  was 
performed. The muscular control (cyan) was compared to mA (purple) and the neuronal control was 
compared to nA (red) by Sidak’s multiple comparisons test (no significant differences). Right side: an 
exemplary western blot showing bands for SQST-1 in samples and controls (both bands correspond to 
SQST-1 (175). In the same experiment, tubulin was detected as a loading control (lower part).
For SQST-1, no change in cellular levels was detected in the A background. This 
can  indicate  that  expression  or  turnover  of  SQST-1,  a  substrate  of  autophagy, 
remains  unaltered.  To complement  this  analysis,  LGG-1 needed to  be  quantified 
analogously:
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Figure 49: Quantification of LGG-1 in A background
Left  side:  LGG-1 expression levels  were quantified in  three independent  experiments.  The y-axis 
indicates  the  fold-induction  normalized  to  the  controls  (set  as  1).  One-way  ANOVA  testing  was 
performed. The muscular control (cyan) was compared to mA (purple) and the neuronal control was 
compared to nA (red) by Sidak’s multiple comparisons test and significant results were indicated by 
stars (muscular control vs. m A: p = 0,0112). Right side: an exemplary western blot showing bands 
for LGG-1 in samples and controls. In the same experiment, tubulin was detected as a loading control  
(lower part).
In this experiment, LGG-1 levels in mA were significantly reduced but did not differ 
significantly in the neuronal model. Reduction of LGG-1 paired with constant levels of 
SQST-1 implies defects in initiation of autophagy (175) and this matches the previous 
observation of aberrant membrane clusters or amphisomes (Figure 46, left side). 
To summarize, by IP-MS/MS analysis I could demonstrate an induction of proteotoxic 
stress, the involvement of molecular chaperones and other organismal defects, all of  
which are in agreement with described models of A pathology. Furthermore, defects 
in autophagy (in the muscular model)  and a deleterious effect on the ER (in the 
neuronal model) could be confirmed on the ultrastructural and biochemical level.
4.2.3. Primary vulnerable neurons
The principal utility of labeling A in this approach is tracking the distribution and 
aggregation state of wrmScarlet-A in C. elegans in vivo. Due to the interaction with 
labeled  A (see  Figure  43),  the  distribution  of  unlabeled  A could  be  inferred. 
Fluorescence  lifetime  imaging  microscopy  (FLIM)  was  employed  to  quantify  the 
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progression of A aggregation over age. In brief, observing the fluorescence lifetime 
of wrmScarlet can be used to monitor and quantify the aggregation and formation of 
amyloid fibrils by A, more so than simple distribution of the fluorophore (i. e. into 
cellular  foci).  A reduction of  the fluorescence lifetime τ,  compared to  the control, 
implies that the fluorophore is located in a microenvironment adjacent to aggregated 
or fibrillar material  (194). Nematodes on days 3, 4, 7 or 10 of life were analyzed to 
quantify the aggregation state of A (FLIM experiments by CG).
The  generated  FLIM  data  indicated  an  age-dependent  decline  of  fluorescence 
lifetime of wrmScarlet in those strains overexpressing A. By contrast, the decline of 
fluorescence lifetime was mild for the control strains where A is absent. From this, it 
could  be  concluded  that  aggregation  of  A occurs  and  is  directly  affecting  the 
microenvironment  of  wrmScarlet.  The  difference  between  control  and  A strains 
emerged on day 4 of life, coinciding with the onset of proteostatic decline (115) and 
became more pronounced at later stages of life.
Most importantly, FLIM-analysis of nA revealed that starting on day 3 of life, in a 
small fraction of neurons, aggregation of A as measured by fluorescence lifetime is 
more pronounced than in other neurons. This group of six neurons located in the 
anterior  ganglion  displayed  early  aggregates,  hinting  that  they  are  particularly 
vulnerable to A overexpression.
Figure 50: Detection of neurons in nA vulnerable to aggregation
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A visualization depicting select neurons located in the anterior ganglion of  C. elegans. Cholinergic 
neurons  are  marked  blue,  dopaminergic  neurons  are  marked  green,  glutamatergic  neurons  are 
marked yellow. Black lines roughly indicate the shape of the nematodes skin and the pharynx. Dashed 
outlines indicate neurons that are on the opposite site of their respective counterpart. The red arrow 
roughly indicates the expected position of the vulnerable neurons. This graphic was adapted from 
published literature (195,196).
The intriguing observation that a specific subset of neurons stands at the beginning 
of  A aggregation  and  possibly  proteostatic  collapse  necessitated  further 
investigation. Recent research has revealed that initial  populations of aggregated, 
proteotoxic A can spread inside an organism and promote pathology in adjacent 
cells,  or  systemically  (57,58,197),  fortifying  the  hypothesis  that  A pathogeny 
progresses  in  a  cascade-like  manner.  Additionally,  proteomic  (Table  4,  1-5)  and 
biochemical (Figures 47 - 49) findings underline the involvement of protein transport 
and membrane stress in the A model. Following the hypothesis that the observed 
vulnerable neurons are key in promoting organismal pathology, it was mandatory to 
elucidate their identity. Based on their specific location, previous knowledge about 
the (deterministic) development of  C. elegans neurons (Figure 50) and reports that 
cholinergic neurons are characteristically vulnerable to A pathology  (198,199), the 
six IL2 neurons were predicted as likely candidates. To confirm this, I  cloned the 
promoter  of  klp-6,  which  is  expressed  in  the  IL2  neurons  (200),  to  generate  a 
transcriptional reporter ([pklp6::GFP]). A transgenic C. elegans strain was generated 
by microinjection (CG), and I performed crossing with the strain nA. By microscopy, 
I could confirm that the vulnerable neurons overlapped with the GFP-reporter:
Figure 51: Colocalization between IL2 transcriptional reporter and nA
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Laser scanning microscopy showing GFP expressed to the IL2 neurons (i), neuronal wrm-Scarlet A, 
(ii), the overlay of both channels (iii) and an image including both channels and dissection microscopy  
(iv). The white dashed spheroids indicate the location of the IL2 neurons and the overlap between the 
GFP marker and A. The scale bar is 20 µm. 
If the identified set of six IL2 neurons is an early hot spot of A aggregation and 
moreover, key in spreading organismal pathology, modulation of A in these neurons 
should have a systemic effect. A short hairpin (shA) construct of the configuration 
A1-42 forward/reverse::sl2 was generated (CG), which could be used to achieve cell-
specific knockdown of A1-42 paired with the appropriate promoter (201,202). I cloned 
the construct into the vector pPD95.77 + pklp-6, partially removing GFP, to achieve 
IL2-specific knockdown of A. In parallel, the promoter of tol-1 was used in the same 
fashion to achieve knockdown in URY neurons, which are physically close to IL2 
neurons (Figure 50), as a control for cell-specificity, and both constructs were used to 
generate  transgenic  strains  by  microinjection  (CG).  Crossing  was  performed  to 
generate  the  strains  nAxshA(IL2)  and  nAxshA(URY)  which  should  result  in 
attenuated expression of A in the respective neurons. Then,  FLIM analysis was 
performed on nematodes on day 4 of life to validate the effect of the cell-specific 
knockdown (CG).
The data obtained by CG indicated that cell-specific knockdown of A in IL2 neurons 
could reduce the relative abundance of A aggregates in head neurons, coupled to 
longer  fluorescence  lifetimes.  This  can  be  taken  as  evidence  that  cell-specific 
treatment  reduces the  burden of  A proteotoxicity  beyond  the  targeted  cells.  To 
assess if there was an amelioration of systemic pathology, additional physiological 
experiments  were  performed:  the  lifespan of  nematodes treated with  cell-specific 
RNAi of A was assayed in combination with a swim-exhaustion assay.
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Figure 52: Cell-specific knockdown of A in IL2 neurons ameliorates proteotoxicity
Left side: A scatter dot-plot of the fraction of nematodes that were paralyzed after 30 min in a swim-
exhaustion assay. The strain nA (red), nA subjected to cell-specific A knockdown in IL2 neurons 
(yellow)  and  the  same,  but  targeted  to  URY  neurons  (magenta)  are  presented.  Wild  type  N2 
nematodes (black) are also shown for comparison. One-way ANOVA testing was performed, followed 
by Bonferroni’s multiple comparisons test. Significant results are indicated by stars. Swim-exhaustion 
assay data was prepared together with CG. Right side: Lifespan assay of nA (red) and nA treated 
with cell-specific knockdown of A in IL2 neurons. The fraction of surviving nematodes per day of live 
is presented, as well as the mean lifespan for each strain. The black line indicates the timespan for  
which a log-rank test  was performed and the significance is indicated by a star (p < 0,01).  The 
experiment was performed together with Sara Ayala Mariscal and results are presented for a total of 
100-150 assayed nematodes. Log-rank testing was performed by CG.
The additional assays demonstrated that cell-specific depletion of A in Il2 neurons 
can systemically improve fitness in response to exhaustion and slightly ameliorates 
the significantly reduced lifespan of nA during the reproductive phase (also compare 
Figure 25 for wild-type lifespans).
In  conclusion,  cell-specific  knockdown  in  the  identified  IL2  neurons,  but  not  the 
adjacent URY neurons, ameliorates the impact of neuronal A overexpression in the 
newly generated AD model. Both nA and nAxsh(URY) demonstrated a similar ratio 
of neurons with aggregated material on day 4 of live. Likewise, attenuation of A 
overexpression in URY neurons does not rescue the decline in fluorescence lifetime 
observed.  More  importantly,  depleting  A only  in  these  IL2  neurons  improves 
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organismal fitness of the assayed nematodes. This supports the hypothesis that IL2 
neurons are specifically vulnerable to A proteotoxicity and present a starting point 
for spreading of pathology to other cells.
5. Discussion
5.1. The non-canonical C. elegans sHsp HSP-17
The proteostasis network (PN) aids in protein folding, defends the proteome against 
stressors  that  would  lead to  protein  misfolding  and aggregation  and,  if  this  fails, 
protects  the  cell  against  deleterious  effects  of  aberrant  proteins.  Molecular 
chaperones are the main agents of the PN, aiding other proteins in reaching and 
maintaining  their  correct  fold  and  re-achieving  it  upon  misfolding  or  otherwise 
promoting  their  degradation.  Failure  of  this  process  can  be  caused  by  aging, 
mutation or external insults and is equally causative of aging and neurodegenerative 
disease  (10,32). As part of the chaperone network, small heat shock proteins are 
ATP-independent, ubiquitous, highly expressed and bind unfolded protein substrates, 
buffering them against aggregation. The sHsp substrate is thereby made available for 
ATP-dependent  molecular  chaperones,  to  perform  disaggregation  and  refolding 
(11,62).
In the work presented here, I  have analyzed the non-canonical  small  heat shock 
protein HSP-17 from C. elegans. HSP-17 was shown to exhibit limited conventional 
molecular chaperone capacity (e.g. suppression of aggregation) and instead, acted 
as a „molecular aggregase“. This term was coined previously for yeast Hsp42, which 
can act in a cytoprotective manner by promoting aggregation  (110).  Here, I  have 
demonstrated for HSP-17 as the first metazoan protein to promote the aggregation of 
the model substrate MDH in vitro and both artificial Q40-YFP as well as endogenous 
KIN-19 substrates in vivo. The physiological significance of HSP-17 was elucidated, 
showing that it  is cytoprotective under basal  and stressed conditions, relevant for 
reproduction and development and most present in the alimentary system.
82
Figure 53: Overview of HSP-17 activity
In  vitro:  Native  protein  substrates  such  as  MDH  or  Luciferase  were  utilized  (I).  The  substrates 
aggregate  due  to  proteotoxic  challenges  such  as  external  stressors  or  aging.  Red:  HSP-17  can 
enhance aggregation for the selected substrates (II). Red: HSP-17 can become insoluble alongside 
the substrate, potentially altering the resulting aggregate (III). Protein aggregates can be recovered by 
ATP-dependent molecular chaperones (such as the triad of HSP-1, HSP-110 and J-Proteins in  C. 
elegans).  Red:  HSP-17  partially  inhibits  this  recovery  (IV).  After  disaggregation  and  refolding  by 
chaperones, native proteins are recovered. Red: it remains to be uncovered if HSP-17 activity will  
result  in  recovery  or  if  HSP-17  can  alter  the  fate  of  aggregated  protein  substrates,  i.  e.  to  be 
segregated (V).  In  vivo:  HSP-17 is most notably  expressed to the pharynx,  the intestine and the 
excretory canal cell as indicated by red hues in the schematic depiction of  C. elegans. Green dots 
represent aggregated protein (I). HSP-17 was overexpressed in a transgenic model strain or depleted 
by RNAi (II). The aggregation of the selected protein substrates (KIN-19, polyQ peptides) is enhanced  
upon HSP-17 overexpression (III).  The viability of  C. elegans (i.  e. fecundity or resistance against 
select stressors) is reduced upon depletion of HSP-17 (IV).
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5.1.1. HSP-17  promotes  aggregation,  but  is  an  inefficient  molecular 
chaperone
It has been understood for a long time that small heat shock proteins are part of the 
cellular chaperones and maintain the solubility of their protein substrates in various 
tissues (86,169). Higher organisms like humans express a large number of different 
sHsps and the efficiency of this process varies greatly for each sHsp, the specific 
substrate and the surrounding medium (91). Similarly, C. elegans expresses multiple 
sHsps  (147),  which  inhibit  the  aggregation  of  model  substrates  even  at  4-fold 
molecular excess  (82,203) while others do not act as chaperones even at 200-fold 
excess (71).
Here, I undertook analysis of HSP-17 chaperone activity. I first found that HSP-17 
can prevent the aggregation of select model substrates only partially and at high 
molecular excess compared to other  C. elegans sHsps. This has been reported for 
additional  C. elegans or  mammalian sHsps  (69,72) and raised the possibility  that 
HSP-17  fulfills  an  additional  activity  besides  acting  as  a  molecular  chaperone. 
Indeed,  in vitro chaperone activity assays with MDH as a substrate revealed that 
HSP-17 can promote  the  aggregation  of  this  substrate.  This  partially  mirrors  the 
activity of yeast Hsp42, one of two yeast sHsps, which can both promote or inhibit  
aggregation of MDH under specific conditions  (110) and is the first instance of this 
activity reported in a metazoan. HSP-17 is smaller than Hsp42, which provides a 
possible  explanation  why  it  does  not  exhibit  both  activities  equally.  Furthermore, 
aggregase activity of  Hsp42 was attributed to a prion-like domain  (170),  which is 
absent  in HSP-17.  From this  I  conclude that  HSP-17 promotes aggregation by a 
different mechanism that remains to be discovered.
The observation that a chaperone family member would promote aggregation poses 
the  question  what  selection  benefit  enhanced  protein  aggregation  has.  In  yeast,  
Hsp42 was shown to be relevant for viability under recurring heat stress  (110) and 
required for  the aggregation of  substrates  at  specific  intracellular  sites  (106,108). 
Molecular aggregase activity has also been reported for  B. subtilis YocM, a protein 
relevant  under  osmotic  stress  conditions  (109) and  likewise,  HSP-17  has  been 
shown  to  be  protective  in  C.  elegans  in  vivo under  both  of  these  stresses. 
Furthermore,  HSP-17  colocalized  with  aggregates  in  vivo,  but  not  those  of  the 
aggregation-prone, stress-granule associated PAB-1  (180). CLEM data of HSP-17-
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GFP in the pharynx further corroborates this, demonstrating that HSP-17 colocalizes 
with distinct, but not all, electron-dense objects in the pharynx. This implies that like 
Hsp42, HSP-17 is not involved in all, but specific cellular aggregation events and it 
appears that  promotion of  aggregation activity  is  beneficial  at  least  under  certain 
stress conditions. Additionally, the human sHsp HSPB8 was reported to cooperate 
with BAG-3 in site-specific aggregate deposition  (104) and in combination with the 
findings  from  yeast,  B.  subtilis or  C.  elegans,  it  appears  that  selective  protein 
aggregation is conserved. In the case of Hsp42 dependent aggregate formation, it 
was shown that aggregate formation is not synonymous with failure of proteostasis  
(204). Research also demonstrated that the aggregation of aberrant proteins can be 
cytoprotective (116) and that selective protein insolubility may indeed be a function of 
the  PN,  segregating  proteotoxic  species  or  preserving  valuable  proteins  for 
resolubilization  (118).  This  remains  true  for  C.  elegans,  where  protein-specific 
aggregation is a common process in aging (114). Here as well, selective formation of 
protein  aggregates  is  required  for  viability  under  stress  conditions,  and  sHsps, 
notably including HSP-17,  are enriched in these aggregates  (120).  I  surmise that 
HSP-17 could be a part of these cytoprotective aggregation processes by directing, 
timing and promoting the aggregation of specific substrates.
5.1.2. HSP-17  co-aggregates  with  substrates  and  affects  aggregate 
processing
When  small  heat  shock  proteins  bind  unfolded  protein  substrates,  they  typically 
maintain them in a soluble or reversibly aggregated state without further processing. 
This provides a reservoir  of  salvageable proteins to be refolded by Hsp70 family 
members in conjunction with J-proteins, which is a conserved process from bacteria 
and  yeast  to  mammals  and  plants  (13,87-89).  In  monocellular  organisms,  co-
aggregation of sHsps enhances the recovery of substrates by the Hsp70 or Hsp100 
machinery (100), even when using heterologous sHsps (99), but substrates are not 
released  from  sHsps  in  the  absence  of  additional  chaperones  (205,206).  More 
recently, the Hsp70 and J-protein based disaggregation of aggregated proteins has 
been demonstrated for humans and C. elegans and likewise, co-aggregation of the 
heterologous yeast Hsp26 enhances recovery in these systems (24,25). 
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My experiments  have  shown that  HSP-17 does  partially  co-aggregate  with  MDH 
while enhancing its aggregation, whereas HSP-17 alone does not seem to readily 
separate to the insoluble fraction  in vitro. Furthermore, it was observed in vivo  that 
the fraction of insoluble HSP-17 increases with age in C. elegans and that HSP-17-
GFP localizes to cellular foci in aged nematodes. Yet, when HSP-17 co-aggregates 
with luciferase as a substrate, unlike with yeast Hsp26, subsequent recovery is not  
enhanced and instead, increasing concentrations of HSP-17 inhibited the recovery of 
luciferase.  The  concentration  at  which  this  occurs  (>  1  µM  HSP-17)  is  not 
stoichiometric  to  luciferase (15  nM)  but  to  the  chaperones  used (HSP-1:  4  µM). 
Similar effects had been described for  E. coli, where the sHsp IbpB is required for 
enhanced disaggregation, while IpbA alone inhibits it (111). In this case, the inhibition 
of recovery can be alleviated by a Hsp70 member leading to the hypothesis that 
recovery of such aggregates is controlled by the abundance of free Hsp70  (112). 
Comparable results are available for the yeast sequestrase Btn2, functionally related 
to  Hsp42,  which  also  enables  localized  aggregation  of  protein  substrates. 
Subsequent recovery is enhanced, but only in the presence of J-protein Sis1 (113). 
In the human system, BAG-3 was shown to integrate the activity of sHsps with the 
Hsp70-machinery  to  achieve  improved  protein  refolding  (103).  In  this  light  it  is 
possible that HSP-17 co-aggregation creates aggregates that can be recovered in 
presence of either an excess of Hsp70 members or possibly a co-chaperone such as 
a J-protein or a BAG-protein. The aggregation of proteins and subsequent recovery 
are  beneficial  to  stress  survival  and  aging  (119,120) and  therefore,  controlling 
aggregation and disaggregation of proteins could confer selective advantages. Small 
heat shock proteins like HSP-17 would play a role in these processes keeping protein 
aggregates inert during unfavorable conditions, reducing the folding burden on the 
chaperone machinery and allow for recovery once chaperone capacity is available.
Conversely,  maintaining  the  solubility  of  protein  substrates  may  not  be  a 
physiologically beneficial outcome in all cases. The co-incubation of human HSPB5 
with A1-40 in vitro is sufficient to prevent the formation of amyloid-fibrils. Yet, this can 
increase  proteotoxicity  in  subsequent  cell  culture  assays,  indicating  that  the 
chaperoned, non-fibrillar A species are more deleterious (207). On the other hand, 
mouse HSPB1 induces the assembly of smaller A oligomers into larger assemblies, 
reducing cytotoxicity  (124).  The trend of insoluble amyloids being less deleterious 
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has been shown for polyQ peptides as well, as cell survival was demonstrated to be 
dependent  on  inclusion  body  formation  in  a  HttEx1Q47-GFP  model  (122) and 
involvement of chaperones in this inclusion body formation has been confirmed more 
recently  (208).  I  could  demonstrate  that  HSP-17  not  only  colocalizes  with 
heterologously expressed polyQ fibrils in vivo and in vitro, but also that the formation 
of Q44-YFP foci in the C. elegans intestine correlates with overexpression or depletion 
of HSP-17. HSP-17 might thus belong to a branch of the PN that protects cells by 
segregating proteotoxic species without maintaining solubility. 
5.1.3. HSP-17 is relevant for viability and KIN-19 is its substrate in vivo
Small heat shock proteins are ubiquitous parts of the PN and often upregulated upon 
heat  stress  (163),  although  organisms  maintain  stress-inducible  and  constitutive 
sHsps in  parallel.  For  example,  yeast  Hsp26 is  heat  induced and heat  activated 
(209), whereas yeast Hsp42 is constitutively expressed and active under non heat 
stress conditions  (210), but still relevant for survival under heat stress  (110). In  C. 
elegans,  the sHsps HSP-25 or  HSP-43 are constitutively  expressed in  body wall 
muscle, cell  junctions or the reproductive system  (165), while others like SEC-1 / 
SIP-1 are developmentally regulated and localized to eggs and the uterus (211). The 
ubiquitous HSP-16.2 is notably induced by and protective during heat stress  (203) 
and has also been shown to be induced by proteotoxic stress following heterologous 
A overexpression, being protective under this condition (161). 
Here, I have demonstrated that C. elegans HSP-17 is constitutively expressed and 
most present in the alimentary system (consisting of the pharynx,  the intestine and 
the anus) as well as the excretory canal cell, a localization it only shares with the 
HSP-16 members (under stressed conditions). Like Hsp42,  the constitutive HSP-17 
was shown to be protective under thermal stress and previous studies indicated that 
HSP-17 can additionally be upregulated by heat stress (176). The prominent 
localization of HSP-17 to the excretory canal cell, implied in osmoregulation (177), 
aligns  with  my  observation  that  HSP-17  is  protective  under  osmotic  stress.  It  is 
interesting that one of the few other known molecular aggregases, B. subtilis YocM, 
is  also protective  under osmotic stress  (109). Osmotic stress affects protein 
homeostasis in the intestine and can induce the aggregation of Q44-YFP (179), which 
I  also  showed  to  be  modulated  by  HSP-17.  The  localization  of  HSP-17  to  the 
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alimentary system, and particularly around the intestinal endotube, also supports my 
finding that HSP-17 is relevant during biotic stress and previous reports that HSP-17 
is induced by heavy metal stress (176). I found that HSP-17 is relevant for fecundity 
and  the  development  of  offspring,  although  unlike  SIP-1  (82),  HSP-17  does  not 
interact with VIT-2. Nonetheless, it is possibly involved in the transport of nutrients to 
eggs,  which  depends  on  vitellogenins  synthesized  in  the  intestine  (181).  In 
combination,  the  localization  of  HSP-17  to  the  intestine,  membranes,  and  the 
involvement of HSP-17 in reproduction and various stress conditions indicate a role 
in  maintaining  intestinal  homeostasis  with  an  impact  on  fecundity. HSP-17  was 
relevant for lifespan in vivo and combined with my in vitro findings, these data point 
to  HSP-17  being  a  part  of  the  PN  that  constitutively  performs  a  non-canonical 
chaperone activity in the cytosol of the alimentary system and the excretory tract. 
Finally, I could show HSP-17 to colocalize with KIN-19, a casein kinase homolog, in 
vivo. KIN-19 was previously reported to be a protein with high propensity to become 
insoluble in age  (114). Additionally, HSP-17 overexpression lead to an increase in 
KIN-19 foci  in  the  pharynx,  indicating  that  KIN-19 is  a  physiological  substrate  of 
molecular aggregase activity. I have shown for HSP-17 to not colocalize with PAB-1 
or  nuclei,  matching  the  reported  aggregation  pattern  of  KIN-19  (114,180). 
Observations  that  KIN-19  overexpression  leads  to  defect  in  C.  elegans larval 
development are supported by findings that KIN-19 is involved in the formation of the 
embryo (212), the regulation of cell division during development  (213) and cell fate 
determination (214). In this context, comparison to the mycobacterial sHsp HspX is 
interesting. HspX was shown to enhance the aggregation of select substrates and 
promote  their  polar  localization,  and  was  labeled  a  “pro-aggregase”  and  “polar 
sortase”  (107).  By  analogy,  the  link  between  HSP-17,  KIN-19,  cell  division  and 
development  may  be  based  on  protein  aggregate  formation  and  sorting  in 
conjunction with cell division events.
Intriguingly, concurrent overexpression of HSP-17 exacerbated this effect, whereas 
depletion  of  HSP-17  slightly  ameliorated  the  developmental  defects.  In  studies 
analyzing the effect of osmotic stress on protein aggregation in  C. elegans, KIN-19 
was  also  reported  to  be  aggregation-prone  under  this  stress  condition  alongside 
polyQ peptides  (8).  This provides another link to the involvement of  HSP-17 with 
osmotic stress and the excretory canal cell. Taken together, these findings indicate 
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that deleterious KIN-19 dysregulation is moderated by HSP-17, possibly by affecting 
its aggregation during development, stress and aging. By this mechanism, HSP-17 
might pose an example of physiologically controlled, specific protein aggregation.
5.2. A new model of A pathology in C. elegans
In neurodegenerative diseases such as Alzheimer’s disease, a pivotal factor is the 
aggregation of the APP cleavage product amyloid-1-42 and subsequent – hypothetical 
– prion-like spreading of its aggregates within the organism  (36). However, clinical 
attempts targeting this peptide have remained fruitless and the exact involvement of 
amyloids like A or MAPT is subject to discussion  (51). Therefore, models are still 
needed to explore the basis of A aggregation and the trajectory it has within living 
organisms. Previous endeavors created muscular (151) or neuronal (155) models of 
A toxicity in  C. elegans,  but forwent labeling. Furthermore, A proteotoxicity was 
also analyzed in the context of select neurons: glutamatergic neurons  (159), ASE 
neurons (157) or BAG neurons (158). In all of these studies, unlabeled A was used. 
Attempts at generating a model of GFP-labeled A expression in C. elegans neurons 
revealed that consistent labeling of A lead to formation of A oligomers, but not 
amyloid fibrils (156).
Here, in a project carried out together with Christian Gallrein, a new model of A 
proteotoxicity in C. elegans was generated, which expressed unlabeled A alongside 
a smaller moiety of labeled A. Following successful generation of transgenic strains 
expressing A in neurons or body wall muscle of  C. elegans, I could demonstrate 
that both labeled and unlabeled peptide are present in the transgenic model and that 
both moieties of A interact. Proteomic and biochemical analysis revealed that the 
newly generated models were under proteotoxic stress and exhibited dysfunctions in 
the  endo-membrane  system,  autophagy  and  protein  sorting,  mirroring  previous 
observations  on  C.  elegans models  of  A toxicity.  Notably,  the  IL2  neurons  of 
C. elegans specifically  proved  more  vulnerable  to  A proteotoxicity  than  other 
neurons and mark the beginning of systemic A pathology. Targeted depletion of A 
in these neurons provided systemic amelioration of A proteotoxicity, providing an 
important perspective on the amyloid-cascade hypothesis and possible treatments. 
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This type of model might then serve as a bridge for PN activity and aid in transferring 
findings for C. elegans chaperones, including sHsps, to the human system.
Figure 54: A new model of A pathology in C. elegans
Overview of crucial observations in the generated model (sketch). A model of A pathology with sub-
stoichiometric labeling was generated for neurons (red) and body wall muscle (blue). The fluorophore 
used is wrmScarlet in both cases (I). The models reprised hallmark features of A proteotoxicity (II). In 
vivo microscopy revealed that a subset of head neurons was more vulnerable to A aggregation than 
other neurons. The eutelic nature of C. elegans allowed to identify these as the IL2 neurons and they 
appear to be pivotal  in systemic  A pathology. Nematode anatomy was adapted from  WormAtlas 
(215). Head neuron organization was adapted from published literature (195,196).
5.2.1. Sub-stoichiometric labeling enables a new model of A pathology
A fluorophore-labeled model of A pathology in C. elegans was created that allowed 
for concurrent unhindered aggregation and fibril formation by an unlabeled moiety of 
A (216,217) and the intended pathology was confirmed for neuronal and body wall  
muscle expression.  In  the new model,  the A peptide is  targeted to  the ER and 
returned to  the  cytosol  after  cleavage due to  the  used signal  peptide  (152,154), 
although it  is  understood that  a large portion of  A pathology takes place in  the 
extracellular space (218). Nonetheless, intracellular A was demonstrated to play a 
role in pathology as well (219-221), which allowed me to investigate the impact of A 
in the cell. 
Among the chaperones interacting with mA in vivo were J-proteins, including the 
stress inducible members DNJ-13 & DNJ-19, which are expressed in muscular tissue 
(19) and the calnexin homolog CNX-1, pointing to the involvement of ER-stress in the 
model. The identified Hsp90 member DAF-21 is also relevant to muscle homeostasis 
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(222). These chaperones had not been identified as A interactors so far, but confirm 
proteotoxicity in the muscles and the ER. The HSP-16 family is a group of heat-
inducible sHsps (223) which were identified in previous analyses of C. elegans mA 
models  (160) and reported to be upregulated and cytoprotective in response to A 
proteotoxicity  (161).  Together  with  the  constitutive  Hsc70  member  HSP-1  (224) 
identified in mA, IP-MS/MS from the neuronal model revealed interaction with the 
Hsc70 member F44E5.4. Interaction with A peptide of these Hsc70 members and 
HSP-16  members  previously  identified  (160,187) demonstrate  reproducibility  in 
C. elegans models of A pathology. Furthermore, the identification of a number of PN 
members points to a general proteotoxic effect of A in the newly generated model 
and gene ontology analysis by the  DAVID functional  annotation tool  corroborated 
these data. 
In particular, the GO term locomotion has been identified and indeed, in muscular A 
models  of  C.  elegans,  progressive  paralysis  has  been  reported  as  a  symptom 
(188,189).  Likewise,  the  involvement  of  redox  processes  in  the  new  A model 
supports the understanding that oxidative stress plays a role in A pathology (225) 
and  that  redox  homeostasis  is  linked  to  protein  homeostasis  (191).  Notably,  the 
terms RME and cullin-deneddylation imply an involvement  of  endocytosis,  UPRER 
points  to  ER-stress  and the  terms secretion  by  cell  and protein  transport  further 
corroborate  this,  hinting  at  issues  in  protein  trafficking.  These  findings  were 
confirmed by TEM and  in  vivo  analysis.  My observations may stem in  part  from 
targeting the A peptide to the ER, although it does not remain there. Nonetheless, 
these data show that A can perturb membrane transport and ER function and, taken 
together, reinforce the idea of dysfunctional protein sorting and membrane damage 
as a mechanism in A pathology (56). 
For the muscular model mA, structures were prominently observed which could be 
endosomes, exosomes, lysosomes or autophagosomes that failed to form and were 
labeled  as  “amphisomes”.  This  could  tie  in  to  findings  that  A accumulates  in 
multivesicular  bodies  (in  neurons),  which  provide  a  site  for  fibril  formation  and 
potential  export  of  A from  the  cell  (193).  A  connection  between  the  observed 
amphisomes and the described multivesicular bodies matches my observations in 
the ER and the endomembrane system and through export of aggregated A, points 
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to a pathway of A spreading (58). Conversely, defects in autophagy leading to the 
induction of incomplete autophagosomes have been described in combination with 
A (192). Autophagic flux is reported to be faulty in A pathology (226) and I have 
quantified the levels of the p62 homolog SQST-1 and the LC3 homolog LGG-1 to  
assess this effect, ultimately concluding that cells fail at initiating autophagy and it  
does not proceed  (175). In short, by proteomics and biochemical analysis, I could 
demonstrate that protein trafficking, the endomembrane system and autophagy are 
disturbed in the newly generated models, positioning them as a platform to assay 
known and hypothetical defects in A pathology.
5.2.2. IL2  neurons  mark  the  onset  of  organismal  A aggregation  and 
pathology
In FLIM experiments carried out by Christian Gallrein on the neuronal model nA, it 
became evident that the onset of A aggregation takes place in a specific subset of 
head  neurons.  These  neurons  were  then  identified  as  the  IL2  neurons.  RNAi-
mediated knockdown of  A exclusively in the IL2 neurons, but not in the adjacent 
URY neurons, ameliorated the relative amount of aggregates and lead to an increase 
in fluorescence lifetime and thus reduced aggregation of A in head neurons overall. 
The depletion of  A specifically in IL2 neurons also improved paralysis symptoms, 
compared to the nA control and caused a slight, yet significant, improvement in the 
median lifespan.  These data imply that  on one hand,  there is  a  mechanism that 
renders IL2 neurons more susceptible to  A proteotoxicity and on the other,  that 
failure of proteostasis in these neurons allows for systemic pathology – or treatment.
IL2 neurons were demonstrated to be necessary in dauer larvae of  C. elegans to 
induce nictation behavior, a dispersal strategy with putative benefits under stressed 
conditions  (227). In adult, non-dauer nematodes, no specific function was reported 
for IL2 neurons (200), however they were identified as part of the neurons expressing 
the neuropeptide Y-receptor like NPR-1  (228).  IL2 neurons are cholinergic,  motor 
neuron-like, activated by acetylcholine  (229) and belong to the neurons specifically 
expressing the nicotinic acetylcholine receptor subunits DEG-3 and DES-2, which 
have  been  associated  with  vulnerability  to  neurodegeneration  (230).  The  data 
available makes it difficult to link the vulnerability of IL2 neurons to a specific function 
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or position within the C. elegans organism, but based on the described properties I 
speculate that specific receptors may play a role. 
Crucially, in the human system a vulnerability of cholinergic neurons to A pathology 
was  also  reported (198,199), specifically  in  the  nucleus  basalis  (231), which  has 
opened up possibilities of pharmaceutical palliative treatment in AD  (232). There is 
evidence that this cell-type specific vulnerability is a common feature of amyloidosis – 
α-synuclein, a pivotal amyloid in PD, was shown in C. elegans to have more severe 
effects on dopaminergic neurons (149) and proteotoxic polyQ-peptides were shown 
to most severely affect motor neurons (150). I thereby conclude that the cholinergic 
IL2 neurons are specifically affected by A due to their characteristic configuration 
and this mirrors the vulnerability of other neuron types to the respective amyloids.  
Importantly, modelling this effect in  C. elegans allowed for the first time to pinpoint 
this to a specific type of neurons rather than a general group of neurons or a brain 
region, due to the compact and eutelic nature of  C. elegans.  In vivo labeling and 
monitoring  of  this  process  provided  an  age-resolved  dataset  of  this  crucial 
vulnerability that cannot be achieved in cell culture or post mortem brain biopsies.
5.3. Outlook
5.3.1. HSP-17 and facilitated aggregation
In this work I  have presented  C. elegans HSP-17 as the first  metazoan sHsp to 
promote substrate aggregation in vitro and in vivo, a mechanism distinct from the well 
described activity  of  sHsps to  prevent  aggregation of  substrates.  This  effect  was 
physiologically  relevant  and  targeted  to  select  substrates,  native  and  non-native. 
Following  this  line,  it  will  be  interesting  to  identify  additional  sHsps  exhibiting 
molecular aggregase activity,  particularly in the human system. Previous research 
strongly  focused on chaperones inhibiting  or  reverting  substrate  aggregation  and 
research  on  chaperones  facilitating  and  directing  aggregation  will  provide  new 
perspectives  on  the  PN  and  neurodegenerative  disease.  For  HSP-17,  it  will  be 
helpful  to  elucidate what  identifies substrates for  molecular  aggregase activity,  in 
what  manner  HSP-17  confers  insolubility  to  them and  how  the  resulting  protein 
aggregates  are  changed.  These  findings  could  shed  new  light  on  general 
mechanisms to identify aggregase substrates, understand the properties of protein 
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aggregates and their management in relation to organismal health. In the context of  
C. elegans physiology, HSP-17 seems to be the first sHsp predominantly active in 
the intestine and its involvement in membrane transport or the generation of offspring 
remains to be elucidated.
5.3.2. A new model to visualize the progression of A pathology
The data I  present  cover a new model  of  A in  C. elegans which combines the 
benefits of fluorescent labeling and native-like expression. The utility of the model 
could be confirmed as it fulfills the expected constitution and reiterates established 
and  putative  hallmarks  of  A pathology.  The  differentiated  nature  of  C.  elegans 
allowed for  the precise identification of  IL2 neurons as hotspots of  proteotoxicity.  
Thus,  the  new  model  could  be  beneficial  for  the  identification  of  such  cell-type 
specific vulnerabilities in mice or humans to facilitate the development of therapy. 
Importantly,  the  mechanisms  by  which  IL2  neurons  are  vulnerable  to  amyloid 
pathology need to be elucidated, followed by transferring these findings to higher 
eukaryotes.  In  parallel,  it  will  be  interesting  to  assay  the  modulation  of  A 
proteotoxicity in C. elegans in a cell-specific manner, including by small molecules or 
the activity of molecular chaperones such as the sHsps. Thus, the model presented 
here could serve as an initial platform for precise analysis and amelioration of A 
aggregation in neurons.
6. Material and methods
6.1. Chemicals & solutions
Standard chemicals for laboratory use were obtained from Sigma Aldrich (St. Louis, 
USA), Carl Roth (Karlsruhe, Germany) and Merck (Darmstadt, Germany). Chemicals 
used in particular were:
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Acetic acid VWR, Radnor, USA
Agar-Agar Kobe 1 Carl Roth
Agarose Bio+Sell, Nürnberg, Germany
AmbionTM TRIzolTM reagent Thermo Fisher Scientific, Waltham, USA
Ampicillin Carl Roth
Ammonium persulfate Carl Roth
L-Arginine Carl Roth
Adenosine triphosphate Carl Roth
-mercaptoethanol Carl Roth
BactoTM Peptone BD Biosciences, New Jersey, USA
Bromophenol blue Carl Roth
Bovine serum albumin Carl Roth
Calcium chloride Carl Roth
Chloramphenicol Carl Roth
2-Chloroacetamide Sigma Aldrich
Chloroform Fisher Scientific, Schwerte, Germany
Cholesterol Sigma Aldrich
cOmpleteTM protease inhibitor cocktail Roche Diagnostics, Mannheim, 
Germany
Coomassie Brilliant Blue R-250 Carl Roth
L-Cysteine Carl Roth
Cy5-N-Hydroxysuccinimide GE Healthcare, Buckinghamshire, UK
4´,6-diamidino-2-phenylindole Carl Roth
Dimethyl sulfoxide Carl Roth
Deoxynucleotidetriphosphates Thermo Fisher Scientific, Waltham, USA
Dithiothreitol Carl Roth
Ethylenediaminetetraacetic acid Carl Roth
Ethanol VWR, Radnor, USA
Epoxy Sigma Aldrich
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Formaldehyde (37 %) Carl Roth
L-Glutamic acid Sigma Aldrich




Glycylglycine AppliChem GmbH, Darmstadt, Germany
Gold powder, 0,33 micron / 99,9 % Chempur, Karlsruhe, Germany




HM20 resin Polysciences, Eppelheim, Germany
Hydrochloric acid (32 %) Carl Roth
Imidazole Carl Roth
Isopropyl--D-1-thiogalactopyranosid Thermo Fisher Scientific, Waltham, USA
Isopropyl alcohol VWR, Radnor, USA
LB agar Serva, Heidelberg, Germany
LB media Carl Roth
Levamisole AppliChem GmbH, Darmstadt, Germany
Magnesium acetate Carl Roth
Magnesium chloride Carl Roth
Magnesium Sulfate Carl Roth
Manganese(II) chloride AppliChem GmbH, Darmstadt, Germany
Methanol Carl Roth
Milk powder Carl Roth
Mono- & dipotassium phosphate Carl Roth
Monosodium citrate Carl Roth
Mono- & disodium phosphate Carl Roth
MOPS (3-(N-
morpholino)propanesulfonic acid)
AppliChem GmbH, Darmstadt, Germany
NP-40 Surfactant Amps Thermo Fisher Scientific, Waltham, USA
Nuclease free water Carl Roth
Phosphoenolpyruvic acid AppliChem GmbH, Darmstadt, Germany
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Pierce BCA Reagents A & B Thermo Fisher Scientific, Waltham, USA
Phenylmethylsulfonyl fluoride Sigma Aldrich
Polyvinylpyrrolidone Sigma Aldrich
RedSafeTM Nucleic acid staining solution Fisher Scientific, Schwerte, Germany
RIPA lysis buffer, 10x Merck Millipore, Burlington, USA
Rotiphorese Gel 30 (37.5:1) 
Acrylamide : Bisacrylamide solution
Carl Roth
Roti-Quant (for Bradford assay) Carl Roth
Roti-Block, 10x Carl Roth
Rubidium chloride AppliChem GmbH, Darmstadt, Germany
Sodium dodecyl sulfate Carl Roth
SOC-media New England Biolabs, Ipswich, USA
Sodium azide Carl Roth
Sodium chloride Carl Roth
Sodium hydroxide Carl Roth
Spermidine Sigma Aldrich
Potassium acetate Carl Roth
Potassium chloride Carl Roth
Potassium hydroxide Carl Roth
Sodium hypochlorite solution Fisher Scientific, Schwerte, Germany
Streptomycin (Gibco) Thermo Fisher Scientific, Waltham, USA




Tricin AppliChem GmbH, Darmstadt, Germany
Tris(hydroxymethyl)aminomethane Carl Roth
Triton X-100 Carl Roth
Tween 20 Carl Roth
Uranyl acetate Sigma Aldrich
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6.2. Gel markers and loading dyes
Table 6: List of gel markers and loading dyes used in this work
Product Company
DNA loading dye (6x) Thermo Fisher Scientific, Waltham, USA
GeneRulerTM (1kb & 50 bp) Thermo Fisher Scientific, Waltham, USA
PageRulerTM Prestained Protein Ladder Thermo Fisher Scientific, Waltham, USA
6.3. Enzymes
6.3.1. Enzymes (general)
Table 7: List of restriction enzymes used in this work
Product Company
Citrate synthase Sigma Aldrich
DNAse I AppliChem GmbH, Darmstadt, Germany




Herculase II Fusion DNA Polymerase Agilent, Santa Clara, USA
Luciferase Sigma Aldrich
Lysozyme Carl Roth
Malate dehydrogenase Sigma Aldrich
Phusion High-Fidelity DNA Polymerase Kirstein Lab
PreScissionTM Protease GE Healthcare, Buckinghamshire, UK
Proteinase K Thermo Fisher Scientific, Waltham, USA
Pyruvate kinase Sigma Aldrich
SUMO protease (Ulp1 fragment) Kirstein Lab
T4 DNA Ligase (1U / µl) incl. buffer Thermo Fisher Scientific, Waltham, USA
Trypsin Carl Roth
6.3.2. Restriction Enzymes
All  restriction  enzymes used and  CutSmart Buffer  have been  bought  from New 
England Biolabs, Ipswich, USA.
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6.4. Antibodies
Table 8: List of antibodies used in this work






1 : 1000 BioLegend, San Diego, USA
Anti-GFP, rabbit - Enzo Life Sciences, Farmingdale, 
USA
Anti-HSP-17, rabbit 1 : 2500 / 
1 : 4000
Kirstein lab / Pineda Antikörper 
Service, Berlin, Germany
Anti-LGG-1, rabbit 1 : 1000 Kirstein lab / Pineda Antikörper 
Service, Berlin, Germany
Anti-SQST-1/p62, rabbit 1 : 1000 Kirstein lab / Pineda Antikörper 
Service, Berlin, Germany
Anti--tubulin, mouse 1 : 2500 Sigma Aldrich
Cy3-anti-rabbit, goat 1 : 10000 Thermo Fisher Scientific, 
Waltham, USA
Anti-mouse IR 800, goat 1 : 10000 LI-COR, Lincoln, USA
Goat-anti-rabbit IgG (H+L) 
ML, conjugated with 12 nm 
colloidal gold
- Jackson Laboratories, Bar 
Harbor, USA
Pierce goat-anti-mouse IgG 
+ IgM (H+L), peroxidase 
conjugated
1 : 10000 / 
1 : 15000
Thermo Fisher Scientific, 
Waltham, USA
Pierce goat-anti-rabbit IgG 
(H+L), peroxidase 
conjugated
1 : 10000 / 
1 : 15000
Thermo Fisher Scientific, 
Waltham, USA
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6.5.  Buffers and media
All buffers and media used, excluding buffers provided by commercial sources (i. e. 
buffers for commercial enzymes).
6.5.1. General use
Table 9: List of buffers used in this work
Solution Preparation
Antibody buffer A (AbA) 1x PBS; 1% BSA; 0,5% Triton-X-100
Assay buffer (luciferase assay) 25 mM Glycylglycin; 100 mM KCl; 15 mM 
MgCl2; 5 mM ATP
C. elegans lysis buffer 20 mM HEPES-KOH; 110 mM KAc; 2 mM 
MgAc2; pH 7,4
Coomassie staining solution 40% Methanol (v/v); 10% Acetic acid (v/v); 
50% H2O (v/v); 0,5% Coomassie brilliant 
blue (w/v)
Coomassie destaining / fixing 
solution
40% Methanol (v/v); 10% Acetic acid (v/v); 
50% H2O (v/v)
Formaldehyde solution 4% Formaldehyde in 100 mM K2HPO4; pH 
7,2
HMK (luciferase assay) 50 mM HEPES-KOH; 100 mM KCl; 5 mM 
MgCl2; 1 mM DTT; 10 µM BSA; pH 7,4
HMK (general use) 30 mM HEPES-KOH; 140 mM KCl; 5 mM 
MgCl2; pH 7,4
Light scattering buffer (CS) 40 mM HEPES-KOH; pH 7,4
Buffer is filtered and degassed.
Light scattering buffer (GAPDH) 1x PBS; pH 7,4
Buffer is filtered and degassed.
For dialysis and storage of aliquots, 1 mM 
DTT and 5% (v/v) glycerol are added.
Light scattering buffer (MDH) 30 mM HEPES-KOH; 5 mM MgCl2; 50 mM 
KCl; pH 7,4
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Buffer is filtered and degassed.
M9 58 g Na2HPO4; 30 g KH2PO4; 5 g NaCl; 10 g 
NH4Cl2 in one liter of H2O.
Solution is sterilized by autoclaving.
NGM agar 3 g NaCl; 2,5 g Bacto Peptone; 17 g Agar 
Agar Kobe 1; 5 mg cholesterol; 1 mM CaCl2; 
1 mM MgSO4; 25 mM KH2PO4; pH 6 in one 
liter of H2O.
NGM agar, RNAi As NGM agar, supplemented with 1 mM 
Ampicillin and 1 mM IPTG.
PBS (10x) 1,37 M NaCl; 27 mM KCl; 100 mM 
Na2HPO4; 18 mM KH2PO4
Sterilized by autoclaving.
PBST (1x) 1x PBS supplemented with 0,05% (v/v) 
Tween 20.
PCR buffer 0 (10x) 100 mM Tris; 500 mM KCl; 1% Triton X-100 
(v/v); pH 8,8
PCR buffer I (10x) 100 mM Tris; 500 mM KCl; 20 mM MgCl2; 
1% Triton X-100 (v/v); pH 8,8
PCR buffer II (10x) 100 mM Tris; 500 mM KCl; 20 mM MgSO4; 
1% Triton X-100 (v/v); pH 8,8
PVP solution 10 mg PVP in 500 µl H2O; 99,5 ml Ethanol.
Pyruvate kinase solution 
(luciferase assay)
20 µl of pyruvate kinase stock in 75 µl of 
HMK (for luciferase assay, approximately 
20 u of Pyruvate kinase).
5 µl of 200 mM ATP are added directly 
before used.
Sample loading buffer 
(SDS-PAGE, 2x)
50% (v/v) 4x sample loading buffer; 50% 
H2O; 100 mM DTT
Sample loading buffer 
(SDS-PAGE, 4x)
100 mM Tris-HCl; 4%SDS (w/v); 30% 
glycerol (v/v); 0,02% (w/v) bromophenol-
blue
SEC running buffer 30 mM HEPES-KOH; 140 mM KCl; 5 mM 
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MgCl2; pH 7,4
Buffer is filtered and degassed.
SDS-PAGE running buffer 
(10x)
250 mM Tris; 1,92 M Glycin; 1% (w/v) SDS
Separating gel buffer (SDS-PAGE) 1,5 M Tris-HCl; 0,4% SDS (w/v); pH 8,8
Stacking gel buffer (SDS-PAGE) 0,5 M Tris-HCl; 0,4% SDS (w/v); pH 6,8
TAE (50x) 242 g Tris; 5,71% acetic acid; 50 mM EDTA 
(pH 8) in one liter of H2O.
TBS (10x) 200 mM Tris; 1,5 M NaCl
Solution is filtered by autoclaving.
TBST (10x) 200 mM Tris; 1,5 M NaCl; 1% Tween 20 
(v/v)
Solution is filtered by autoclaving.
TFB1 100 mM RbCl; 80 mM MnCl; 10 mM CaCl2; 
30 mM KAc; 15% glycerol (v/v)
Adjusted to pH 5,3 with acetic acid; 
sterilized by filtration
TFB2 67 mM RbCl; 75 mM CaCl2; 10 mM MOPS; 
15% glycerol (v/v); pH 7,5
Sterilized by filtration
Transfer buffer (Western blot) 192 mM glycine; 25 mM Tris; 20% methanol
Tricine SDS-PAGE anode buffer 2 M Tris-HCl; pH 8,9
Tricine SDS-PAGE cathode buffer 100 mM Tris-HCl, 100 mM Tricine; 0,5% 
SDS (w/v)
Tricine SDS-PAGE gel buffer 5 M Tris-HCl; 0,5% SDS (w/v); pH 8,45
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6.5.2. Recombinant protein purification
Solution Preparation
Lysis / Wash buffer 
(HttEx1 constructs) LWB
50 mM NaH2PO4; 5 mM Tris; 150 mM NaCl; 5 
mM MgCl2; pH 8
A pinch of DNAseI is added shortly before use for 
lysis. 0,1% (v/v) Trition X-100 is added shortly 
before use for washing.
Dialysis buffer 
(HttEx1 constructs) DB
50 mM Tris; 150 mM NaCl; 1 mM EDTA; 5% (v/v) 
glycerol; pH 7,4
Elution buffer EB 30 mM HEPES-KOH; 50 mM KCl; 5 mM MgCl2; 
10% glycerol (v/v); pH 7,4
Elution buffer EB2
(HttEx1 constructs)
50 mM NaH2PO4; 5 mM Tris; 150 mM NaCl; 5 
mM MgCl2; pH 8
20 mM reduced glutathione are added shortly 
before use and the pH is adjusted to 8,6.
High salt buffer HSB 30 mM HEPES-KOH; 1M KCl; 0,05% Tween 20; 
pH 7,4
20 mM imidazole and 1 mM TCEP are added 
shortly before use.
High salt buffer 2 HSB2 30 mM HEPES-KOH; 1M KCl; 5 mM MgCl2; pH 
7,4
Buffer is filtered and degassed.
Low salt buffer LSB 30 mM HEPES-KOH; 50 mM KCl; pH 7,4
20 mM imidazole and 1 mM TCEP are added 
shortly before use. For dialysis, no imidazole is 
added and 1 mM TCEP is replaced by 1 mM 
-Mercaptoethanol.
Low salt buffer 2 LSB2 30 mM HEPES-KOH; 25 mM KCl; 5 mM MgCl2; 
pH 7,4
Buffer is filtered and degassed.
Lysis buffer LB 30 mM HEPES-KOH; 500 mM KCl; 5 mM MgCl2; 
10% glycerol (v/v); pH 7,4
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20 mM imidazole; 1 mM PMSF; a pinch of 
DNAseI and cOmplete protease inhibitor are 
added shortly before use.
6.6. Kits
Table 10: List of laboratory kits used in this work
Product Company
Maxima First Strand cDNA Synthesis Kit Thermo Fisher Scientific, Waltham, USA
Pierce ECL Western Blot Substrate Thermo Fisher Scientific, Waltham, USA
QIAquick gel extraction kit Qiagen, Hilden, Germany
NucleoSpin Plasmid Isolation Kit Macherey-Nagel, Düren, Germany
NucleoSpin RNA Isolation Kit Macherey-Nagel, Düren, Germany
ZR Plasmid Miniprep Classic Zymo Research, Irvine, USA
Gel filtration high molecular weight 
calibration kit
GE Healthcare, Chalfont St. Giles, UK
6.7. Primers
Primers were purchased from BioTeZ, Berlin, Germany.












































Table 12: List of plasmids used in this work
Plasmid Source
pPD95.77 (GFP) 1
(expression of transgenes in C. elegans; includes GFP)
Kirstein Lab
pSumo 1
(recombinant expression of His-SUMO tagged proteins in 
E. coli)
Kirstein Lab
pSumo + HSP-1 Kirstein Lab
pSumo + HSP-110 Kirstein Lab
pSumo + DNJ-12 Kirstein Lab
pSumo + DNJ-13 Kirstein Lab
pSumo + HSP-12.6 Kirstein Lab
pL4440 (RNAi-feeding vector for C. elegans) 1 Kirstein Lab
pDONR221 + A1-42 Wanker Lab
pGEX-6P-1 + GST-HttEx1Q48 Wanker Lab
pGEX-6P-1 + GST-HttEx1Q48Stop1c Kirstein Lab
pPD95.77 + [prgef-1::GFP] Kirstein Lab
pEY54 + [pklp-6::mNeptune2.5] Hobert Lab
pSEM87 + [wrmScarlet-twk-18] Boulin Lab 
6.9. Laboratory equipment and devices
Table 13: List of devices used in this work
Product Company
Agarose gel electrophoresis systems Carl Roth, Sigma Aldrich
Anion exchange chromatography 
column – ResourceTM Q
GE Healthcare, Chalfont St. Giles, UK
Centrifuge – Heraeus Fresco 17 Thermo Fisher Scientific, Waltham, USA
Centrifuge – 3K12 SIGMA, Osterode am Harz, Germany
Centrifuge – Ministar VWR, Radnor, USA
1 Vector maps are shown in supplementary materials 12-14.
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Centrifuge – Sorvall LYNX 6000 
incl. Rotor F9-6x1000 LEX
Thermo Fisher Scientific, Waltham, USA
Electron Microscope – Zeiss 900 Zeiss, Oberkochen, Germany
Laboratory scales 440-49N & PCB Kern, Balingen, Germany
Centrifuge – 5417C incl. rotor F45-30-11 Eppendorf, Hamburg, Germany
Flaming/Brown micropipette puller – 
P97
Sutter Instrument, Novato, USA
Fluorescence microscope M165FC Leica, Wetzlar, Germany
Fluorescence spectrometer Jasco 
FP8300
Jasco, Pfungstadt, Germany
Freezer KM-DU73Y1E Panasonic, Kadoma, Japan
Freeze substitution processor - AFS Leica, Wetzlar, Germany
FPLC system – ÄKTA Explorer GE Healthcare, Chalfont St. Giles, UK
Heating block incubator – HLC Ditabis, Pforzheim, Germany
High pressure freezer HPM100 Leica, Wetzlar, Germany
Homogenizer – Precellys 24 Bertin Technologies, Montigny-le-
Bretonneux, France
Ice maker – Scotsman AF80 Wolf Laboratories, York, UK
Imaging system – Lumi-Imager F1TM Boehringer, Mannheim, Germany
Imaging system – Odyssey Image 
System FC
LI-COR, Lincoln, USA
Incubator – Heraeus Kelvitron Thermo Fisher Scientific, Waltham, USA
Incubator – HerA Therm Thermo Fisher Scientific, Waltham, USA
Incubator – TC255 Lovibond, Amesbury, UK
Inverted phase contrast microscope – 
DMI 3000B
Leica, Wetzlar, Germany
Laser scanning microscopes LSM780 & 
LSM510
Zeiss, Oberkochen, Germany
Magnetic reaction vessel rack – 
MagRackTM 6
GE Healthcare, Chalfont St. Giles, UK
Microfluidizer – LM10 Microfluidics, Westwood, USA
Microinjection pump – FemtoJet Eppendorf, Hamburg, Germany
Microinjection needle holder – Eppendorf, Hamburg, Germany
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InjectMan 4
Microwave – HMT75M451 Robert Bosch GmbH, Stuttgart, 
Germany
Magnetic stirrer – RET basic IKA, Staufen, Germany
Mass spectrometer – UltiMate 3000 
RSLC nano LC system coupled to 
Orbitrap Elite
Thermo Fisher Scientific, Waltham, USA
“Nanodrop” Spectrophotometer – 
NanoVue Plus
GE Healthcare, Chalfont St. Giles, UK
Micropipettes Brand, Wertheim, Germany
PCR cycler – Mastercycler Gradient Eppendorf, Hamburg, Germany
pH meter Mettler Toledo, Ohio, USA
Pipettor – Pipetboy Integra Bioscience, Integra, Germany
Plate reader – F200 Pro Tecan, Männedorf, Germany
Power supply – PowerPac HC / Basic Bio-Rad, Hercules, USA
QTof-MS system Waters Corporation, Milford, USA
Quartz glass cuvettes – QS; including 
HellmanexTM III cleaning solution
Hellma Analytics, Müllheim, Germany
SDS-PAGE system – Mini PROTEAN 
cell chambers
Bio-Rad, Hercules, USA
“Semi dry” blotting system – TurboTM 
Transfer System
Bio-Rad, Hercules, USA
Size exclusion chromatography column 
– HiLoad Superdex 75 16/600
GE Healthcare, Chalfont St. Giles, UK
Spectrophotometer – V-1200 VWR, Radnor, USA
Size exclusion chromatography column 
– Superose 6 10/300 GL
GE Healthcare, Chalfont St. Giles, UK
Shaking incubator – Innova 4230 New Brunswick Scientific, Edison, USA
Shaking incubator – Multitron Pro Infors HT, Bottmingen, Switzerland
Shaking incubator – SM-30 control Edmund Bühler GmbH, Hechingen, 
Germany
Stereomicroscope – SMZ 745 Nikon, Tokio, Japan
FPLC injection loop – GE Healthcare, Chalfont St. Giles, UK
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0,5 ml / 5 ml / 50 ml (Superloop)
Microtome Leica, Wetzlar, Germany
Ultracentrifuge – OPTIMA Beckman Coulter, Brea, USA
UPLC system – Acquity H-Class Plus
incl. XEVOG2-XS QTof analyzer
Waters Corporation, Milford, USA
UPLC protein BEH column - Acquity Waters Corporation, Milford, USA
Rolling incubator – RS-TR-5 Phoenix Instruments, Garbsen, 
Germany
Vacuum pump KNF Lab, New Jersey, USA
Vortex mixer – Vortex-Genie 2 Scientific Industries, Bohemia, USA




Table 14: List of consumables used in this work
Product Company
Blotting paper sheets Sartorius, Göttingen, Germany
Centrifugal filter units – Amicon, 
10 kDa MWCO; 0,5 ml
Merck Millipore, Burlington, USA
Centrifugal filter units – Spin-X UF, 
10 kDa MWCO; 5 ml
Corning Life Sciences, Corning, USA
Culture plates (single) Sarstedt, Nümbrecht, Germany
Dialysis membrane – Spectra/Por 
molecular membrane tubing (6-8 kDa)
Spectrum Chemical Manufacturing 
Corporation, New Brunswick, USA
EM Grids Sigma Aldrich
Glass cover slips Carl Roth
Glass slides Carl Roth
Gloves, latex neoLab, Heidelberg, Germany
Gloves, nitril – Kimtech Sterling Kimberly-Clark, Dallas, USA 
Glutathione Sepharose 4B GST-tagged 
protein purification resin
GE Healthcare, Chalfont St. Giles, UK
Gravity flow columns Bio-Rad, Hercules, USA
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Kwik-FilTM borosilicate glass capillaries 
1B100F-4
World Precision Instruments, Sarasota, 
USA
Membrane filter (round), 0,2 µM cut-off 
– OE66
GE Healthcare, Chalfont St. Giles, UK
Membrane filter (syringe mounted), 0,2 
µM cut-off - FiltroPur
Sarstedt, Nümbrecht, Germany
Microdialysis devices – Xpress Dialyzer Scienova, Jena, Germany
Nickel NTA agarose resin Abbott Laboratories, North Chicago, 
USA
Optical adhesive film for well-plates Carl Roth
Parafilm Bemis, Neenah, USA
Pasteur pipettes Carl Roth
PCR tubes (single) Sarstedt, Nümbrecht, Germany
PCR tubes (stripes) Kisker Biotech, Steinfurt, Germany
PierceTM Protein A/G magnetic beads Thermo Fisher Scientific, Waltham, USA
Pipette tips Sarstedt, Nümbrecht, Germany
Platinum wire Carl Roth
Polystyrene cuvettes, disposable - 
Rotilabo
Carl Roth
Precellys lysing kits (0,5 ml & 2 ml) Bertin Technologies, Montigny-le-
Bretonneux, France
PVDF-membrane; 0,2 µM – Roti-Fluoro Carl Roth
Reversed-phase chromatography matrix 
– Poroshell 120 EC-C18, 2,7 µm
Agilent Technologies, Santa Clara, USA
Reaction Tubes, low binding reaction 
tubes (1,5 ml; 2 ml; 15 ml, 50 ml)
Sarstedt, Nümbrecht, Germany
Serological pipettes Sarstedt, Nümbrecht, Germany
Ultracentrifuge reaction tubes (1,5 ml) Beckman Coulter, Brea, USA
96-well plates, clear Techno Plastic Products, Trasadingen, 
Switzerland
96-well plates, white Corning Life Sciences, Corning, USA
384-well plates, black Corning Life Sciences, Corning, USA
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6.11. C. elegans strains
6.11.1. Strains generated for or used in this work
Table 15: List of C. elegans strains generated for or used in this work
Designation Description Source
p12.6 [phsp-12.6::gfp] This project
p12.6tG [phsp-12.6::hsp-12.6::gfp] This project
p17G [phsp-17::gfp] This project
p17tG [phsp-17::hsp-17:gfp] This project
p17tR [phsp-17::hsp-17::wrmScarlet] This project
BJ49 kcIs6 [ifb-2p::ifb-2::CFP] Leube Lab
BK36 qpIs11 [vha-1p::GFP + unc-119(+)] I CGC
CF3166 muEx473 [kin-19p::kin-19::tagRFP + tph-1p::GFP] CGC
DCD214 uqIs24 [myo-2p::tagRFP::pab-1] David Lab





JKM3 [rgef-1p::wrmScarlet::unc-54(3'UTR) + rps-
0p::HygroR]
Kirstein Lab




JKM8 Ex [myo-3p::wrmScarlet-Abeta::unc-54(3'UTR) + 
rps-0p::HygroR]
Kirstein Lab
N2 “Wild type” CGC
OG412 drIs20 [vha-6p::Q44::YFP + rol-6(su1006) + 
pBluescript II]
CGC
mQ0 [unc-54p::YFP] Morimoto Lab
iQ85 [vha-6p::Q85::YFP] Morimoto Lab




The construct for p17tG was injected into RT2676 
to generate an extrachromosomal array.
This study
RT311 pwIs69 [vha6p::GFP::rab-11+Cbr-unc-119(+)] CGC
RT327 pwIs170 [vha6p::GFP::rab-5+Cbr-unc-119(+)] CGC
RT476 wIs170 [vha6p::GFP::rab-7 + Cbr-unc-
119(+)]
CGC
RT525 pwIs206 [vha6p::GFP::rab-10+Cbr-unc-119(+)] CGC
SJ4143 zcIs17 [ges-1::GFP(mit)] CGC




WH346 ojIs34 [GFP::car-1 + unc-119(+)] CGC
6.11.2. Crossed strains generated for this work
Table 16: List of C. elegans strains crossed for this work


















In each row, crossing between strain A and B (AxB) is indicated.
6.12. Bacterial strains
Table 17: List of bacterial strains used in this work
Strain Genotype
BL21 (DE3) pRare E. coli [fhuA2 [lon] ompT gal (λ DE3) [dcm] 
∆hsdS  pRARE (CamR) 
λ DE3 = λ sBamHIo ∆EcoRI-B int::
(lacI::PlacUV5::T7 gene1) i21 ∆nin5]
C3040 NEB stable competent E. coli [F' proA+B+ lacIq ∆(lacZ)M15 
zzf::Tn10 (TetR) ∆(ara-leu) 7697 araD139 fhuA 
∆lacX74 galK16 galE15 e14-  Φ80dlacZ∆M15 
recA1 relA1 endA1 nupG rpsL (StrR) rph spoT1 
∆(mrr-hsdRMS-mcrBC)]
DB11 Serratia marcescens (insect pathogenic Gram-
negative bacterium) [KanR, TetR, StrepR]
DH5 E. coli [dlacZ Delta M15 Delta(lacZYA-argF) 
U169 recA1 endA1 hsdR17(rK-mK+) supE44 
thi-1 gyrA96 relA1]
HT115 (DE3) E. coli [F-, mcrA, mcrB, IN(rrnD-rrnE)1, 
rnc14::Tn10(DE3 lysogen: lacUV5 promoter -T7 
polymerase] (C. elegans RNAi strain)
OP50 E. coli (C. elegans food source), Uracil 
auxotroph
6.13. Software and online tools
Table 18: List of software and online tools used in this work
Software Creator / Company
Amplify4 Bill Engels (University of Wisconsin)
BLAST NCBI, Bethesda, USA
BUSCA Savojardo et al., University of Bologna, 
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Italy (233)
DAVID functional annotation tool Laboratory of Human Retrovirology and 
Immunoinformatics, Frederick, USA 
(234,235)
EzColocalization Stauffer et al. (236)
Fiji Various (237,238)
E-RNAi Horn & Boutros, DKFZ Heidelberg, 
Germany (239)
EndNote X9 Clarivate Analytics, Philadelphia, USA
Excel Microsoft Corporation, Redmond, USA
Illustrator Adobe Inc., San José, USA
OASIS – online application for survival 
analysis
Yang et al. (240)
Perseus Max Planck Institute of Biochemistry 
(241) 
Photoshop Adobe Inc., San José, USA
PLAAC Lancaster et al. (171)
Prism 8 GraphPad Software, San Diego, USA
PRIDE – proteomics identifications 
database
EMBL-EBI, Cambridge, UK (242)
Serial Cloner 2.6.1 Franck Perez (Serial Basics)
Word Microsoft Corporation, Redmond, USA
6.14. In vitro methods
6.14.1. Plasmid DNA preparation
For  preparation  of  plasmid  DNA,  E.  coli cells  (commonly  DH5)  were  grown 
overnight in LB-media, supplemented with 100 µg / ml Ampicillin, until stationary, at 
37 °C. Plasmids containing polyQ constructs were instead grown in  E. coli C3040 
cells. Cells were harvested by centrifugation (20000 x g, 1 min) and the supernatant 
was discarded. The step was repeated until the desired volume of cells had been 
collected.  The isolation of  plasmids was carried out  with the  NucleoSpin Plasmid 
Isolation Kit, following the manufacturer’s instructions. The DNA was collected in a 
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1,5  ml  reaction  vessel  and  concentrations  determined  with  a  Nanodrop 
Spectrophotometer, by measuring absorption at 320, 260 & 280 nm (243). Plasmids 
were stored at -20 °C.
6.14.2. C. elegans RNA preparation
For preparation of C. elegans RNA, nematodes were harvested by washing them off 
NGM-agar  plates  with  M9 media  followed by  centrifugation.  After  removal  of  the 
supernatant, per plate, 250 µl of Trizol reagent were added to the pellet. The mixture 
was agitated on a vortex mixer for 1 min at RT followed by 20 min at 4 °C. The 
mixture was then incubated resting on ice for 12 min. 50 µl of chloroform were added 
before agitating the pellet  manually.  The mixture was let  to rest for  3 min at RT 
before centrifugation at 15300 x g, at 4 °C. The supernatant was then processed with 
the NucleoSpin RNA Isolation Kit, according to the manufacturer’s instructions. The 
concentration of RNA was determined as above, before storage at -80 °C.
6.14.3. cDNA preparation
cDNA was prepared from C. elegans RNA preparations with the Maxima First Strand 
cDNA Synthesis Kit,  according to the manufacturer’s instructions, using 500 ng of 
RNA for each run. cDNA was used immediately or stored at -20 °C.
6.14.4. PCR methods
PCR was performed in a Mastercycler Gradient PCR thermocycler. In general, PCR 
was carried out in 50 or 20 µl volumes of water supplemented with 10x PCR buffer I; 
0,4 mM nucleotide mix (0,1 mM of each nucleoside triphosphate); 1 µl of template (i. 
e. plasmid carrying the gene of interest or cDNA); 0,3 µM of each primer and 1 µl of  
Phusion DNA Polymerase.
To perform PCR directly from  C. elegans, a solution of 1 mg / ml Proteinase K in 
PCR buffer I was prepared. Roughly 10 animals were transferred into 10 µl of the 
mixture and heated to 65 °C for at least 90 min before inactivation at 95 °C for at 
least 30 min. The resulting 10 µl were used as the template for PCR (based on a 
method developed by Ian Chin-Sang, Queens University, Canada and (244)).
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A standard PCR program was used for every experiment (i.e. initial melting at 98 °C 
for 1 min, followed by at least 34 cycles of melting, annealing and elongation at 72 °C 
for 40 sec and one final step of elongation for 10 minutes. As a standard annealing 
temperature,  55  °C  was  used.  Alternatively,  Amplify4 was  used  to  calculate 
annealing temperatures of primers in silico. 
If PCR experiments did not succeed, up to 8% of DMSO were added to the reaction 
mix,  annealing  temperatures  were  reduced  or  optimized  by  gradient  PCR;  PCR 
buffer  I  was  exchanged to  PCR buffer  II  or  0  (allowing  to  manually  adjust  Mg2+ 
concentrations) or the initial melting step was increased to 5 min,  ad libitum, in no 
particular order. To amplify long target DNA strands, elongation times were increased 
to 2 / 20 min.
6.14.5. Cloning methods
For His-SUMO-tagged recombinant expression of proteins in E. coli, the CDS of the 
respective protein was amplified by PCR using the indicated primers and template.  
The  amplified  construct  was  isolated  by  agarose  gel  electrophoresis  followed  by 
isolation  using  the  QIAquick gel  extraction  kit.  Agarose  gel  electrophoresis  was 
performed in  1x  TAE buffer  using  RedSafe  for  nucleotide  staining,  following  the 
manufacturer’s instructions, adjusting agarose concentrations ad libitum (between 1 
and 2 % w/v). The purified DNA and the vector pSUMO were digested using the 
indicated restriction enzymes. After dephosphorylation by Alkaline Phosphatase, the 
prepared insert and vector were ligated by T4 DNA ligase, using a ratio of vector :  
insert  of  1:1;  1:3  and  1:5.  Ligation  was  carried  out  overnight,  at  15 °C,  before 
transformation into E. coli DH5.  
Unless specified otherwise, enzymes and kits were used following the manufacturer’s 
instructions. Serial Cloner was used to establish cloning strategies and generate the 
resulting constructs in silico. The generated plasmids were confirmed by commercial 
DNA sequencing services, using a primer recognizing the T7 promotor provided by 
the company (LGC Genomics, Berlin, Germany and SourceBioscience, Nottingham, 
UK).
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Table 19: List of primer pairs used for cloning into pSumo
Target CDS Primers used Restriction enzymes used
hsp-17 hsp-17 f & r BsaI & NotI
hsp-17+Cystein hsp-17 f & hsp-17r+C BsaI & NotI
hsp-20B hsp-20B f & r BsmBI & NotI
hsp-21 hsp-21 f & r BsaI & NotI
hsp-25a hsp-25 f & r BsaI & NotI
hsp-25b hsp-25b f & hsp-25r BsaI & NotI
hsp-43 hsp-43 f&r BsaI & NotI
A1-42 Abeta f & r BsaI & NotI
For the generation of constructs for C. elegans transformation, the vector pPD95.77 
was used. Promotor sequences were amplified from purified genomic DNA (Kirstein 
Lab), plasmid DNA (see list of plasmids) or directly from C. elegans (transcriptional 
reporters).  CDS were amplified from pSumo or plasmid DNA and cloned into the 
promoter constructs (translational reporters). Constructs generated follow the pattern 
[promoter::gfp or [promotor::cds::gfp]. The construct [phsp-17::hsp-17::gfp] was used 
to  generate  [phsp-17::hsp-17::wrmScarlet].  The  construct  for  the  JKM-strains  is 
described in the results section. The primers M13 reverse (provided by sequencing 
service, binds 5’ of the construct) and rSeq (binds GFP / wrmScarlet) were used for 
sequencing.  The  primer  revSeqSL  was  used  to  sequence  the  A1-42  stem-loop 
construct.
Table 20: List of primer pairs used for cloning into pPD95.77
Target Sequence Primers used Restriction enzymes used
wrmScarlet, for hsp-17 p17+ 17 + Sca f & r AgeI & BtgZI
phsp-17 p17 f & r SphI & SalI
hsp-17 p17+ 17 f & r XmaI & AgeI
hsp-12.6 p12.6 + 12.6 f & r XmaI & KpnI
A1-42 (replacing GFP) AbetaB f & r NheI & XhoI
ASl2 (replacing GFP) AbetaSL2 f & r AgeI & XhoI
wrmScarlet, for A1-42 wrmSca f & r XbaI & NheI
prgef-1 rgef f & r SphI & KpnI
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pklp-6 pklp-6 f & r SphI & KpnI
For  the  generation  of  new  RNAi  constructs,  partial  sequences  of  the  protein  of 
interest CDS have been sub-cloned into the C. elegans RNAi-feeding vector pL4440 
(245). The exact target and the primer sequences have been determined with the 
web-tool E-RNAi  (239). Sequencing was performed to confirm the constructs using 
primers binding the T7-promoter.
Table 21: List of primer pairs used for cloning into pL4440
Target CDS Primers used Restriction enzymes used
hsp-17 hsp-17 RNAi f & r KpnI & HindIII
6.14.6. Generation of competent E. coli cells
To generate competent  E. coli DH5, 1 L of LB-media supplemented with 20 mM 
MgSO4 and 10 mM KCl were induced with 10 ml of a stationary culture of  E. coli 
DH5 and grown to an OD600 between 0,6 and 0,8. Cells were then incubated on ice 
for 10 min before centrifugation at 14000 x g and 4 °C. The pellet was resuspended 
in 300 ml of TFB1 and incubated for 20 min on ice. Cells were centrifuged for 5 min  
at 1500 x g and 4 °C. The resulting pellet was resuspended in 20 ml of cold TFB2; 
the cells were then flash frozen in liquid nitrogen and stored at -80 °C.
6.14.7. Bacterial transformation
To transform competent  E. coli, 100 µl of cells were thawed on ice and mixed with 
ligation mixtures (from molecular cloning) or plasmids of interest. The mixture was 
incubated on ice for at least 20 min before heat shock at 42 °C for 1 min. The cells 
were returned to ice for 5 min and then mixed with 1 ml of LB-media for incubation at 
37 °C for at least 60 min. Cells were then plated on LB-agar supplied with ampicillin 
or used to induce liquid precultures.
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6.14.8. Expression of recombinant proteins
The recombinant overexpression of proteins for  in vitro assays was carried out in 
E. coli BL21 (DE3) pRare. Competent BL21 cells were mixed with a vector carrying 
the CDS of the POI in an expression cassette (i. e. pSumo or pGex) and transformed 
as described. After transformation, cells were grown to stationary phase overnight in 
presence of 100 µg / ml Ampicillin and 25 µg / ml Chloramphenicol. On the next day,  
the preculture was used to induce the required volume of main culture (between 1 
and 4 l) in a ratio of 1 : 100, using the same antibiotics. The main culture was grown 
at 37 °C to an OD600 between 0,5 and 0,8 before induction with IPTG. After a set 
time, cells were harvested by centrifugation at  8000 x g (first run) and 30000 x g 
(second  run).  Pellets  were  flash  frozen  in  liquid  nitrogen  and  stored  at  -20 °C. 
Conditions of induction and expression are indicated in the table.
Table 22: List of expression conditions for recombinant proteins
Recombinant 
protein
Concentration  of 
IPTG for induction
Temperature  of 
overexpression
Time  of 
overexpression
A1-42 0,5 mM 37 °C 4 h
HSP-12.6 1 mM 30 °C 16 h
HSP-17 0,5 mM 30 °C 4 h
other sHsps 0,5 mM 20 °C 16 h
HSP-1, HSP-110, 
DNJ-12, DNJ-13
1 mM 20 °C 16 h
HttEx1Q48 1 mM 18 °C 16 h
6.14.9. Generation of polyclonal antibodies
Polyclonal  anti-HSP-17  antibodies  were  generated  by  immunizing  rabbits  with 
purified  HSP-17  (Pineda,  Germany).  The  immunized  sera  were  tested  against 
purified HSP-17 and against wild type C. elegans lysates.
119
6.14.10. Nickel-affinity chromatography.
For  immobilized-metal  affinity  chromatography  (IMAC),  bacterial  pellets  from 
recombinant  overexpression  were  resuspended  in  approximately  10  times  their 
volume of (LB) by agitation with a glass stick and on a magnetic stirrer. The bacteria 
were  then lysed using  an LM10 microfluidizer  in  three cycles  at  18000 psi.  The 
lysates were centrifuged at 30000 x g for 20 minutes and the cleared lysate was 
mixed with  approximately  1  ml  of  Ni-NTA per  liter  of  main culture  (for  all  sHsps 
except  HSP-12.6,  0,25  ml  of  beads  were  used  per  liter  of  main  culture).  After  
incubating the beads for  90 min on a rolling mixer,  they were passed through a 
plastic  gravity  flow column to attain  an even bedding of  beads.  The beads were 
washed with 25 ml of HSB followed by 25 ml of LSB, before addition of 3 ml EB. The 
beads were agitated for 30 min before the first  elution fraction was collected. An 
additional  7 ml of  EB were added and collected by gravity  flow in  fractions.  The 
fractions  were  tested  for  protein  by  mixing  small  drops  with  Bradford  solution; 
fractions  containing  protein  were  then pooled.  For  1  mg of  total  protein,  4 µg of 
SUMO-protease  were  added  to  remove  the  tag  over  2  hours.  If  a  further 
chromatography  step  was  planned  (i.  e.  anion  exchange),  the  protein  was 
concentrated to around 5 ml by centrifugal filter devices. Following removal of tag, 
reverse  nickel-affinity  chromatography  was  performed:  the  protein  mixture  was 
incubated with 1 ml of nickel beads, equilibrated in LSB, for 10 min, before flow-
through was collected by gravity flow. All steps were performed on ice and samples 
were taken for analysis by SDS-PAGE. 
6.14.11. GST-tagged protein purification
For  GST-sepharose  chromatography  (of  HttEx1Q48Stop1c1),  bacterial  pellets  from 
recombinant  overexpression  were  resuspended  in  approximately  10  times  their 
volume of LWB (including DNaseI) by agitation with a glass stick and on a magnetic 
stirrer. The bacteria were then lysed using an LM10 microfluidizer in three cycles at 
18000 psi. The lysates were centrifuged at 30000 x g for 40 minutes and the cleared 
lysate was mixed with approximately 1 ml of GST-sepharose beads per liter of main 
culture. After incubating the beads for 60 min on a rolling mixer, they were passed 
1 For  the “Stop1c”  construct,  the C-terminal  stop codon was slightly  altered to  ensure full-length 
expression of the construct.
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through a plastic gravity flow column to attain an even bedding of beads. The beads 
were washed with 25 ml of LWB (including Triton X-100) followed by 25 ml of LWB 
(no Triton X-100), before addition of 3 ml EB. The beads were agitated for 30 min 
before the elution fraction was collected by gravity flow and readied for dialysis.
6.14.12. Dialysis
For proteins purified by IMAC without need for further chromatography, removal of 
tag was performed during dialysis of the pooled, eluted protein fractions overnight.  
The protein solution was mixed with the SUMO-protease and filled into dialysis tubing 
before being placed in  at  least  2  L of  LSB,  at  4 °C,  under  gentle  agitation by a 
magnetic  stir  bar.  HttEx1Q48 constructs  were  dialyzed  against  DB.  After  dialysis, 
protein  was  collected  and  purification  was  continued  with  reverse  nickel-affinity 
chromatography as  described above.  The solution  was then aliquoted and flash-
frozen in liquid nitrogen before storage at -80 °C.
6.14.13. Anion exchange chromatography (AEC)
Following nickel-affinity  chromatography,  the flow-through of reverse nickel-affinity 
chromatography was diluted  to  50  ml  in  LSB2 and cleared by  syringe-filter.  The 
protein solution was loaded into a 50 ml Superloop and injected onto a ResourceQ 
anion-exchange  chromatography  column  equilibrated  in  LSB2.  The  column  was 
washed with 5 CV of LSB2 before elution of protein by a gradient of LSB2 to HSB2 
over 25 CV. Fractions containing the POI were determined (in the first run) by SDS-
PAGE. The fractions containing the protein of interest were pooled, aliquoted and 
flash-frozen in liquid nitrogen before storage at -80 °C. Chromatography was carried 
out  using  an  FPLC  (ÄKTA  Explorer)  at  4 °C,  following  the  manufacturer’s 
instructions.
6.14.14. Size exclusion chromatography (SEC)
For  preparative  SEC,  protein  samples  (from  nickel-affinity  or  anion-exchange 
chromatography)  were  concentrated  to  5  ml  using  centrifugal  filter  devices  and 
cleared by syringe filtration. Samples were then loaded onto a HiLoad Superdex 75 
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16/600 column, equilibrated in SEC running buffer, utilizing a 5 ml injection loop. The 
run was performed in the same buffer, following the manufacturer’s instructions, at 
4 °C, at a flow rate of 1 ml / min. Fractions containing protein were collected and 
analyzed before pooling fractions containing the POI and aliquotizing them. Proteins 
were flash frozen in liquid nitrogen and stored at -80 °C.
For analytical SEC, purified and aliquoted protein samples were concentrated to 500 
µl using centrifugal filter devices and cleared by centrifugation. Samples were loaded 
onto a Superose 6 10/300 GL column, equilibrated in SEC running buffer, from a 500 
µl  injection  loop.  The  run  was  performed  in  the  same  buffer,  following  the 
manufacturer’s  instructions,  at  20 °C,  at  a  flow rate  of  0,4  ml  /  min.  Samples  of 
fractions were collected for further analysis by SDS-PAGE.
6.14.15. SDS-PAGE
SDS-Polyacrylamide gels for protein analysis were prepared in a commercial system 
(Bio-Rad). In brief, the separation gel was loaded into the assembly and covered with 
isopropanol  which  was  removed  after  the  gel  had  solidified.  The  gel  was  then 
covered  with  the  stacking  gel,  into  which  the  respective  gel  comb for  10  or  15 
pockets was inserted. For gradient gels, two separation gels were prepared, taken up 
in equal volume into a serological pipette, pre-mixed by taking in air and then cast 
(based on a method by Tal Lorberbaum, Columbia University). The composition of 
the gels was as follows (amounts given for two 0,75 mm gels or 1 1,5 mm gel):
Table 23: Recipes used for SDS-Gels
Tris-Glycine gel components
(10% / 12,5% / 15%)
Separation gel Stacking 
gel
Acrylamide / Bisacrylamide mixture 
(30%)
2,67 ml / 3,33 ml / 4 ml 1,5 ml
Separation gel buffer 2 ml -
Stacking gel buffer - 2,5 ml
H2O 3,33 ml / 2,67 ml / 2 ml 6 ml
APS 80 µl 100 µl
TEMED 8 µl 10 µl
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Tris-Tricine gel components
(4% / 14% / 20%)
Acrylamide / Bisacrylamide mixture 
(30%)
1,33 ml / 4,72 ml / 6,66 ml 0,97 ml
Tris-Tricine gel buffer 3,33 ml 2,5 ml
50 % glycerol stock 0 ml / 2 ml / 0 ml
H2O - 6,55 ml
APS 33 µl 50 µl
TEMED 10 µl 30 µl
Samples for the gel were mixed in a 1:1 ratio with 2x SDS-PAGE sample loading 
buffer  and denatured at 98 °C for at  least 10 min. Prestained protein ladder was 
added as provided.  After loading, Tris-Glycine gels were run at constant current (25 
mA per gel). Tris-Tricine gels were run at constant voltage (70 V for stacking gel, 150 
V for separation gel). Migration of proteins was stopped ad libitum. 14% Tris-Tricine 
gels were used for HSP-17. For HSP-12.6, 15% Tris-Glycine gels were used. A was 
analyzed  with  10-20% Tris-Tricine  gels.  SQST-1  and LGG-1  were  analyzed  with 
12,5% Tris-Glycine gels on the TransBlot Turbo system.
6.14.16. Protein gel staining methods
Protein gels were transferred to Coomassie staining solution for staining and fixation 
for at least 15 min. After staining, the mixture was washed off at least twice with H 2O, 
followed  by  incubation  in  destaining  /  fixing  solution  for  1  h.  Gels  were  then 
transferred to fresh destaining solution and further destained as desired.
6.14.17. Protein quantification
Quantification of proteins by Bradford assay was carried out in clear 96-well plates. 
Bradford  reagent  was  prepared  according  to  the  manufacturer’s  instructions  and 
placed into the required wells, in 200 µl volumes, excluding border wells. For each 
Sample, 1 µl was pipetted into the reagent, in triplicates. A row of 10 wells of reagent  
without  sample  was  prepared  as  a  background  sample.  A  calibration  curve  was 
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prepared from BSA, ranging from 1 to 10 mg / ml (1 mg increments) BSA for  C. 
elegans lysates or 0-5 – 7 mg / ml (0,5, 1, 1,5, 2, 3, 4, 5, 6, 7) BSA for purified protein 
samples. After mixing the samples and incubating for 5 min at most, the absorption of 
each sample at 595 nm was determined in a plate reader. Protein concentrations 
were determined using the calibration curve. A fresh calibration was prepared for 
every experiment.
6.14.18. Immunoprecipitation
Independent populations of young C. elegans adults (N2 for HSP-17 or JKM2/7 for 
A) were lysed in triplicates and centrifuged for 5 min at 8000 x g to remove insoluble  
material before being adjusted to the same total protein concentration. After adding 
10 µl of antibody binding the POI (anti-HSP-17 polyclonal antibody or anti-A 6E10), 
the mixture was incubated for 16 h. As control, the same procedure was carried out 
in triplicates using anti-GFP antibodies (for HSP-17) or the worm strains JKM3/8 (for 
A). 25 µl magnetic beads loaded with Protein A/G were washed three times with 
TBST, one time with HMK and added to the mixture. After incubation for 90 min, the 
beads were washed with TBST three times and samples eluted by boiling in 2x SDS 
sample buffer. Following this, samples were further incubated at 55 °C for 30 minutes  
before alkylation with 15 mM chloroacetamide in the dark, for 30 min.
For immunoprecipitation followed by Western blotting (for A), lysis was carried out in 
RIPA lysis buffer and anti-GFP antibody was used. Separation of magnetic beads 
from liquid phase was carried out using a magnetic reaction vessel rack.
6.14.19. Proteomic analysis of immunoprecipitation samples
Prior  to  MS/MS analysis,  samples  were  separated  by  SDS-PAGE until  they  had 
migrated into the separation gel for approximately 2 cm. The individual lanes were 
excised (excluding the stacking gel  and the loading-dye front).  Subsequent  steps 
were performed by Heike Stephanowitz (FMP): protein digestion from gel bands was 
carried  out  using  trypsin  at  an  enzyme-to-protein  ration  of  1:20  (w/w)  at  37  °C 
overnight as described previously (246).
LC/MS  analysis  was  performed  using  an  UltiMate  3000  RSLC nano  LC  system 
coupled on-line to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientifc). 
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Reversed-phase  separation  was  performed using  a  50 cm analytical  column (in-
house packed with Poroshell 120 EC-C18, 2.7µm, Agilent Technologies) with a 120 
min gradient.  MS1 scans were performed in the orbitrap using 60,000 resolution; 
MS2 scans were acquired in the ion trap with an AGC target of 5E3 and maximum 
injection time of 50 ms. 
Label  free  quantification  was  performed  as  previously  published  (247).  Proteins 
enriched in the sample condition over the control  condition, or proteins that were 
identified  in  the  sample,  but  not  in  the  control  condition,  were  considered  to  be 
enriched.
Data  analysis  including  label  free  quantification  was  performed  using  MaxQuant 
(version 1.6.1.0) using the following parameters: MS ion mass tolerance: 4.5 ppm; 
MS2 ion mass tolerance: 0.5 Da; variable modification: Cys carbamidomethyl, Met 
oxidation, Propionamide; allowed number of mis-cleavage: 2, database: SwissProt 
database of  C. elegans whole proteome (10/2016 27944 sequences and 12832868 
residues searched); label free quantification and match between runs were enabled.  
Results were reported at 1% FDR at the protein level.
6.14.20. Intact protein QTof-MS
Intact proteins were analyzed using a  Waters H-class instrument equipped with a 
quaternary solvent manager, a Waters sample manager-FTN, a Waters PDA detector 
and  a  Waters column  manager  with  an  Acquity  UPLC  protein  BEH  C4  column 
(300 Å, 1.7 μm, 2.1 mm x 50 mm). Proteins were eluted at a column temperature of 
80 °C with a flow rate of 0.3 ml/min. The following gradient was used: A = H2O + 
0.01% formic acid, B = acetonitrile + 0.01% formic acid. 5-95% B 0-6 min at 40 °C. 
Mass analysis was conducted with a Waters XEVO G2-XS QTof analyzer. Proteins 
were ionized in positive ion mode applying a cone voltage of 40 kV. Raw data was 
deconvoluted with MaxEnt 1. Operation of the device was carried out by A. Baumann 
(FMP).
6.14.21. Light scattering
For light  scattering,  the POI was thawed and centrifuged for 1 min at  14000 x g 
before concentrations were determined by Bradford assay. MDH as a substrate was 
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pelleted (from ammonium-sulfate suspension) by centrifugation for 1 min at 14000 x 
g. Then, the supernatant was discarded and replaced with the light scattering buffer. 
GAPDH and CS were dialyzed against their respective light scattering buffers before 
being used as substrates for light scattering or aliquoted and flash frozen in liquid  
nitrogen before storage at -20 °C and treated like the POI for further experiments 
(248).
Before each experiment, the cuvettes and stir bars were rinsed with H2O, ethanol, 
H2O  and  the  respective  light  scattering  buffer.  Between  samples,  the  rinse  was 
repeated with H2O and buffer. For measurements, the required volume of buffer (total 
volume in  cuvette:  1  ml)  was inserted  into  the  cuvette  and measured under  the 
indicated conditions. The measurement was stopped when the baseline stabilized 
and the buffer had reached the intended temperature. The POI was then added and 
measured  until  a  stable  baseline  was  reached.  Subsequently,  the  substrate  of 
aggregation  was  added  and  the  measurement  started  (the  mixture  was 
supplemented with 2 mM DTT for MDH). After measurements, the cuvette and stir 
bar were returned to Hellmanex cleaning solution (3% in H2O, at 30 °C). The buffers 
used for each substrate are indicated in the materials section.
Table 24: Fluorimeter settings used for static light scattering
Fluorimeter setting Value
Slit width 2,5 nm each
Sensitivity medium
Interval 5 s
Wavelength 360 nm and 550 nm (for 47 °C) or 360 
nm and 600 nm (for 41 °C)
Cuvette holder temperature 47,2 °C or 41,2 °C (MDH); 43,2 °C (CS); 
45,2 °C (GAPDH)
Remaining settings Set to default
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6.14.22. Sedimentation of MDH aggregates
Aggregation experiments with MDH were carried out under the same conditions as 
static  light  scattering  experiments,  but  in  50  µl  of  total  volume.  The  indicated 
concentration of MDH was incubated at 47 °C for 30 min or at 41 °C for 60 min in 
MDH light scattering buffer. HSP-17 was added to experiments as indicated in the 
results section.  For separation of soluble and insoluble material,  the mixture was 
centrifuged at 20000 x g for 30 min before supernatant was removed and mixed with 
2x SDS sample buffer. The pellet was resolubilised in 50 µl of the same buffer before 
addition of 2x SDS sample buffer.
6.14.23. Luciferase disaggregation and refolding assay
For luciferase assay, all POI indicated were thawed and concentrations determined 
by Bradford assay. A Luciferase mixture was prepared as follows: Luciferase was 
diluted from stock to 15 nM (in HMK) and kept as native or heat treated for 15 min at 
45 °C. For heat treatment, sHsps were included in the mixture as described in the 
results section. For addition of sHsps after luciferase heat treatment, sHsps in the 
respective amount were heat treated separately.
The final assay mixture was prepared to a volume of 125 µl as indicated:
Table 25: Reaction mixture for luciferase assay
Component Amount added
Pyruvate kinase solution 9,25 µl





sHsp as indicated in results section
Luciferase mixture 42 µl (added directly before 
measurement)
HMK as needed for 125 µl final volume
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Samples were measured in triplicates. For each sample, 100 µl of assay buffer were 
prepared in a white flat bottom 96-well plate. For measurement, 5 µl of the reaction 
mixture were transferred to the assay buffer,  followed by 100 µl  of  1 µM luciferin 
solution.  Luminescence  was then detected  in  a  plate  reader,  after  5  s  of  orbital 
shaking. Measurements were carried out at t0 (when the luciferase mixture is added 
into the reaction mixture) and after 7; 15; 30; 60; 90 and 120 minutes.
6.14.24. Transmission electron microscopy
For TEM analysis, 3 µM HttEx1Q48 were incubated in HMK after addition of 1,4 µl 
Prescission protease per 100 µl of sample (t0). Samples were flash frozen in liquid 
nitrogen at t0 and after 18 h. Small heat shock proteins were added to the mixture as 
indicated in  the results  section.  Further  preparation and mounting of  samples for 
TEM analysis, including immunogold-labeling, were carried out by D. Puchkov (FMP), 
as described previously (27).
6.14.25. Western blotting
Western blotting was carried out after SDS-PAGE in a wet chamber (Bio-Rad). In 
brief, PVDF membrane was wetted in methanol for 1 min before 5 min equilibration in  
transfer buffer.  The SDS-PAGE gel  was also transferred to transfer buffer before 
assembling  the  blot  as  per  the  manufacturer’s  instructions.  Western  blots  were 
performed at constant voltage of 100 V for 90 min. Samples containing A1-42 were 
blotted for no longer than 60 min. After blotting, membranes were blocked for 1 h in  
5% (w/v) milk powder. For A1-42, 4% BSA (w/v) was used instead. Primary antibody 
incubation was carried out overnight at 4 °C in 1x Roti Block. Incubation with anti-
Huntingtin  antibodies  was  carried  out  in  3%  milk  powder  instead.  Secondary 
antibodies were incubated for 60 to 90 min in 1x Roti Block. Detection of peroxidase-
conjugated  antibodies  was  carried  out  using  ECL-reagent,  following  the 
manufacturer’s  instructions,  utilizing  the  Lumi-Imager.  Fluorophore-conjugated 
antibodies were detected using the Odyssey system.
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Semi-dry  blotting  was  carried  out  analogously,  using  the  buffer  provided  by  the 
manufacturer and following the pre-set programs of the Turbo Transfer System (Bio-
Rad). 
6.14.26. Absolute protein quantification ex vivo
To quantify absolute levels of HSP-17 in  C. elegans, lysates were generated from 
nematode populations of the same age in triplicates and centrifuged for 5 min at 
8000 x g  to  remove insoluble material.  Lysates  were  then analyzed by Bradford 
assay and adjusted to the same protein level before labeling with 0,625 pmol / µl  
Cy5-NHS for 15 minutes in the dark. The samples were then blotted (using 1 µg to  
17,5 µg of lysate protein) in parallel to calibration samples of purified HSP-17 of a 
known concentration. HSP-17 was detected by anti-HSP-17 antibody (primary) and 
anti-rabbit-peroxidase conjugated antibody (secondary) on the Lumi-Imager system. 
HSP-17 concentration in the samples was then calculated based on the calibration; 
Cy5  fluorescence  at  700  nm  was  detected  by  Odyssey system  and  used  for 
normalization.
6.15. C. elegans methods
6.15.1. Maintenance of C. elegans
C. elegans was kept on NGM-agar plates seeded with E. coli OP50 as food source at 
20  °C  for  experimentation  and growth  or  at  15  °C for  maintenance,  adhering  to 
standard protocols (249). To avoid starvation, worms were transferred to new media 
at least  once a week by a platinum wire pick using a dissecting or fluorescence 
microscope.  To  generate  lysates  of  C.  elegans,  worms were  collected  using  M9 
buffer and transferred to  Precellys lysing kits in  C. elegans lysis buffer. Lysis was 
performed for all experiments in 3 steps of shaking for 10 seconds at 6000 rpm.
6.15.2. Crossing of C. elegans
To cross  C. elegans strains, 7 young adult males of one strain were placed on a 
NGM-agar  plate  with  one  young  adult  hermaphrodite  of  the  second  strain.  To 
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generate males of a strain of interest, N2 males were crossed with that strain (N2 
males were maintained by crossing them with N2 hermaphrodites). To generate an 
initial population of N2 males, youg adult N2 hermaphrodites were exposed to heat 
shock  (30 °C,  6h)  and  their  offspring  was  screened  for  males.  Successfully 
nematodes were identified by microscopy and isolated until  homozygous offspring 
were identified.
6.15.3. Synchronization of C. elegans
To  synchronize  C.  elegans populations,  NGM-agar  plates  containing  eggs  were 
washed with M9 buffer to remove hatched animals.  The eggs were subsequently 
transferred to a new plate and left to hatch.
Alternatively,  bleaching  was  carried  out.  From  a  plate  containing  gravid 
hermaphrodites, nematodes were washed off using M9 buffer and transferred to a 15 
ml reaction vessel. To a volume of 7,5 ml of M9 buffer, 0,5 ml of 10 M NaOH and 2 
ml of sodium hypochlorite solution were added. The worms were agitated by vortex 
mixer for approximately 4 minutes, before being sedimented by centrifugation at 500 
x g for 1 min, removal of the bleaching solution and washing with H 2O. The wash was 
repeated two times with M9 buffer. After centrifugation at 500 x g for 1 min, liquid was 
removed, retaining a volume of around 500 µl. The mixture was transferred to NGM-
agar plates and eggs were left to hatch overnight.
6.15.4. RNAi experiments with C. elegans
For RNAi-mediated knockdown of genes of interest in C. elegans, NGM-agar plates 
(RNAi) were seeded with E. coli HT115 instead of E. coli OP50. The bacteria carried 
the plasmid p4440L containing the RNAi-construct  for  the respective gene, or an 
empty vector for control. Bacteria were grown in LB-media supplemented with 10 µg /  
ml Tetracycline and 100 µg / ml Ampicillin. Two hours before seeding, bacteria were 
induced with 1 mM IPTG. Nematodes were kept  on the plates from hatching, as 
described above. Bacteria carrying RNAi-constructs not generated for this work were 
taken from the Ahringer Library (250).
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6.15.5. Transformation of C. elegans by microinjection
Transgenic  strains  of  C.  elegans were  generated  by  microinjection,  following 
established  methods  (251).  Needles  for  microinjection  were  pulled  from  glass 
capillaries using a horizontal micropipette puller. Injection mixes contained the vector 
pPD95.77, including the gene of interest, purified by Zymo Kit and eluted in nuclease 
free water. Concentrations of the vector were adjusted for each gene (typically less 
than 10 ng / µl). To provide background DNA, GeneRuler DNA-ladder was added (to  
a  concentration  of  150  ng  /  µl).  Alternatively,  co-injection  of  1  µg  /  µl  of 
oligonucleotides  (the  primer  “Integration”)  has  been  utilized  to  generate 
chromosomally  integrated  translational  reporters  as  described  previously  (for  the 
strains p17tG & p17tR) (252). After transformation, injected worms were isolated and 
their offspring screened for transgenic (fluorescent) animals.
6.15.6. Transformation of C. elegans by gene bombardment
For transformation of  C. elegans by gene gun, established protocols were utilized 
(253,254). In brief, a large population of young adult hermaphrodite nematodes was 
prepared (around 10 NGM-agar plates per construct to be bombarded).  For each 
construct,  1 mg of gold particles were mixed with 100 µl spermidine solution and 
sonicated. After 10 min of incubation at RT, 10 µg of the DNA to be used (i. e. the 
vector pPD95.77) were mixed with 100 µl of the gold solution and incubated for 10 
min at RT. This was repeated after adding 360 µl H2O. 100 µl 1M CaCl2 were added 
before vortex mixing the solution for 10 s. The mixture was then incubated for 10 min 
at RT before centrifugation at 17000 x g for 30 s. The gold particles were washed 3 
times with 500 µl of ethanol, dried, and resuspended in PVP solution.
In parallel, the nematodes for transformation were collected in M9 buffer and left to 
settle on ice. Empty NGM-agar plates were seeded with 12 µl of OP50 before cooling 
down on ice. The nematodes were transferred to the dried OP50 spots to achieve a 
dense  distribution  of  animals  before  shooting  them  with  the  gold  particles.  The 
bombardment was carried out using a custom-made gene gun. After bombardment, 
worms  were  transferred  to  new  NGM-agar  plates  and  screened  for  transgenic 
(fluorescent)  progeny on the following days. Transgenic nematodes were isolated 
and kept in culture. 
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6.15.7. Fixation and DAPI staining of C. elegans
For nuclear staining of  C. elegans  nematodes were harvested and washed three 
times with M9 media. After incubation on ice for 5 min, the nematodes were mixed 
with 500 µl of formaldehyde solution for 30 min. Nematodes were then washed three 
times with PBST before being transferred to a 500 µg / ml solution of DAPI in AbA. 
The specimens were incubated for 2 h in the dark, on a rolling mixer. They were then 
washed  two  times  with  AbA  for  30  min  before  a  final  wash  in  AbA  overnight. 
Subsequently, the nematodes were imaged by LSM as described below.
6.15.8. Confocal laser scanning microscopy
Imaging of  C. elegans was carried out  on a confocal  laser  scanning microscope 
(LSM780). Nematodes chosen for imaging were mounted on pads of 2% agarose in 
H2O, on glass slides. The worms were placed inside a drop of 2 mM levamisole to 
anesthetize them. Parameters of imaging, such as aperture, laser intensity or filter 
sets  were  chosen  to  provide  adequate  imaging  and  kept  constant  for  each 
experiment.  Image material  generated was displayed,  analyzed and prepared for 
Figures with Fiji.
6.15.9. Developmental assay
For developmental assay, 10 L1 nematodes for each condition analyzed were placed 
on NGM-agar plates,  in three independent  replicates.  For each day, worms were 
scored for their developmental stage (L1, L2-L3, L4, adult, lost). Worms that were not 
found or died were censored and not considered for analysis. 
6.15.10. Life span assay
To analyze life span of  C. elegans strains, the indicated number of hermaphrodite 
nematodes was transferred to fresh NGM-agar plates as L1 larvae. RNAi conditions 
and strains were used as reported in the results section. Experiments were carried 
out in triplicates with approximately 100 – 150 animals per condition. For each day, 
all  observed  nematodes  were  scored  as  alive,  dead  (worms  not  moving  upon 
physical stimulation) or missing (missing worms were censored and excluded from 
analysis).  Worms were  transferred  to  new NGM-agar  plates  to  provide  food and 
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separate them from their progeny as required. The Oasis online tool was used to 
analyze  the  resulting  data  (240),  displaying  median  lifespan  and  the  percentage 
fraction of alive worms.
6.15.11. Fecundity assay
For fecundity assays, the indicated number of L4 nematodes were isolated on NGM-
agar plates and the number of eggs laid was counted for each specimen on each 
day. Nematodes were passaged to new plates to separate them from their progeny. 
Each experiment was performed in three independent replicates for each condition 
analyzed.
6.15.12. Thermotolerance assay
To assay thermotolerance, young adult (day 4 old) hermaphrodites were placed on 
NGM-agar  plates  and  exposed  to  heat  shock  at  35°C  for  6 hours  and  then 
transferred to 20 °C for 24 hours before survivors were counted. Three independent 
repeats were performed with 25 nematodes for each condition. The percentages of 
the surviving nematodes were analyzed.
6.15.13. Osmotic stress assay
To assay osmotic stress in C. elegans, young adult hermaphrodites were transferred 
to NGM-agar plates that had been prepared with 250 mM NaCl (five-fold the normal 
concentration).  For each condition, 20 worms were assayed in three independent 
replicates.  Survival  of  the  worms  was  observed  for  each  day  and  they  were 
transferred to new plates to separate them from their progeny. For RNAi conditions,  
nematodes  were  kept  on  RNAi-plates  from  hatching  onwards  before  they  were 
transferred to the osmotic stress plates.
6.15.14. Biotic stress assay
To assay stress by pathogenic bacteria in  C. elegans, young adult hermaphrodites 
were transferred to NGM-agar plates that had been seeded with Serratia marcescens 
DB11 instead of E. coli OP50. Survival of the nematodes was observed for each day, 
for 20 nematodes in three independent replicates. The experiment was carried out in  
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parallel  with  OP50,  to  normalize  the  expected  survival  for  each  condition.  S. 
marcescens  DB11 was grown at 25 °C, in presence of 10 µg / ml Tetracycline, 50 
µg / ml Streptomycin and 35 µg / ml Kanamycin.
6.15.15. Quantification of KIN-19 foci
To quantify pharyngeal KIN-19 foci in C. elegans, LSM images of the pharynx were 
taken for each nematode. For each specimen analyzed, bright-field microscopy was 
used to identify a comparable z-layer before an image was taken including tagRFP 
fluorescence.  The images generated were analyzed by  Fiji.  To quantify  individual 
foci,  the head or intestine of the worm was defined as a region of interest to be 
analyzed by the “Find Maxima” feature, using default settings.
6.15.16. Fractionation of insoluble material from C. elegans
To fractionate soluble and insoluble proteins from  C. elegans,  populations of  the 
indicated age were collected and lysed. Centrifugation was carried out at 500 x g for 
3 min to pellet cell debris and nematode cuticula before supernatant of all conditions 
was  quantified  by  Bradford  assay  and  normalized.  For  each  condition,  50  µl  of 
normalized lysates were centrifuged at 20000 x g for 30 min at 4 °C. Supernatant 
was mixed with  2x SDS-loading buffer;  the pellet  was resolubilized in 50 µl  lysis 
buffer before mixing with 2x SDS-loading buffer. Analysis of the fractions was carried 
out by SDS-PAGE and Western blotting.
6.15.17. Analysis of iQ-foci by counting
To quantify formation of intestinal polyQ-foci in  C. elegans, 20 nematodes for each 
condition were analyzed by fluorescence microscopy in  two independent  repeats. 
Starting on day 4 of life, for each worm and day, polyQ-foci were counted (by YFP-
fluorescence). Nematodes were scored and clustered to display either no foci, one or 
more foci, 3 or more foci and finally 10 or more foci.
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6.15.18. Analysis of relative fluorescence intensity
To quantify fluorescence levels in whole nematodes, wide field images were taken by 
LSM780 for each specimen analyzed, using the respective fluorescence filter (YFP 
for phsp3::yfp). The z-level was adjusted by bright field to be comparable in each 
case.  Images were  analyzed in  Fiji.  Each nematode was defined as  a region  of 
interest to measure “Integrated density”, “Area” and “Mean gray value”. Fluorescence 
levels were considered to be integrated density divided by area; with the mean gray 
value of a random non-nematode pixels being the background (usually 0).
6.15.19. Swim-exhaustion assay
To assess paralysis of C. elegans in response to physical exhaustion, three sets of 
20 nematodes per condition, on day 4 of live, were placed into a column of 3-4 mm 
M9 media and slightly dispersed. After 30 minutes of incubation at rt, the number of 
nematodes moving was scored and plotted as the fraction of total nematodes used. 
Experiments were performed in triplicates.
6.16. Statistical analysis and in silico analysis 
6.16.1. Statistical analysis
Statistical analysis was performed using Excel (to determine standard deviations and 
standard error of means) and Prism (for ANOVA testing). By Prism, p-values < 0,05 
were considered significant: p < 0,05 (*), < 0,01 (**), < 0,001 (***), < 0,0001 (****). 
Dunnett’s  multiple  comparisons  test  (for  a  fixed  control),  Bonferroni’s  multiple 
comparisons  test  (no  fixed  control)  or  Sidak’s  multiple  comparisons  test  (more 
powerful  than Bonferroni)  were applied as suggested by the software. To assess 
survival distribution, a log-rank test was performed, considering p < 0,01 as (*).
6.16.2. In silico analysis of protein sequences
In silico prediction of prion-like amino acid sequences in proteins was carried out by 
the  online  tool  PLAAC,  using  C.  elegans background  frequencies.  Prediction  of 
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protein subcellular localization of proteins by amino acid sequences was carried out 
by BUSCA, using default settings.
6.16.3. Image analysis
Image analysis was carried out using Adobe Photoshop (for general presentation of 
image  material)  and  Fiji (for  additional  preparation  of  microscopies  and  image 
analysis).  Quantification  from  images  was  carried  out  from  raw  data  where 
applicable.  The  Fiji  plugin  EzColocalization was  used  for  C.  elegans analysis  of 
colocalization between fluorophore tagged proteins, without cell identification, using 
standard settings.
6.16.4. Gene ontology analysis
Gene ontology analysis was carried out using the functional annotation tool of the 
DAVID online resource. Proteins enriched in IP-MS/MS experiments were entered 
into the tool to determine gene ontology terms that are significantly enriched in the 
dataset.
7. References
1. Kim,  Y.  E.,  Hipp,  M.  S.,  Bracher,  A.,  Hayer-Hartl,  M.,  and  Hartl,  F.  U.  (2013) 
Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 
82, 323-355
2. Anfinsen,  C. B., Haber, E., Sela, M., and White,  F. H., Jr.  (1961) The kinetics of 
formation of native ribonuclease during oxidation of the reduced polypeptide chain. 
Proc Natl Acad Sci U S A 47, 1309-1314
3. Balchin, D., Hayer-Hartl, M., and Hartl, F. U. (2016) In vivo aspects of protein folding 
and quality control. Science 353, aac4354
4. Ellis, R. J. (2001) Macromolecular crowding: an important but neglected aspect of the 
intracellular environment. Current Opinion in Structural Biology 11, 114-119
5. Ellis, R. J., and Minton, A. P. (2006) Protein aggregation in crowded environments. 
Biol Chem 387, 485-497
6. Lindquist, S. (1986) The heat-shock response. Annu Rev Biochem 55, 1151-1191
7. Morimoto,  R.  I.  (2008)  Proteotoxic  stress  and  inducible  chaperone  networks  in 
neurodegenerative disease and aging. Genes Dev 22, 1427-1438
8. Burkewitz, K., Choe, K., and Strange, K. (2011) Hypertonic stress induces rapid and 
widespread protein damage in C. elegans. Am J Physiol Cell Physiol 301, C566-576
9. Hartl, F. U., Bracher, A., and Hayer-Hartl, M. (2011) Molecular chaperones in protein 
folding and proteostasis. Nature 475, 324-332
136
10. Hipp, M. S.,  Kasturi,  P.,  and Hartl,  F. U. (2019) The proteostasis  network and its 
decline in ageing. Nat Rev Mol Cell Biol 20, 421-435
11. Haslbeck, M., and Vierling, E. (2015) A first line of stress defense: small heat shock 
proteins and their function in protein homeostasis. J Mol Biol 427, 1537-1548
12. Ding, L., and Candido, E. P. (2000) HSP43, a small heat-shock protein localized to 
specific cells of the vulva and spermatheca in the nematode Caenorhabditis elegans. 
Biochem J 349, 409-412
13. Parsell,  D.  A.,  Kowal,  A.  S.,  Singer,  M.  A.,  and  Lindquist,  S.  (1994)  Protein 
disaggregation mediated by heat-shock protein Hsp104. Nature 372, 475-478
14. Mogk, A., Tomoyasu, T., Goloubinoff, P., Rudiger, S., Roder, D., Langen, H., and 
Bukau, B. (1999) Identification of thermolabile Escherichia coli proteins: prevention 
and reversion of aggregation by DnaK and ClpB. EMBO J 18, 6934-6949
15. Kirstein, J., Moliere, N., Dougan, D. A., and Turgay, K. (2009) Adapting the machine: 
adaptor proteins for Hsp100/Clp and AAA+ proteases. Nat Rev Microbiol 7, 589-599
16. Tyedmers,  J.,  Mogk,  A.,  and  Bukau,  B.  (2010)  Cellular  strategies  for  controlling 
protein aggregation. Nat Rev Mol Cell Biol 11, 777-788
17. Mayer, M. P. (2013) Hsp70 chaperone dynamics and molecular mechanism.  Trends 
Biochem Sci 38, 507-514
18. Kampinga,  H.  H.,  and  Craig,  E.  A.  (2010)  The  HSP70  chaperone  machinery:  J 
proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 11, 579-592
19. Arnsburg, K. (2017) Characterization of chaperone signatures and neurodegenerative 
diseases using the
model organism C. elegans. Dr. rer. nat., Humboldt-University of Berlin
20. Craig, E. A., and Marszalek, J. (2017) How Do J-Proteins Get Hsp70 to Do So Many 
Different Things? Trends Biochem Sci 42, 355-368
21. Glover, J. R., and Lindquist, S. (1998) Hsp104, Hsp70, and Hsp40: A novel chaperone 
system that rescues previously aggregated proteins. Cell 94, 73-82
22. Shorter, J. (2011) The mammalian disaggregase machinery: Hsp110 synergizes with 
Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free 
system. PLoS One 6, e26319
23. Andreasson, C., Fiaux, J., Rampelt, H., Mayer, M. P., and Bukau, B. (2008) Hsp110 is 
a nucleotide-activated exchange factor for Hsp70. J Biol Chem 283, 8877-8884
24. Rampelt, H., Kirstein-Miles, J., Nillegoda, N. B., Chi, K., Scholz, S. R., Morimoto, R. 
I.,  and Bukau, B. (2012) Metazoan Hsp70 machines  use Hsp110 to power protein 
disaggregation. EMBO J 31, 4221-4235
25. Nillegoda, N. B., Kirstein, J., Szlachcic, A., Berynskyy, M., Stank, A., Stengel, F., 
Arnsburg,  K.,  Gao,  X.,  Scior,  A.,  Aebersold,  R.,  Guilbride,  D.  L.,  Wade,  R.  C., 
Morimoto, R. I., Mayer, M. P., and Bukau, B. (2015) Crucial HSP70 co-chaperone 
complex unlocks metazoan protein disaggregation. Nature 524, 247-251
26. Gao, X., Carroni, M., Nussbaum-Krammer, C., Mogk, A., Nillegoda, N. B., Szlachcic, 
A., Guilbride, D. L., Saibil, H. R., Mayer, M. P., and Bukau, B. (2015) Human Hsp70 
Disaggregase Reverses Parkinson's-Linked alpha-Synuclein Amyloid Fibrils. Mol Cell 
59, 781-793
27. Scior, A., Buntru, A., Arnsburg, K., Ast, A., Iburg, M., Juenemann, K., Pigazzini, M. 
L., Mlody, B., Puchkov, D., Priller, J., Wanker, E. E., Prigione, A., and Kirstein, J. 
(2018) Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a 
trimeric chaperone complex. EMBO J 37, 282-299
28. Lindquist, S., and Kim, G. (1996) Heat-shock protein 104 expression is sufficient for 
thermotolerance in yeast.  Proceedings  of the National  Academy of Sciences  of the 
United States of America 93, 5301-5306
137
29. Amm, I., Sommer, T., and Wolf, D. H. (2014) Protein quality control and elimination 
of protein waste: the role of the ubiquitin-proteasome system. Biochim Biophys Acta 
1843, 182-196
30. Yu,  L.,  Chen,  Y.,  and  Tooze,  S.  A.  (2018)  Autophagy  pathway:  Cellular  and 
molecular mechanisms. Autophagy 14, 207-215
31. Johansen,  T.,  and Lamark,  T.  (2011) Selective  autophagy mediated  by autophagic 
adapter proteins. Autophagy 7, 279-296
32. Labbadia,  J.,  and Morimoto,  R. I.  (2015) The biology of proteostasis  in aging and 
disease. Annu Rev Biochem 84, 435-464
33. Soto, C., and Pritzkow, S. (2018) Protein misfolding, aggregation, and conformational 
strains in neurodegenerative diseases. Nat Neurosci 21, 1332-1340
34. Ciechanover,  A.,  and  Kwon,  Y.  T.  (2017)  Protein  Quality  Control  by  Molecular 
Chaperones in Neurodegeneration. Front Neurosci 11, 185
35. Gan,  L.,  Cookson,  M.  R.,  Petrucelli,  L.,  and La Spada,  A.  R.  (2018)  Converging 
pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci 21, 1300-
1309
36. Chiti,  F.,  and Dobson,  C.  M. (2017) Protein Misfolding,  Amyloid Formation,  and 
Human Disease: A Summary of Progress Over the Last Decade.  Annu Rev Biochem 
86, 27-68
37. Knowles, T. P., Vendruscolo, M., and Dobson, C. M. (2014) The amyloid state and its 
association with protein misfolding diseases. Nat Rev Mol Cell Biol 15, 384-396
38. Alzheimer, A. (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr f 
Psychiatr. u Psych-Gerichtl Med 64, 146-148
39. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., and Murtagh, F. R. (1995) An 
English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der 
Hirnrinde". Clin Anat 8, 429-431
40. Mucke, L. (2009) Neuroscience: Alzheimer's disease. Nature 461, 895-897
41. Patterson, C. (2018) WorldAlzheimerReport2018. Alzheimer’s Disease International 
42. Wimo, A., and Prince, M. (2010) WorldAlzheimerReport2010.  Alzheimer’s Disease 
International 
43. Shao,  W.,  Peng,  D.,  and Wang,  X.  (2017) Genetics  of  Alzheimer's  disease:  From 
pathogenesis to clinical usage. J Clin Neurosci 45, 1-8
44. Ziegler-Graham,  K.,  Brookmeyer,  R.,  Johnson,  E.,  and  Arrighi,  H.  M.  (2008) 
Worldwide  variation  in  the  doubling  time  of  Alzheimer's  disease  incidence  rates. 
Alzheimers Dement 4, 316-323
45. Bertram, L., and Tanzi, R. E. (2012) The genetics of Alzheimer's disease.  Prog Mol 
Biol Transl Sci 107, 79-100
46. De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, 
W., Von Figura, K., and Van Leuven, F. (1998) Deficiency of presenilin-1 inhibits the 
normal cleavage of amyloid precursor protein. Nature 391, 387-390
47. Plant,  L.  D.,  Boyle,  J.  P.,  Smith,  I.  F.,  Peers,  C.,  and Pearson,  H.  A.  (2003) The 
production of amyloid beta peptide is a critical requirement for the viability of central 
neurons. Journal of Neuroscience 23, 5531-5535
48. Puzzo,  D.,  Privitera,  L.,  Leznik,  E.,  Fa,  M.,  Staniszewski,  A.,  Palmeri,  A.,  and 
Arancio, O. (2008) Picomolar amyloid-beta positively modulates synaptic plasticity 
and memory in hippocampus. J Neurosci 28, 14537-14545
49. Beyreuther, K., Bush, A. I., Dyrks, T., Hilbich, C., Konig, G., Monning, U., Multhaup, 
G., Prior, R., Rumble, B., Schubert, W., Small, D. H., Weidemann, A., and Masters, 
C. L. (1991) Mechanisms of Amyloid Deposition in Alzheimers-Disease.  Annals of 
the New York Academy of Sciences 640, 129-139
138
50. Hardy, J. A.,  and Higgins,  G. A. (1992) Alzheimer's  disease: the amyloid cascade 
hypothesis. Science 256, 184-185
51. Gulisano,  W.,  Maugeri,  D.,  Baltrons,  M.  A.,  Fa,  M.,  Amato,  A.,  Palmeri,  A., 
D'Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., and Arancio, O. 
(2018) Role of Amyloid-beta and Tau Proteins in Alzheimer's Disease: Confuting the 
Amyloid Cascade. J Alzheimers Dis 64, S611-S631
52. Bloom, G. S. (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease 
pathogenesis. JAMA Neurol 71, 505-508
53. Tomiyama, T., Nagata, T., Shimada, H., Teraoka, R., Fukushima, A., Kanemitsu, H., 
Takuma, H., Kuwano, R., Imagawa, M., Ataka, S., Wada, Y., Yoshioka, E., Nishizaki, 
T.,  Watanabe,  Y.,  and  Mori,  H.  (2008)  A  new  amyloid  beta  variant  favoring 
oligomerization in Alzheimer's-type dementia. Ann Neurol 63, 377-387
54. Spires-Jones, T. L., and Hyman, B. T. (2014) The intersection of amyloid beta and tau 
at synapses in Alzheimer's disease. Neuron 82, 756-771
55. De Strooper, B., and Karran, E. (2016) The Cellular Phase of Alzheimer's Disease. 
Cell 164, 603-615
56. Julien, C., Tomberlin, C., Roberts, C. M., Akram, A., Stein, G. H., Silverman, M. A., 
and  Link,  C.  D.  (2018)  In  vivo  induction  of  membrane  damage  by  beta-amyloid 
peptide oligomers. Acta Neuropathol Commun 6, 131
57. Ruiz-Riquelme, A., Lau, H. H. C., Stuart, E., Goczi, A. N., Wang, Z., Schmitt-Ulms, 
G., and Watts, J. C. (2018) Prion-like propagation of beta-amyloid aggregates in the 
absence of APP overexpression. Acta Neuropathol Commun 6, 26
58. Jucker, M., and Walker, L. C. (2018) Propagation and spread of pathogenic protein 
assemblies in neurodegenerative diseases. Nat Neurosci 21, 1341-1349
59. (2020) 2020 Alzheimer's disease facts and figures. Alzheimers & Dementia 
60. Menzies, F. M., Fleming, A., and Rubinsztein, D. C. (2015) Compromised autophagy 
and neurodegenerative diseases. Nat Rev Neurosci 16, 345-357
61. Calamini,  B., Silva, M. C., Madoux, F., Hutt,  D. M., Khanna, S., Chalfant, M. A., 
Saldanha, S. A., Hodder, P., Tait, B. D., Garza, D., Balch, W. E., and Morimoto, R. I. 
(2011) Small-molecule proteostasis regulators for protein conformational diseases. Nat 
Chem Biol 8, 185-196
62. Treweek, T. M., Meehan, S., Ecroyd, H., and Carver, J. A. (2015) Small heat-shock 
proteins: important players in regulating cellular proteostasis.  Cell Mol Life Sci 72, 
429-451
63. Carra,  S.,  Alberti,  S.,  Benesch,  J.  L.  P.,  Boelens,  W.,  Buchner,  J.,  Carver,  J.  A., 
Cecconi,  C.,  Ecroyd,  H.,  Gusev,  N.,  Hightower,  L.  E.,  Klevit,  R.  E.,  Lee,  H.  O., 
Liberek, K., Lockwood, B., Poletti,  A., Timmerman, V., Toth, M. E., Vierling,  E.,  
Wu, T., and Tanguay, R. M. (2019) Small heat shock proteins: multifaceted proteins 
with important implications for life. Cell Stress Chaperones 24, 295-308
64. Vos, M. J., Carra, S., Kanon, B., Bosveld, F., Klauke, K., Sibon, O. C., and Kampinga, 
H.  H.  (2016)  Specific  protein  homeostatic  functions  of  small  heat-shock  proteins 
increase lifespan. Aging Cell 15, 217-226
65. Kriehuber, T., Rattei, T., Weinmaier, T., Bepperling, A., Haslbeck, M., and Buchner, 
J. (2010) Independent evolution of the core domain and its flanking sequences in small 
heat shock proteins. FASEB J 24, 3633-3642
66. Waters, E. R. (2013) The evolution, function, structure, and expression of the plant 
sHSPs. J Exp Bot 64, 391-403
67. Hochberg,  G.  K.  A.,  Shepherd,  D.  A.,  Marklund,  E.  G.,  Santhanagoplan,  I., 
Degiacomi, M. T., Laganowsky, A., Allison, T. M., Basha, E., Marty, M. T., Galpin, 
M. R.,  Struwe,  W.  B.,  Baldwin,  A.  J.,  Vierling,  E.,  and Benesch,  J.  L.  P.  (2018) 
139
Structural  principles  that  enable  oligomeric  small  heat-shock  protein  paralogs  to 
evolve distinct functions. Science 359, 930-934
68. Mymrikov, E. V., Seit-Nebi, A. S., and Gusev, N. B. (2011) Large potentials of small 
heat shock proteins. Physiol Rev 91, 1123-1159
69. Kokke, B. P. A., Leroux, M. R., Candido, E. P. M., Boelens, W. C., and de Jong, W. 
W. (1998) Caenorhabditis  elegans  small  heat-shock proteins  Hsp12.2 and Hsp12.3 
form tetramers and have no chaperone-like activity. Febs Letters 433, 228-232
70. Fu, X. (2014) Chaperone function and mechanism of small heat-shock proteins. Acta 
Biochim Biophys Sin (Shanghai) 46, 347-356
71. Leroux, M. R., Ma, B. J., Batelier, G., Melki, R., and Candido, E. P. (1997) Unique 
structural features of a novel class of small heat shock proteins.  J Biol Chem 272, 
12847-12853
72. van de Klundert, F. A. J. M., Smulders, R. H. P. H., Gijsen, M. L. J., Lindner, R. A., 
Jaenicke, R., Carver, J. A., and De Jong, W. W. (1998) The mammalian small heat-
shock protein  Hsp20 forms dimers  and is  a  poor  chaperone.  European Journal  of 
Biochemistry 258, 1014-1021
73. Haslbeck,  M.,  Weinkauf,  S.,  and  Buchner,  J.  (2019)  Small  heat  shock  proteins: 
Simplicity meets complexity. J Biol Chem 294, 2121-2132
74. Hanazono, Y., Takeda, K., Oka, T., Abe, T., Tomonari, T., Akiyama, N., Aikawa, Y., 
Yohda, M., and Miki, K. (2013) Nonequivalence observed for the 16-meric structure 
of  a  small  heat  shock  protein,  SpHsp16.0,  from  Schizosaccharomyces  pombe. 
Structure 21, 220-228
75. Shi, J., Koteiche, H. A., McDonald, E. T., Fox, T. L., Stewart, P. L., and McHaourab, 
H.  S.  (2013)  Cryoelectron  microscopy  analysis  of  small  heat  shock  protein  16.5 
(Hsp16.5)  complexes  with  T4 lysozyme reveals  the  structural  basis  of  multimode 
binding. J Biol Chem 288, 4819-4830
76. Kim, K. K., Kim, R., and Kim, S. H. (1998) Crystal structure of a small heat-shock 
protein. Nature 394, 595-599
77. van Montfort, R. L., Basha, E., Friedrich, K. L., Slingsby, C., and Vierling, E. (2001) 
Crystal structure and assembly of a eukaryotic small heat shock protein.  Nat Struct 
Biol 8, 1025-1030
78. Jehle,  S.,  van  Rossum,  B.,  Stout,  J.  R.,  Noguchi,  S.  M.,  Falber,  K.,  Rehbein,  K., 
Oschkinat,  H.,  Klevit,  R.  E.,  and Rajagopal,  P.  (2009) alphaB-crystallin:  a  hybrid 
solid-state/solution-state  NMR  investigation  reveals  structural  aspects  of  the 
heterogeneous oligomer. J Mol Biol 385, 1481-1497
79. Bagneris, C., Bateman, O. A., Naylor, C. E., Cronin, N., Boelens, W. C., Keep, N. H., 
and  Slingsby,  C.  (2009)  Crystal  structures  of  alpha-crystallin  domain  dimers  of 
alphaB-crystallin and Hsp20. J Mol Biol 392, 1242-1252
80. Stengel, F., Baldwin, A. J., Painter, A. J., Jaya, N., Basha, E., Kay, L. E., Vierling, E., 
Robinson,  C.  V.,  and  Benesch,  J.  L.  (2010)  Quaternary  dynamics  and  plasticity 
underlie small heat shock protein chaperone function. Proc Natl Acad Sci U S A 107, 
2007-2012
81. Stromer, T., Fischer, E., Richter, K., Haslbeck, M., and Buchner, J. (2004) Analysis of 
the regulation of the molecular chaperone Hsp26 by temperature-induced dissociation: 
the  N-terminal  domail  is  important  for  oligomer  assembly  and  the  binding  of 
unfolding proteins. J Biol Chem 279, 11222-11228
82. Fleckenstein, T., Kastenmuller, A., Stein, M. L., Peters, C., Daake, M., Krause, M., 
Weinfurtner, D., Haslbeck, M., Weinkauf, S., Groll, M., and Buchner, J. (2015) The 
Chaperone Activity of the Developmental Small Heat Shock Protein Sip1 Is Regulated 
by pH-Dependent Conformational Changes. Mol Cell 58, 1067-1078
140
83. Hussein,  R.  M.,  Benjamin,  I.  J.,  and  Kampinga,  H.  H.  (2015)  Rescue  of  alphaB 
Crystallin  (HSPB5)  Mutants  Associated  Protein  Aggregation  by  Co-Expression  of 
HSPB5 Partners. PLoS One 10, e0126761
84. Morelli, F. F., Verbeek, D. S., Bertacchini, J., Vinet, J., Mediani, L., Marmiroli, S.,  
Cenacchi, G., Nasi, M., De Biasi, S., Brunsting, J. F., Lammerding, J., Pegoraro, E., 
Angelini,  C.,  Tupler,  R.,  Alberti,  S.,  and  Carra,  S.  (2017)  Aberrant  Compartment 
Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and 
Function. Cell Rep 20, 2100-2115
85. Aquilina,  J.  A., Shrestha,  S.,  Morris, A. M., and Ecroyd, H. (2013) Structural and 
functional  aspects  of  hetero-oligomers  formed  by  the  small  heat  shock  proteins 
alphaB-crystallin and HSP27. J Biol Chem 288, 13602-13609
86. Jakob, U., Gaestel, M., Engel, K., and Buchner, J. (1993) Small heat shock proteins 
are molecular chaperones. J Biol Chem 268, 1517-1520
87. Lee, G. J., Roseman, A. M., Saibil, H. R., and Vierling, E. (1997) A small heat shock 
protein stably binds heat-denatured model substrates and can maintain a substrate in a 
folding-competent state. Embo Journal 16, 659-671
88. Ehrnsperger,  M.,  Graber,  S.,  Gaestel,  M.,  and Buchner,  J.  (1997) Binding of non-
native protein to Hsp25 during heat shock creates a reservoir of folding intermediates 
for reactivation. Embo Journal 16, 221-229
89. Veinger,  L.,  Diamant,  S.,  Buchner,  J.,  and Goloubinoff,  P.  (1998) The small  heat-
shock  protein  IbpB  from  Escherichia  coli  stabilizes  stress-denatured  proteins  for 
subsequent refolding by a multichaperone network. J Biol Chem 273, 11032-11037
90. Friedrich,  K.  L.,  Giese,  K.  C.,  Buan,  N.  R.,  and  Vierling,  E.  (2004)  Interactions 
between small heat shock protein subunits and substrate in small heat shock protein-
substrate complexes. J Biol Chem 279, 1080-1089
91. Mymrikov, E. V., Daake, M., Richter, B., Haslbeck, M., and Buchner, J. (2017) The 
Chaperone Activity and Substrate Spectrum of Human Small Heat Shock Proteins.  J 
Biol Chem 292, 672-684
92. Mainz, A., Peschek, J., Stavropoulou, M., Back, K. C., Bardiaux, B., Asami, S., Prade, 
E., Peters, C., Weinkauf, S., Buchner, J., and Reif, B. (2015) The chaperone alphaB-
crystallin uses different interfaces to capture an amorphous and an amyloid client. Nat 
Struct Mol Biol 22, 898-905
93. Sakono,  M.,  Utsumi,  A.,  Zako,  T.,  Abe,  T.,  Yohda,  M.,  and  Maeda,  M.  (2013) 
Formation of non-toxic Abeta fibrils  by small  heat shock protein under heat-stress 
conditions. Biochem Biophys Res Commun 430, 1259-1264
94. Shammas, S. L., Waudby, C. A., Wang, S., Buell, A. K., Knowles, T. P., Ecroyd, H., 
Welland, M. E., Carver, J. A., Dobson, C. M., and Meehan, S. (2011) Binding of the 
molecular  chaperone  alphaB-crystallin  to  Abeta  amyloid  fibrils  inhibits  fibril 
elongation. Biophys J 101, 1681-1689
95. Cox,  D.,  and  Ecroyd,  H.  (2017)  The  small  heat  shock  proteins  alphaB-crystallin 
(HSPB5) and Hsp27 (HSPB1) inhibit the intracellular aggregation of alpha-synuclein. 
Cell Stress Chaperones 22, 589-600
96. Cox, D., Whiten, D. R., Brown, J. W. P., Horrocks, M. H., San Gil, R., Dobson, C. M., 
Klenerman, D., van Oijen, A. M., and Ecroyd, H. (2018) The small heat shock protein 
Hsp27 binds  alpha-synuclein fibrils,  preventing  elongation  and cytotoxicity.  J Biol 
Chem 293, 4486-4497
97. Freilich, R., Betegon, M., Tse, E., Mok, S. A., Julien, O., Agard, D. A., Southworth, 
D.  R.,  Takeuchi,  K.,  and  Gestwicki,  J.  E.  (2018)  Competing  protein-protein 
interactions regulate binding of Hsp27 to its client protein tau. Nat Commun 9, 4563
141
98. Oliveira,  A. O.,  Osmand, A., Outeiro,  T.  F.,  Muchowski,  P. J.,  and Finkbeiner,  S. 
(2016) alphaB-Crystallin overexpression in astrocytes modulates the phenotype of the 
BACHD mouse model of Huntington's disease. Hum Mol Genet 25, 1677-1689
99. Mogk, A., Schlieker, C., Friedrich, K. L., Schonfeld, H. J., Vierling, E., and Bukau, B. 
(2003) Refolding of substrates bound to small Hsps relies on a disaggregation reaction 
mediated most efficiently by ClpB/DnaK. J Biol Chem 278, 31033-31042
100. Cashikar, A. G., Duennwald, M., and Lindquist, S. L. (2005) A chaperone pathway in 
protein  disaggregation.  Hsp26  alters  the  nature  of  protein  aggregates  to  facilitate 
reactivation by Hsp104. J Biol Chem 280, 23869-23875
101. Fontaine, J. M., Sun, X., Benndorf, R., and Welsh, M. J. (2005) Interactions of HSP22 
(HSPB8) with HSP20, alphaB-crystallin, and HSPB3. Biochem Biophys Res Commun 
337, 1006-1011
102. Arrigo, A. P. (2013) Human small heat shock proteins: protein interactomes of homo- 
and hetero-oligomeric complexes: an update. FEBS Lett 587, 1959-1969
103. Rauch, J. N., Tse, E., Freilich, R., Mok, S. A., Makley, L. N., Southworth, D. R., and 
Gestwicki, J. E. (2017) BAG3 Is a Modular, Scaffolding Protein that physically Links 
Heat Shock Protein 70 (Hsp70) to the Small Heat Shock Proteins.  J Mol Biol 429, 
128-141
104. Guilbert, S. M., Lambert, H., Rodrigue, M. A., Fuchs, M., Landry, J., and Lavoie, J. 
N.  (2018)  HSPB8  and  BAG3  cooperate  to  promote  spatial  sequestration  of 
ubiquitinated  proteins  and coordinate  the  cellular  adaptive  response to  proteasome 
insufficiency. FASEB J, fj201700558RR
105. Haidar,  M.,  Asselbergh,  B.,  Adriaenssens,  E.,  De Winter,  V.,  Timmermans,  J.  P., 
Auer-Grumbach,  M.,  Juneja,  M.,  and  Timmerman,  V.  (2019)  Neuropathy-causing 
mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 
bodies. Autophagy, 1-18
106. Miller, S. B., Ho, C. T., Winkler, J., Khokhrina, M., Neuner, A., Mohamed, M. Y., 
Guilbride, D. L., Richter, K., Lisby, M., Schiebel, E., Mogk, A., and Bukau, B. (2015) 
Compartment-specific  aggregases  direct  distinct  nuclear  and cytoplasmic  aggregate 
deposition. EMBO J 34, 778-797
107. Zhang, Y. W., Zhu, J. H., Wang, Z. Q., Wu, Y., Meng, X., Zheng, X., and Javid, B. 
(2019) HspX promotes the polar localization of mycobacterial protein aggregates. Sci 
Rep 9, 14571
108. Specht,  S.,  Miller,  S.  B.,  Mogk,  A.,  and Bukau,  B.  (2011) Hsp42 is  required  for 
sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. 
J Cell Biol 195, 617-629
109. Hantke, I., Schafer, H., Janczikowski, A., and Turgay, K. (2019) YocM a small heat 
shock protein can protect Bacillus subtilis cells during salt stress. Mol Microbiol 111, 
423-440
110. Ungelenk, S., Moayed, F., Ho, C. T., Grousl, T., Scharf, A., Mashaghi, A., Tans, S., 
Mayer, M. P., Mogk, A., and Bukau, B. (2016) Small heat shock proteins sequester 
misfolding proteins in near-native conformation for cellular protection and efficient 
refolding. Nat Commun 7, 13673
111. Ratajczak, E., Zietkiewicz, S., and Liberek, K. (2009) Distinct activities of Escherichia 
coli small heat shock proteins IbpA and IbpB promote efficient protein disaggregation. 
J Mol Biol 386, 178-189
112. Zwirowski,  S.,  Klosowska,  A.,  Obuchowski,  I.,  Nillegoda,  N.  B.,  Pirog,  A., 
Zietkiewicz, S., Bukau, B., Mogk, A., and Liberek, K. (2017) Hsp70 displaces small 
heat shock proteins from aggregates to initiate protein refolding. EMBO J 36, 783-796
142
113. Ho, C. T., Grousl, T., Shatz, O., Jawed, A., Ruger-Herreros, C., Semmelink, M., Zahn, 
R., Richter, K., Bukau, B., and Mogk, A. (2019) Cellular sequestrases maintain basal 
Hsp70 capacity ensuring balanced proteostasis. Nat Commun 10, 4851
114. David, D. C., Ollikainen,  N., Trinidad,  J. C., Cary, M. P., Burlingame, A. L., and 
Kenyon, C. (2010) Widespread protein aggregation as an inherent part of aging in C. 
elegans. PLoS Biol 8, e1000450
115. Labbadia, J., and Morimoto, R. I. (2015) Repression of the Heat Shock Response Is a 
Programmed Event at the Onset of Reproduction. Mol Cell 59, 639-650
116. Escusa-Toret,  S.,  Vonk,  W.  I.,  and  Frydman,  J.  (2013)  Spatial  sequestration  of 
misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during 
stress. Nat Cell Biol 15, 1231-1243
117. Miller,  S.  B.,  Mogk, A.,  and Bukau, B. (2015) Spatially  organized aggregation  of 
misfolded proteins as cellular stress defense strategy. J Mol Biol 427, 1564-1574
118. Wallace, E. W., Kear-Scott, J. L., Pilipenko, E. V., Schwartz, M. H., Laskowski, P. R., 
Rojek, A. E., Katanski, C. D., Riback, J. A., Dion, M. F., Franks, A. M., Airoldi, E. 
M., Pan, T., Budnik, B. A., and Drummond, D. A. (2015) Reversible, Specific, Active 
Aggregates of Endogenous Proteins Assemble upon Heat Stress. Cell 162, 1286-1298
119. Saad,  S.,  Cereghetti,  G.,  Feng,  Y.,  Picotti,  P.,  Peter,  M.,  and  Dechant,  R.  (2017) 
Reversible protein aggregation is a protective mechanism to ensure cell cycle restart 
after stress. Nat Cell Biol 19, 1202-1213
120. Walther, D. M., Kasturi, P., Zheng, M., Pinkert, S., Vecchi, G., Ciryam, P., Morimoto, 
R. I., Dobson, C. M., Vendruscolo, M., Mann, M., and Hartl, F. U. (2015) Widespread 
Proteome Remodeling and Aggregation in Aging C. elegans. Cell 161, 919-932
121. Douglas, P. M., Treusch, S., Ren, H. Y., Halfmann, R., Duennwald, M. L., Lindquist, 
S., and Cyr, D. M. (2008) Chaperone-dependent amyloid assembly protects cells from 
prion toxicity. Proc Natl Acad Sci U S A 105, 7206-7211
122. Arrasate,  M., Mitra, S., Schweitzer,  E. S.,  Segal, M. R., and Finkbeiner,  S. (2004) 
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal 
death. Nature 431, 805-810
123. Mannini,  B.,  Cascella,  R.,  Zampagni,  M.,  van Waarde-Verhagen,  M.,  Meehan,  S., 
Roodveldt, C., Campioni, S., Boninsegna, M., Penco, A., Relini, A., Kampinga, H. H., 
Dobson, C. M., Wilson, M. R., Cecchi, C., and Chiti, F. (2012) Molecular mechanisms 
used by chaperones to reduce the toxicity of aberrant protein oligomers.  Proc Natl 
Acad Sci U S A 109, 12479-12484
124. Ojha,  J.,  Masilamoni,  G.,  Dunlap,  D.,  Udoff,  R.  A.,  and  Cashikar,  A.  G.  (2011) 
Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism. Mol Cell 
Biol 31, 3146-3157
125. Binger, K. J., Ecroyd, H., Yang, S., Carver, J. A., Howlett, G. J., and Griffin, M. D. 
(2013)  Avoiding  the  oligomeric  state:  alphaB-crystallin  inhibits  fragmentation  and 
induces dissociation of apolipoprotein C-II amyloid fibrils. FASEB J 27, 1214-1222
126. Brenner, S. (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94
127. Markaki, M., and Tavernarakis, N. (2010) Modeling human diseases in Caenorhabditis 
elegans. Biotechnol J 5, 1261-1276
128. Consortium, C. e. S. (1998) Genome sequence of the nematode C. elegans: a platform 
for investigating biology. Science 282, 2012-2018
129. Lai, C. H., Chou, C. Y., Ch'ang, L. Y., Liu, C. S., and Lin, W. (2000) Identification of 
novel  human  genes  evolutionarily  conserved  in  Caenorhabditis  elegans  by 
comparative proteomics. Genome Res 10, 703-713
130. Byerly, L., Cassada, R. C., and Russell, R. L. (1976) The life cycle of the nematode 
Caenorhabditis elegans. Developmental Biology 51, 23-33
143
131. Sulston, J. E., and Horvitz, H. R. (1977) Post-embryonic cell lineages of the nematode, 
Caenorhabditis elegans. Dev Biol 56, 110-156
132. Altun, Z. F. H., D. H. (2020) Handbook of C. elegans Anatomy. In WormAtlas.  
133. Hariharan, I. K., and Haber, D. A. (2003) Yeast, flies, worms, and fish in the study of 
human disease. N Engl J Med 348, 2457-2463
134. United  Nations  Department  of  Economic  and  Social  Affairs,  P.  D.  (2015)  World 
Population Ageing
2015. United Nations
135. Naidoo, N., Ferber, M., Master, M., Zhu, Y., and Pack, A. I. (2008) Aging impairs the  
unfolded protein response to sleep deprivation and leads to proapoptotic signaling.  J 
Neurosci 28, 6539-6548
136. Niccoli, T., and Partridge, L. (2012) Ageing as a risk factor for disease. Curr Biol 22, 
R741-752
137. Friedman,  D.  B.,  and  Johnson,  T.  E.  (1988)  A  mutation  in  the  age-1  gene  in 
Caenorhabditis  elegans lengthens  life  and reduces  hermaphrodite  fertility.  Genetics 
118, 75-86
138. Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993) A C-Elegans 
Mutant That Lives Twice as Long as Wild-Type. Nature 366, 461-464
139. Dorman, J. B., Albinder, B., Shroyer, T., and Kenyon, C. (1995) The age-1 and daf-2 
genes  function  in  a  common  pathway  to  control  the  lifespan  of  Caenorhabditis 
elegans. Genetics 141, 1399-1406
140. Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., and 
Ruvkun, G. (1997) The Fork head transcription factor DAF-16 transduces insulin-like 
metabolic and longevity signals in C. elegans. Nature 389, 994-999
141. Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., Masaki, K. H., 
Willcox, D. C., Rodriguez, B., and Curb, J. D. (2008) FOXO3A genotype is strongly 
associated with human longevity. Proc Natl Acad Sci U S A 105, 13987-13992
142. Greer, E. L., and Brunet, A. (2008) Signaling networks in aging. J Cell Sci 121, 407-
412
143. Lithgow, G. J., White, T. M., Melov, S., and Johnson, T. E. (1995) Thermotolerance 
and extended life-span conferred by single-gene mutations and induced by thermal 
stress. Proc Natl Acad Sci U S A 92, 7540-7544
144. Morley, J. F., and Morimoto, R. I. (2004) Regulation of longevity in Caenorhabditis 
elegans by heat shock factor and molecular chaperones. Mol Biol Cell 15, 657-664
145. Prahlad, V., Cornelius, T., and Morimoto, R. I. (2008) Regulation of the cellular heat 
shock response in Caenorhabditis  elegans  by thermosensory neurons.  Science 320, 
811-814
146. Walker,  G.  A.,  and  Lithgow,  G.  J.  (2003)  Lifespan  extension  in  C-elegans  by  a 
molecular chaperone dependent upon insulin-like signals. Aging Cell 2, 131-139
147. Aevermann, B. D., and Waters, E. R. (2008) A comparative genomic analysis of the 
small heat shock proteins in Caenorhabditis elegans and briggsae. Genetica 133, 307-
319
148. Kraemer, B. C., Zhang, B., Leverenz, J. B., Thomas, J. H., Trojanowski, J. Q., and 
Schellenberg, G. D. (2003) Neurodegeneration and defective neurotransmission in a 
Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A 100, 9980-9985
149. Lakso,  M.,  Vartiainen,  S.,  Moilanen,  A.  M.,  Sirvio,  J.,  Thomas,  J.  H.,  Nass,  R., 
Blakely, R. D., and Wong, G. (2003) Dopaminergic neuronal loss and motor deficits 
in Caenorhabditis  elegans overexpressing human alpha-synuclein.  J Neurochem 86, 
165-172
144
150. Brignull, H. R., Moore, F. E., Tang, S. J., and Morimoto, R. I. (2006) Polyglutamine 
proteins  at  the  pathogenic  threshold  display  neuron-specific  aggregation  in  a  pan-
neuronal Caenorhabditis elegans model. J Neurosci 26, 7597-7606
151. Link,  C.  D.  (1995)  Expression  of  human  beta-amyloid  peptide  in  transgenic 
Caenorhabditis elegans. Proc Natl Acad Sci U S A 92, 9368-9372
152. Link, C. D., Johnson, C. J., Fonte, V., Paupard, M. C., Hall, D. H., Styren, S., Mathis, 
C. A., and Klunk, W. E. (2001) Visualization of fibrillar amyloid deposits in living, 
transgenic  Caenorhabditis  elegans  animals  using  the  sensitive  amyloid  dye,  X-34. 
Neurobiology of Aging 22, 217-226
153. McColl, G., Roberts, B. R., Gunn, A. P., Perez, K. A., Tew, D. J., Masters, C. L., 
Barnham, K. J., Cherny, R. A., and Bush, A. I. (2009) The Caenorhabditis elegans A 
beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42.  J Biol 
Chem 284, 22697-22702
154. McColl, G., Roberts, B. R., Pukala, T. L., Kenche, V. B., Roberts, C. M., Link, C. D., 
Ryan, T. M., Masters, C. L., Barnham, K. J., Bush, A. I., and Cherny, R. A. (2012) 
Utility  of  an  improved  model  of  amyloid-beta  (Abeta(1)(-)(4)(2))  toxicity  in 
Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol Neurodegener 
7, 57
155. Dosanjh, L. E., Brown, M. K., Rao, G., Link, C. D., and Luo, Y. (2010) Behavioral 
phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta. 
J Alzheimers Dis 19, 681-690
156. Ochiishi, T., Doi, M., Yamasaki, K., Hirose, K., Kitamura, A., Urabe, T., Hattori, N., 
Kinjo, M., Ebihara, T., and Shimura, H. (2016) Development of new fusion proteins 
for visualizing amyloid-beta oligomers in vivo. Sci Rep 6, 22712
157. Cotella, D., Hernandez-Enriquez, B., Wu, X., Li, R., Pan, Z., Leveille, J., Link, C. D., 
Oddo,  S.,  and Sesti,  F.  (2012) Toxic role  of  K+ channel  oxidation  in  mammalian 
brain. J Neurosci 32, 4133-4144
158. Sinnige, T., Ciryam, P., Casford, S., Dobson, C. M., de Bono, M., and Vendruscolo, 
M.  (2019)  Expression  of  the  amyloid-beta  peptide  in  a  single  pair  of  C.  elegans 
sensory  neurons  modulates  the  associated  behavioural  response.  PLoS  One 14, 
e0217746
159. Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E., Chung, C. Y., Baru, V., 
Shulman,  J.  M.,  Parrado,  A.,  Bevis,  B.  J.,  Valastyan,  J.  S.,  Han,  H.,  Lindhagen-
Persson, M., Reiman, E. M., Evans, D. A., Bennett, D. A., Olofsson, A., DeJager, P. 
L., Tanzi, R. E., Caldwell, K. A., Caldwell, G. A., and Lindquist, S. (2011) Functional 
links  between  Abeta  toxicity,  endocytic  trafficking,  and  Alzheimer's  disease  risk 
factors in yeast. Science 334, 1241-1245
160. Fonte, V., Kapulkin, W. J., Taft, A., Fluet, A., Friedman, D., and Link, C. D. (2002) 
Interaction of intracellular beta amyloid peptide with chaperone proteins.  Proc Natl 
Acad Sci U S A 99, 9439-9444
161. Fonte, V., Kipp, D. R., Yerg, J., 3rd, Merin, D., Forrestal, M., Wagner, E., Roberts, C. 
M., and Link, C. D. (2008) Suppression of in vivo beta-amyloid peptide toxicity by 
overexpression of the HSP-16.2 small chaperone protein. J Biol Chem 283, 784-791
162. Altun,  Z.  F.,  Hall,  D.  H.,  and  Herndon,  L.  A.  (2006)  WormAtas  Hermaphrodite 
Handbook - Introduction. WormAtlas 
163. Mogk,  A.,  Ruger-Herreros,  C.,  and  Bukau,  B.  (2019)  Cellular  Functions  and 
Mechanisms of Action of Small Heat Shock Proteins. Annu Rev Microbiol 73, 89-110
164. Ezemaduka, A. N., Yu, J., Shi, X., Zhang, K., Yin, C. C., Fu, X., and Chang, Z. (2014) 
A small heat shock protein enables Escherichia coli to grow at a lethal temperature of 
145
50 degrees  C conceivably  by maintaining  cell  envelope  integrity.  J Bacteriol 196, 
2004-2011
165. Candido, E. P. (2002) The small heat shock proteins of the nematode Caenorhabditis 
elegans: structure, regulation and biology. Prog Mol Subcell Biol 28, 61-78
166. Zhang, K., Ezemaduka, A. N., Wang, Z., Hu, H., Shi, X., Liu, C., Lu, X., Fu, X., 
Chang, Z., and Yin, C. C. (2015) A novel mechanism for small heat shock proteins to 
function as molecular chaperones. Sci Rep 5, 8811
167. Ding, L., and Candido, E. P. (2000) HSP25, a small heat shock protein associated with 
dense bodies and M-lines of body wall muscle in Caenorhabditis elegans. J Biol Chem 
275, 9510-9517
168. Krause,  M.  (2013)  Structural  and functional  characterization  of  small  heat  shock 
proteins of the nematode Caenorhabditis elegans. Dr. rer. nat, Technische Universität 
München
169. Horwitz,  J.  (1992)  Alpha-Crystallin  Can  Function  as  a  Molecular  Chaperone. 
Proceedings of the National Academy of Sciences of the United States of America 89, 
10449-10453
170. Grousl, T., Ungelenk, S., Miller, S., Ho, C. T., Khokhrina, M., Mayer, M. P., Bukau, 
B., and Mogk, A. (2018) A prion-like domain in Hsp42 drives chaperone-facilitated 
aggregation of misfolded proteins. J Cell Biol 
171. Lancaster, A. K., Nutter-Upham, A., Lindquist, S., and King, O. D. (2014) PLAAC: a 
web and command-line  application  to  identify  proteins  with prion-like amino acid 
composition. Bioinformatics 30, 2501-2502
172. Sarov, M., Murray, J. I.,  Schanze, K., Pozniakovski,  A., Niu, W., Angermann, K., 
Hasse,  S.,  Rupprecht,  M.,  Vinis,  E.,  Tinney,  M.,  Preston,  E.,  Zinke,  A.,  Enst,  S.,  
Teichgraber,  T.,  Janette,  J.,  Reis,  K.,  Janosch,  S.,  Schloissnig,  S.,  Ejsmont,  R.  K., 
Slightam, C., Xu, X., Kim, S. K., Reinke, V., Stewart, A. F., Snyder, M., Waterston, 
R.  H.,  and  Hyman,  A.  A.  (2012)  A genome-scale  resource  for  in  vivo  tag-based 
protein function exploration in C. elegans. Cell 150, 855-866
173. Husken, K., Wiesenfahrt, T., Abraham, C., Windoffer, R., Bossinger, O., and Leube, 
R. E. (2008) Maintenance of the intestinal tube in Caenorhabditis elegans: the role of 
the intermediate filament protein IFC-2. Differentiation 76, 881-896
174. Kim, W. (2013) Ortholist. Greenwald Laboratory
175. Feleciano, D. R., Juenemann, K., Iburg, M., Bras, I. C., Holmberg, C. I., and Kirstein, 
J.  (2019)  Crosstalk  Between  Chaperone-Mediated  Protein  Disaggregation  and 
Proteolytic Pathways in Aging and Disease. Front Aging Neurosci 11, 9
176. Ezemaduka, A. N., Wang, Y., and Li, X. (2017) Expression of CeHSP17 Protein in 
Response to Heat Shock and Heavy Metal Ions. J Nematol 49, 334-340
177. Nelson,  F.  K.,  and  Riddle,  D.  L.  (1984)  Functional-Study  of  the  Caenorhabditis-
Elegans  Secretory-Excretory  System  Using  Laser  Microsurgery.  Journal  of 
Experimental Zoology 231, 45-56
178. Mohri-Shiomi,  A.,  and Garsin,  D.  A.  (2008) Insulin  signaling  and the  heat  shock 
response modulate protein homeostasis in the Caenorhabditis elegans intestine during 
infection. J Biol Chem 283, 194-201
179. Moronetti  Mazzeo,  L.  E.,  Dersh,  D.,  Boccitto,  M.,  Kalb,  R.  G.,  and Lamitina,  T. 
(2012) Stress and aging induce distinct polyQ protein aggregation states.  Proc Natl 
Acad Sci U S A 109, 10587-10592
180. Lechler,  M.  C.,  Crawford,  E.  D.,  Groh,  N.,  Widmaier,  K.,  Jung,  R.,  Kirstein,  J., 
Trinidad, J. C., Burlingame, A. L., and David, D. C. (2017) Reduced Insulin/IGF-1 
Signaling  Restores  the  Dynamic  Properties  of  Key Stress  Granule  Proteins  during 
Aging. Cell Rep 18, 454-467
146
181. Grant, B., and Hirsh, D. (1999) Receptor-mediated endocytosis in the Caenorhabditis 
elegans oocyte. Molecular Biology of the Cell 10, 4311-4326
182. Ewald, C. Y., and Li, C. (2012) Caenorhabditis elegans as a model organism to study 
APP function. Exp Brain Res 217, 397-411
183. Bindels, D. S., Haarbosch, L., van Weeren, L., Postma, M., Wiese, K. E., Mastop, M., 
Aumonier, S., Gotthard, G., Royant, A., Hink, M. A., and Gadella, T. W. J. (2016) 
mScarlet:  a  bright  monomeric  red fluorescent  protein  for  cellular  imaging.  Nature 
Methods 14, 53-56
184. El Mouridi, S., Lecroisey, C., Tardy, P., Mercier, M., Leclercq-Blondel, A., Zariohi, 
N.,  and  Boulin,  T.  (2017)  Reliable  CRISPR/Cas9  Genome  Engineering  in 
Caenorhabditis elegans Using a Single Efficient sgRNA and an Easily Recognizable 
Phenotype. G3 (Bethesda) 7, 1429-1437
185. Li, D., and Wang, M. (2012) Construction of a bicistronic vector for the co-expression 
of two genes in Caenorhabditis elegans using a newly identified IRES. Biotechniques 
52, 173-176
186. Kaufman,  R.  J.,  Murtha,  P.,  and Davies,  M. V.  (1987) Translational  efficiency of 
polycistronic  mRNAs  and  their  utilization  to  express  heterologous  genes  in 
mammalian cells. The EMBO Journal 6, 187-193
187. Hassan, W. M.,  Dostal,  V.,  Huemann,  B. N.,  Yerg,  J.  E.,  and Link,  C. D. (2015) 
Identifying  Abeta-specific  pathogenic  mechanisms  using  a  nematode  model  of 
Alzheimer's disease. Neurobiol Aging 36, 857-866
188. Link, C. D., Cypser, J. R., Johnson, C. J., and Johnson, T. E. (1999) Direct observation 
of stress response in Caenorhabditis elegans using a reporter transgene. Cell Stress & 
Chaperones 4, 235-242
189. Cohen,  E.,  Bieschke,  J.,  Perciavalle,  R.  M.,  Kelly,  J.  W.,  and  Dillin,  A.  (2006) 
Opposing activities protect against age-onset proteotoxicity. Science 313, 1604-1610
190. Butterfield, D. A., Castegna, A., Lauderback, C. M., and Drake, J. (2002) Evidence 
that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's 
disease brain contribute to neuronal death. Neurobiology of Aging 23, 655-664
191. Kirstein,  J.,  Morito,  D.,  Kakihana,  T.,  Sugihara,  M.,  Minnen,  A.,  Hipp,  M.  S., 
Nussbaum-Krammer, C., Kasturi, P., Hartl,  F. U., Nagata, K., and Morimoto, R. I. 
(2015) Proteotoxic  stress and ageing triggers  the loss of redox homeostasis  across 
cellular compartments. EMBO J 34, 2334-2349
192. Nixon,  R.  A.,  Wegiel,  J.,  Kumar,  A.,  Yu,  W.  H.,  Peterhoff,  C.,  Cataldo,  A.,  and 
Cuervo, A. M. (2005) Extensive involvement of autophagy in Alzheimer disease: an 
immuno-electron microscopy study. J Neuropathol Exp Neurol 64, 113-122
193. Willen, K., Edgar, J. R., Hasegawa, T., Tanaka, N., Futter, C. E., and Gouras, G. K. 
(2017) Abeta accumulation causes MVB enlargement and is modelled by dominant 
negative VPS4A. Mol Neurodegener 12, 61
194. Kaminski Schierle,  G. S.,  Bertoncini,  C. W.,  Chan, F. T.  S.,  van der Goot,  A. T., 
Schwedler, S., Skepper, J., Schlachter, S., van Ham, T., Esposito, A., Kumita, J. R., 
Nollen, E. A. A., Dobson, C. M., and Kaminski, C. F. (2011) A FRET sensor for non-
invasive imaging of amyloid formation in vivo. Chemphyschem 12, 673-680
195. White, J. G., Southgate, E., Thomson, J. N., and Brenner, S. (1986) The structure of 
the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond 
B Biol Sci 314, 1-340
196. Bargmann, C. I., and Avery, L. (1995) Laser killing of cells in Caenorhabditis elegans. 
Methods Cell Biol 48, 225-250
197. Pedrero-Prieto,  C.  M.,  Flores-Cuadrado,  A.,  Saiz-Sanchez,  D.,  Ubeda-Banon,  I., 
Frontinan-Rubio,  J.,  Alcain,  F.  J.,  Mateos-Hernandez,  L.,  de  la  Fuente,  J.,  Duran-
147
Prado,  M.,  Villar,  M.,  Martinez-Marcos,  A.,  and  Peinado,  J.  R.  (2019)  Human 
amyloid-beta enriched extracts: evaluation of in vitro and in vivo internalization and 
molecular characterization. Alzheimers Res Ther 11, 56
198. Bowen, D. M., Smith, C. B., White, P., and Davison, A. N. (1976) Neurotransmitter-
related enzymes and indices  of hypoxia in senile  dementia  and other abiotrophies. 
Brain 99, 459-496
199. Davies, P., and Maloney, A. J. (1976) Selective loss of central cholinergic neurons in 
Alzheimer's disease. Lancet 2, 1403
200. Peden, E. M., and Barr, M. M. (2005) The KLP-6 kinesin is required for male mating 
behaviors and polycystin localization in Caenorhabditis elegans.  Curr Biol 15, 394-
404
201. Esposito, G., Di Schiavi, E., Bergamasco, C., and Bazzicalupo, P. (2007) Efficient and 
cell specific knock-down of gene function in targeted C. elegans neurons. Gene 395, 
170-176
202. Wei, X., Potter, C. J., Luo, L., and Shen, K. (2012) Controlling gene expression with 
the Q repressible binary expression system in Caenorhabditis elegans. Nat Methods 9, 
391-395
203. Leroux,  M.  R.,  Melki,  R.,  Gordon,  B.,  Batelier,  G.,  and  Candido,  E.  P.  (1997) 
Structure-function  studies  on  small  heat  shock  protein  oligomeric  assembly  and 
interaction with unfolded polypeptides. J Biol Chem 272, 24646-24656
204. Saarikangas,  J.,  and  Barral,  Y.  (2015)  Protein  aggregates  are  associated  with 
replicative aging without compromising protein quality control. Elife 4
205. Wang,  K.,  and  Spector,  A.  (2000)  alpha-crystallin  prevents  irreversible  protein 
denaturation  and acts  cooperatively  with  other  heat-shock proteins  to  renature  the 
stabilized partially denatured protein in an ATP-dependent manner.  Eur J Biochem 
267, 4705-4712
206. Haslbeck,  M.,  Miess,  A.,  Stromer,  T.,  Walter,  S.,  and  Buchner,  J.  (2005) 
Disassembling protein aggregates in the yeast cytosol. The cooperation of Hsp26 with 
Ssa1 and Hsp104. J Biol Chem 280, 23861-23868
207. Stege, G. J., Renkawek, K., Overkamp, P. S., Verschuure, P., van Rijk, A. F., Reijnen-
Aalbers, A., Boelens, W. C., Bosman, G. J., and de Jong, W. W. (1999) The molecular 
chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.  Biochem Biophys 
Res Commun 262, 152-156
208. Chen, J. Y., Parekh, M., Seliman, H., Bakshinskaya, D., Dai, W., Kwan, K., Chen, K. 
Y., and Liu, A. Y. C. (2018) Heat shock promotes inclusion body formation of mutant 
huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction. J Biol 
Chem 293, 15581-15593
209. Haslbeck, M., Walke, S., Stromer, T., Ehrnsperger, M., White, H. E., Chen, S., Saibil, 
H. R., and Buchner, J. (1999) Hsp26: a temperature-regulated chaperone. EMBO J 18, 
6744-6751
210. Haslbeck,  M.,  Braun,  N.,  Stromer,  T.,  Richter,  B.,  Model,  N.,  Weinkauf,  S.,  and 
Buchner, J. (2004) Hsp42 is the general small heat shock protein in the cytosol of 
Saccharomyces cerevisiae. EMBO J 23, 638-649
211. Linder,  B.,  Jin,  Z.,  Freedman,  J.  H.,  and  Rubin,  C.  S.  (1996)  Molecular 
characterization  of  a  novel,  developmentally  regulated  small  embryonic  chaperone 
from Caenorhabditis elegans. J Biol Chem 271, 30158-30166
212. Shirayama, M., Soto, M. C., Ishidate, T., Kim, S., Nakamura, K., Bei, Y., van den 
Heuvel, S., and Mello, C. C. (2006) The Conserved Kinases CDK-1, GSK-3, KIN-19, 
and  MBK-2  Promote  OMA-1  Destruction  to  Regulate  the  Oocyte-to-Embryo 
Transition in C. elegans. Curr Biol 16, 47-55
148
213. Walston, T., Tuskey, C., Edgar, L., Hawkins, N., Ellis, G., Bowerman, B., Wood, W., 
and Hardin, J. (2004) Multiple Wnt signaling pathways converge to orient the mitotic 
spindle in early C. elegans embryos. Dev Cell 7, 831-841
214. Banerjee, D., Chen, X., Lin, S. Y., and Slack, F. J. (2010) kin-19/casein kinase Ialpha 
has dual functions in regulating asymmetric division and terminal differentiation in C. 
elegans epidermal stem cells. Cell Cycle 9, 4748-4765
215. Altun,  Z.  F.,  Hall,  D.  H.,  and  Herndon,  L.  A.  (2005)  WormAtlas  Hermaphrodite 
Handbook - Nervous System - General Description. WormAtlas 
216. Pinotsi,  D., Michel,  C. H.,  Buell,  A. K., Laine,  R. F.,  Mahou, P.,  Dobson, C. M., 
Kaminski,  C.  F.,  and  Kaminski  Schierle,  G.  S.  (2016)  Nanoscopic  insights  into 
seeding mechanisms and toxicity  of alpha-synuclein species in neurons.  Proc Natl 
Acad Sci U S A 113, 3815-3819
217. Young, L. J., Kaminski Schierle, G. S., and Kaminski, C. F. (2017) Imaging Abeta(1-
42) fibril elongation reveals strongly polarised growth and growth incompetent states. 
Phys Chem Chem Phys 19, 27987-27996
218. Sepulcre, J., Sabuncu, M. R., Becker, A., Sperling, R., and Johnson, K. A. (2013) In 
vivo characterization of the early states of the amyloid-beta network. Brain 136, 2239-
2252
219. Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., and LaFerla, F. M. (2005)  
Intraneuronal Abeta causes the onset of early Alzheimer's  disease-related cognitive 
deficits in transgenic mice. Neuron 45, 675-688
220. Kobro-Flatmoen, A., Nagelhus, A., and Witter, M. P. (2016) Reelin-immunoreactive 
neurons in entorhinal cortex layer II selectively express intracellular amyloid in early 
Alzheimer's disease. Neurobiol Dis 93, 172-183
221. Toh, W. H., Tan, J. Z., Zulkefli, K. L., Houghton, F. J., and Gleeson, P. A. (2017) 
Amyloid precursor protein traffics from the Golgi directly to early endosomes in an 
Arl5b- and AP4-dependent pathway. Traffic 18, 159-175
222. Gaiser, A. M., Kaiser, C. J., Haslbeck, V., and Richter, K. (2011) Downregulation of 
the Hsp90 system causes defects in muscle cells of Caenorhabditis elegans. PLoS One 
6, e25485
223. Stringham, E. G., Dixon, D. K., Jones, D., and Candido, E. P. (1992) Temporal and 
spatial  expression  patterns  of  the  small  heat  shock  (hsp16)  genes  in  transgenic 
Caenorhabditis elegans. Mol Biol Cell 3, 221-233
224. Arnsburg, K., and Kirstein-Miles, J. (2014) Interrelation between protein synthesis, 
proteostasis and lifespan. Current Genomics 15, 66-75
225. Markesbery, W. R. (1997) Oxidative Stress Hypothesis in Alzheimer's Disease. Free 
Radical Biology and Medicine 23, 134-147
226. Bordi,  M.,  Berg,  M.  J.,  Mohan,  P.  S.,  Peterhoff,  C.  M.,  Alldred,  M.  J.,  Che,  S., 
Ginsberg,  S.  D.,  and  Nixon,  R.  A.  (2016)  Autophagy  flux  in  CA1  neurons  of 
Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel 
neuritic dystrophy. Autophagy 12, 2467-2483
227. Lee, H., Choi, M. K., Lee, D., Kim, H. S., Hwang, H., Kim, H., Park, S., Paik, Y. K., 
and Lee,  J.  (2011) Nictation,  a dispersal  behavior  of the nematode Caenorhabditis 
elegans, is regulated by IL2 neurons. Nat Neurosci 15, 107-112
228. Coates, J. C., and de Bono, M. (2002) Antagonistic pathways in neurons exposed to 
body fluid regulate social feeding in Caenorhabditis elegans. Nature 419, 925-929
229. Pereira, L., Kratsios, P., Serrano-Saiz, E., Sheftel, H., Mayo, A. E., Hall, D. H., White, 
J.  G., LeBoeuf,  B., Garcia,  L.  R., Alon, U., and Hobert,  O. (2015) A cellular and 
regulatory map of the cholinergic nervous system of C. elegans. Elife 4
149
230. Yassin,  L.,  Gillo,  B.,  Kahan,  T.,  Halevi,  S.,  Eshel,  M.,  and  Treinin,  M.  (2001) 
Characterization of the DEG-3/DES-2 receptor: A nicotinic acetylcholine receptor that 
mutates to cause neuronal degeneration. Mol Cell Neurosci 17, 589-599
231. Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., and DeLong, M. R. (1981) 
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus 
basalis. Ann Neurol 10, 122-126
232. Summers, W. K., Majovski, L. V., Marsh, G. M., Tachiki, K., and Kling, A. (1986) 
Oral  tetrahydroaminoacridine in long-term treatment  of senile  dementia,  Alzheimer 
type. N Engl J Med 315, 1241-1245
233. Savojardo,  C.,  Martelli,  P.  L.,  Fariselli,  P.,  Profiti,  G.,  and  Casadio,  R.  (2018) 
BUSCA:  an  integrative  web  server  to  predict  subcellular  localization  of  proteins. 
Nucleic Acids Res 46, W459-W466
234. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative 
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-
57
235. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment 
tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic 
Acids Res 37, 1-13
236. Stauffer, W., Sheng, H., and Lim, H. N. (2018) EzColocalization: An ImageJ plugin 
for visualizing and measuring colocalization in cells and organisms. Sci Rep 8, 15764
237. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., 
Preibisch,  S.,  Rueden,  C.,  Saalfeld,  S.,  Schmid,  B.,  Tinevez,  J.  Y.,  White,  D.  J., 
Hartenstein,  V.,  Eliceiri,  K., Tomancak,  P.,  and Cardona, A. (2012) Fiji:  an open-
source platform for biological-image analysis. Nat Methods 9, 676-682
238. Rueden, C. T., Schindelin, J., Hiner, M. C., DeZonia, B. E., Walter, A. E., Arena, E. 
T., and Eliceiri, K. W. (2017) ImageJ2: ImageJ for the next generation of scientific 
image data. BMC Bioinformatics 18, 529
239. Horn, T., and Boutros, M. (2010) E-RNAi: a web application for the multi-species 
design of RNAi reagents--2010 update. Nucleic Acids Res 38, W332-339
240. Yang, J. S., Nam, H. J., Seo, M., Han, S. K., Choi, Y., Nam, H. G., Lee, S. J., and  
Kim, S. (2011) OASIS: online application for the survival analysis of lifespan assays 
performed in aging research. PLoS One 6, e23525
241. Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., 
and Cox, J. (2016) The Perseus computational platform for comprehensive analysis of 
(prote)omics data. Nat Methods 13, 731-740
242. Perez-Riverol,  Y.,  Csordas,  A.,  Bai,  J.,  Bernal-Llinares,  M.,  Hewapathirana,  S., 
Kundu, D. J., Inuganti, A., Griss, J., Mayer, G., Eisenacher, M., Perez, E., Uszkoreit, 
J., Pfeuffer, J., Sachsenberg, T., Yilmaz, S., Tiwary, S., Cox, J., Audain, E., Walzer, 
M., Jarnuczak, A. F., Ternent, T., Brazma, A., and Vizcaino, J. A. (2019) The PRIDE 
database and related tools and resources in 2019: improving support for quantification 
data. Nucleic Acids Res 47, D442-D450
243. Desjardins, P., and Conklin, D. (2010) NanoDrop microvolume quantitation of nucleic 
acids. J Vis Exp 
244. Williams, B. D., Schrank, B., Huynh, C., Shownkeen, R., and Waterston, R. H. (1992) 
A genetic mapping system in Caenorhabditis elegans based on polymorphic sequence-
tagged sites. Genetics 131, 609-624
245. Timmons, L., and Fire, A. (1998) Specific interference by ingested dsRNA.  Nature 
395, 854
246. Lange,  S.,  Sylvester,  M.,  Schumann,  M.,  Freund,  C.,  and  Krause,  E.  (2010) 
Identification  of  Phosphorylation-Dependent  Interaction  Partners  of  the  Adapter 
150
Protein  ADAP  using  Quantitative  Mass  Spectrometry:  SILAC  vs  O-18-Labeling. 
Journal of Proteome Research 9, 4113-4122
247. Cox,  J.,  Hein,  M. Y.,  Luber,  C.  A.,  Paron,  I.,  Nagaraj,  N.,  and Mann,  M. (2014) 
Accurate  proteome-wide  label-free  quantification  by  delayed  normalization  and 
maximal peptide ratio extraction,  termed MaxLFQ.  Mol Cell Proteomics 13, 2513-
2526
248. Haslbeck,  M.,  and Buchner,  J.  (2015) Assays  to  characterize  molecular  chaperone 
function in vitro. Methods Mol Biol 1292, 39-51
249. Stiernagle,  T.  (2006)  Maintenance  of  C.  elegans.   (Community,  T.  C.  e.  R.  ed., 
WormBook
250. Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin,  
A.,  Le  Bot,  N.,  Moreno,  S.,  Sohrmann,  M.,  Welchman,  D.  P.,  Zipperlen,  P.,  and 
Ahringer,  J.  (2003)  Systematic  functional  analysis  of  the  Caenorhabditis  elegans 
genome using RNAi. Nature 421, 231-237
251. Evans, T. C. (2006) Transormation and microinjection.  (Community, T. C. e. R. ed., 
WormBook
252. Mello, C. C., Kramer, J. M., Stinchcomb, D., and Ambros, V. (1991) Efficient gene 
transfer in C.elegans: extrachromosomal maintenance and integration of transforming 
sequences. EMBO J 10, 3959-3970
253. Wilm, T., Demel, P., Koop, H. U., Schnabel, H., and Schnabel, R. (1999) Ballistic 
transformation of Caenorhabditis elegans. Gene 229, 31-35
254. Radman,  I.,  Greiss,  S.,  and  Chin,  J.  W.  (2013)  Efficient  and  rapid  C.  elegans 
transgenesis by bombardment and hygromycin B selection. PLoS One 8, e76019
8. Supplemental Information
Supplementary Figure 1: HSP-12.6 does not affect aggregation of MDH at 41 °C or 47 °C 
Static light scattering analysis of 500 nM MDH, alone (blue curves), or in the presence of 1 µM HSP-
12.6 (red curves). All  curves are averages of triplicate measurements. The same concentration of 
HSP-12.6 used, 2-fold / 1000 nM, was analyzed by itself under identical conditions (black curves). The 
buffer used was also analyzed (grey curves). Light scattering intensity is given in arbitrary units (au). 
Left side shows analysis at 41 °C, right side shows analysis at 47 °C.
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Supplementary Figure 2: HSPB5 does not affect aggregation of MDH at 41 °C 
Static light scattering analysis of 500 nM MDH, alone (blue curve), or in the presence of 1 µM HSPB5 
(red curve). All curves are averages of triplicate measurements. The same concentration of HSPB5 
used, 2-fold / 1000 nM, was analyzed by itself under identical conditions (black curve). The buffer used 
was also analyzed (grey curve). Light scattering intensity is given in arbitrary units (au).
Supplementary Figure 3: Hsp42 contains a prion-like domain 
Exemplary  analysis  of  Hsp42  by  PLAAC,  showing  that  Hsp42  contains  a  prion-like  domain  as 
previously  reported  (170).  See  Figure  14  for  a  comparison  of  HSP-17.  PLAAC calculated  a 
COREscore and an LLR (log-likelihood ratio) of 11,937.
152
Supplementary Figure 4: HSP-17 cannot be sedimented after heat treatment at 41 °C or 47 °C 
Sedimentation analysis of HSP-17 after heat treatment, at 41 °C or 47 °C. The soluble fraction (S) and  
the insoluble fraction (P) are shown side by side. The bands corresponding to HSP-17 (around 17  
kDa) are indicated. The relative intensity of the bands, quantified by Fiji and normalized to 100%, is 
tabulated below the gel. The numbers given are the result of 3 repeats of the same analysis, the gel 
shown is representative.
Supplementary Figure 5: Reactivation of luciferase is unaffected by addition of HSP-12.6 
Luciferase was aggregated by heat treatment. The disaggregation was carried out by the indicated 
molecular chaperones and measured by quantifying emitted light, normalized to native luciferase (blue 
curve). The same measurement was carried out with increasing concentrations of HSP-12.6 being 
added to  luciferase  before aggregation  (left  side),  or  (right  side)  for  the disaggregation  step  (red 
curves, darker shades of red indicate higher concentrations of HSP-12.6 as indicated in the legend). 
All data points are averages of triplicate measurements.
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Supplementary Figure 6: HSP-17 and PAB-1 do not colocalize in the pharynx 
Representative confocal LSM of  C. elegans  p17tG crossed with the strain DCD214 (expression of 
tagRFP-PAB-1 to the pharynx). Separate channels and combined channel are provided, as noted on 
the images. Scale bars are 20 µm.
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Supplementary Figure 7: HSP-17 and KIN-19 colocalize in the pharynx 
Representative confocal LSM of C. elegans p17tG crossed with the strain CF3166 (expression of KIN-
19-tagRFP controlled by the native promoter). Separate channels and combined channel are provided, 
as noted on the images. The pharynx of multiple nematodes was analyzed and quantification using the 
Fiji plugin EzColocalization yielded a PCC of 0,58 (standard deviation is 0,19) and an SRCC of 0,63  
(standard deviation is 0,08). A total of 9 nematodes were analyzed. Scale bars are 20 µm. 
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Supplementary Figure 8: HSP-17 does not colocalize with VIT-2 in the intestine 
Representative confocal LSM of C. elegans p17tR crossed with the strain DH1033 (expression of VIT-
2-GFP to the intestine).  Separate channels and combined channel are provided, as noted on the 
images. Scale bars are 50 µm. 
Supplementary Figure 9: HSP-17 shows limited colocalization with CHC-1 
Representative confocal LSM of C. elegans p17tG microinjected into the strain RT2676 (expression of 
tagRFP-CHC-1 to  the intestine,  chc-1 being a  C. elegans homolog  of  clathrin  heavy chain).  The 
arrows in  the third  frame are pointing to  foci  of  unique tagRFP-CHC-1 localization,  colocalization 
between both in the upper intestine, and unique HSP-17-GFP localization. Separate channels and 
combined channel are provided, as noted on the images. Scale bars are 20 µm. 
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Supplementary Figure 10: HSP-17 shows infrequent colocalization with RAB-7
Representative confocal LSM of C. elegans p17tR crossed with the strain RT476 (expression of GFP-
RAB-7 to the intestine). The arrows are pointing to a vesicle like structure where HSP-17-wrmScarlet 
and GFP-RAB-7 colocalize. Separate channels and combined channel are provided, as noted on the 
images. Scale bars are 20 µm. 
Supplementary Figure 11: Western blotting of C. elegans strain mA lysates
A: Western blotting of JKM7 lysates with 6E10 antibodies to detect wrmScarlet-A1-42 (around 35 kDa) 
and A1-42  (around 10 kDa). Three experiments of independent sample nematodes are provided and 
the  unlabeled  A moiety  appears  to  be  in  abundance  (by  about  5-fold  as  quantified  by  Fiji).  B: 
analogous analysis of the same strain with the same method (two independent nematode groups, 
analyzed in parallel). The labeled A moiety appears to be in excess.
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Supplementary Figure 12: Vector map of pSumo 
A  vector  map  of  pSumo,  used  for  expression  of  His-SUMO-tagged  recombinant  proteins.  The 
restriction sites for NotI and BsaI used for molecular cloning are indicated, as are the location of the 
6xHis-tag and T7 promoter regions. The vector carries an ampicillin resistance gene.
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Supplementary Figure 13: Vector map of pPD95.77 
A vector map of pPD95.77, used as a vehicle to enter transgenes into C. elegans. The CDS of GFP 
used for the generation of reporter strains (and sometimes replaced with wrmScarlet), is indicated, as 
are  notable  restriction  sites  used  for  molecular  cloning  of  my  constructs.  The  vector  carries  an 
ampicillin resistance gene.]
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Supplementary Figure 14: Vector map of pL4440 
A vector map of L4440, used to transform  E. coli HT115 for RNAi-feeding in  C. elegans.  Notable 
restriction sites used for molecular cloning of my constructs are indicated, along with the T7 promoter  
sites used for transcription of dsRNA. The vector carries an ampicillin resistance gene. 
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11. Data availability
11.1. Image data of translational hsp-17 reporter strains
Z-stack  images  of  the  HSP-17  transgenic  animals  (phsp-17::hsp-17::wrmScarlet) 
have been deposited on the Zenodo platform to provide a comprehensive dataset on 
the expression of  HSP-17 in  the whole body,  the head region and the tail.  DOI: 
10.5281/zenodo.3594412
11.2. Proteomics data generated from IP-MS/MS analysis of HSP-17
The  mass  spectrometry  proteomics  data  have  been  deposited  to  the 
ProteomeXchange  Consortium  via  the  PRIDE  (242) partner  repository  with  the 
dataset  identifier PXD016485.  Supplementary table 1 (provided as digital  content) 
contains  a  list  of  MS/MS  experimental  parameters,  the  peptides  detected,  the 
identified proteins and the evaluation thereof (by  Perseus) as carried out by Heike 
Stephanowitz, modified for accessibility and a condensed list of resulting proteins, 
sorted by relative enrichment over control (proteins used for DAVID analysis marked 
in red). A complete list of GO terms identified by DAVID was also included.
11.3. Proteomics data generated from IP-MS/MS of mA & nA
The proteomics data generated by mass spectrometry have been deposited to the 
ProteomeXchange  Consortium  via  the  PRIDE  (242) partner  repository  with  the 
dataset  identifier PXD017590 (mA)  &  PXD017591 (nA).  Supplementary  table  2 
(provided  as  digital  content)  contains  an  exhaustive  list  of  the  experimental 
parameters of the MS/MS experiment, peptides detected, the identified proteins and 
the  evaluation  thereof  (by  Perseus)  as  carried  out  by  Heike  Stephanowitz  and 
modified for accessibility. For mA, a complete list of GO terms identified by DAVID 
from significantly enriched hits was also included.
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